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Saponins are high molecular weight glycosides that composed of a sugar 
moiety (glycone) and a steroid or triterpenoid moiety (aglycone). Polyphyllin D is a 
steroid saponin, which can be found in the Traditional Chinese Medicine (TCM) 
Paris Polyphylla. It was organic synthesized and was nomenclatured as Hong Kong 
compound 18 (HK18). In this project, we have studied the anti-tumor activities and 
the action mechanisms of HK18 on human hepatocellular carcinoma cell line HepG2 
and multidrug resistant cell line R-HepG2. 
By MTT and tryphan blue exclusion assays, we have found that HK18 was 
cytotoxic to both HepG2 and R-HepG2 cells in a dose and time dependent manner. It 
was less toxic to normal tissues as demonstrated by incubating with macrophages 
and in vivo study. And low concentrations of HK18 only induced a very small 
percentage of hemolysis. 
HK18 could induce apoptosis as illustrated by DNA fragmentation and 
phosphatidylserine extemalization on both cancer cell lines. It could induce 
mitochondrial membrane potential (Wm) depolarization in a dose dependent manner. 
Addition of the inhibitor of mitochondrial permeability transition (MPT), Bongkrekic 
acid could lower the cytotoxic effect of HK18. By using flow cytometry, it has been 
found that intracellular hydrogen peroxide and calcium levels were enhanced in 
HK18-treated HepG2 and R-HepG2 cells which are the mediators of MPT. 
Besides, caspase 3 was activated in HK18-treated HepG2 and R-HepG2 
cells as indicated by Western blot with decreased pro-caspase 3 level and increased 
PARP cleavage in a dose and time dependent manner in both cancer cell lines. It was 
further confirmed by enzymatic assays. Both of caspase 3 and caspase 9 enzymatic 
activities were enhanced while caspase 8 activity remained unchanged. 
Apart from this, the release of apoptogenic proteins from mitochondria of 
HK18 treated HepG2 cells was examined. Cytochrome c and apoptosis inducing 
factor (AIF) have been found to be released upon treatment. 
Furthermore, the effects of HK18 on the Bcl-2 family were analyzed. It has 
been found that the anti-apoptotic protein Bcl-2 level decreased in a dose dependent 
manner as assessed by Western blot analysis on the two caner cell lines. Besides, 
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Abstract 
RT-PCR was employed to study at the mRNA level. It has been found that HK18 
could lower the anti-apoptotic bcl-2 and bcl-XL levels but no effect on the 
pro-apoptotic gene bak of HepG2 cells. 
The effect of HK18 on the expression of P-glycoprotein (P-gp) in R-HepG2 
cells was investigated. It has been found that treating R-HepG2 cells with HK18 
would down-regulate the expression of P-gp gradually. In combining with the neutral 
property of HK18, we proposed that HK18 was not a substrate of P-gp. 
In sum, HK18 can induce both HepG2 cells and R-HepG2 cells to undergo 
apoptotic cell death. The possible action mechanism involves the mitochondrial-
dependent apoptotic pathway. 
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摘 要 
脑 亜 
] 同 女 
兽式（又名县素或黃酮甘)是高分子量的配醣,它由醣及固醇配醣基或三 
醇配醣基所組成。從七葉一枝花中可提煉出一種名爲笛體官武(polyphyllin D )的 
固醇類兽戒；透過有機合成方法我們合成了這種留體兽武並稱之爲Hong Kong 









Membrane Potential, Wm)隨劑量而下降。我們發現線粒體滲透轉移的抑壓劑 
Bongkrekic acid能降低HK18的毒性，另外HK18能提升細胞內的線粒體滲透轉 
移中介物過氧化氫及離子的濃度。 
而透過西方轉漬法（Western B l o t )，我們發現H K 1 8會刺激H e p G 2及 
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Chapter 1 Introduction 
1. INTRODUCTION 
In these few decades, the medicinal and pharmacological effects of natural 
products aroused a great interest for scientists. It is because they possess diverse 
pharmacological effects such as hypolipidemic, anti-platelet, anti-tumor and 
immunomodulatory activities with relatively low side effects. These biological 
activities are useful in reducing the risk of cardiovascular disease and cancer 
development, which are the leading causes of death worldwide (Craig, 1999; 
Gerber et al., 2002; Wargovich, 1999; Kucuk, 2002). From these natural products, a 
wide variety of phytochemicals have been identified. For example, flavonoids of 
many edible plants such as green tea and citrus have been proven to exhibit 
anti-tumor activities, anti-inflammation and cardiovascular protective activities 
(Kris-Etherton and Keen, 2002; Manthey et al., 2001; Riemersma et al., 2001). 
Polyphenolics such as reseveratrol from grapes and red wine have been found to 
possess anti-tumor activities and can inhibit oxidation of low density lipoprotein and 
hence reduce the risk of atherosclerosis and coronary heart diseases (Frankel et al., 
1993; Surh et al., 1999; Jang et al., 1997). Apart from these, other active components 
from natural products such as lignans, plant sterols, curcumins, coumarins and 
saponins also have significant health promoting activities (Craig, 1999). Among 
these phytochemicals, saponin is one of the focuses. It is because saponins exhibit 
diverse biological activities and can be found in many plants that we consume. 
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1.1 Characteristic of Saponins 
Saponins are high molecular weight glycosides, which comprise of two main 
parts: a saccharide moiety linked with a steroid or triterpene group. They can be 
found in many plants and some marine animals. Some of them are surface active and 
hence used as detergent for centuries. The common feature of forming soapy lather 
when shaken with water was used as a primary method in determining the presence 
of saponins (although some saponins do not form lather with water). Actually the 
name "saponin" is derived from the Latin word "sapo" which means soap 
(Hostettmann and Marston，1995a) 
1.1.1 Occurrence of Saponins 
Saponins are widely distributed in the plant kingdom. They can be found in 
many plants, which are consumed by human beings. For examples, soybeans, 
peanuts, broad beans, kidney beans, garlic, potatoes, tomatoes，onions, tea (Oleszek， 
2000) and some Traditional Chinese Medicine (TCM) such as Panax ginseng. 
Besides, they are found in different parts of a plant including roots, shoots, flowers 
and seeds. Some marine animals particularly the echinoderms such as sea cucumbers 
and starfishes also contain saponins (Hostettmann and Marston, 1995b). 
1.1.2 General Properties of Saponins 
1.1.2.1 Emulsifying Agents 
Saponins are amphiphilic in nature. The steroid or triterpene group is 
responsible for the hydrophobic property while the saccharide moiety contributes to 
the hydrophilic character. Therefore, saponins are surface active and form micelles in 
- 3 -
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the same way as detergents (Hostettmann and Marston, 1995d). 
1.1.2.2 Forming Complex with Cholesterol 
Saponins can form complex with cholesterol, lecithin, ergosterol, phenols and 
thiophene (Hostettmann and Marston, 1995d). Systematic studies on the ability of 
saponins to complex with cholesterol have been carried out. This saponin-cholesterol 
complex formation property is making use of vaccination, which will be discussed 
later. 
1.1.2.3 Hemolytic Property 
Some of the saponins are hemolytic. The emulsifying nature of saponins 
reduces the surface tension of the aqueous and lipid phases of red blood cell 
membrane, which leads to departure of lipids from the membrane. Hence, the red 
blood cell membrane becomes permeable and allows water and Na+ influx and K+ 
ions to leave. Finally, membrane rupture and hemoglobin leaks out (Hostettmann and 
Marston, 1995d). Incubating the saponin of interest with red blood cells and then 
measuring the amount of hemoglobin released can be used to study this property. The 
higher the hemolytic activity, the larger the amount of hemoglobin released. The 
hemolytic activity varies considerably with the structure of glycoside. In general, 
hemolytic activity of saponins decreased with the length and the branching of the 
sugar chain (Romussi et aL, 1980). 
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1.1.3 Structure of Saponins 
Saponins are high molecular weight glycosides, which consist of two main 
parts. A polycyclic backbone linked with a saccharide moiety via ether or ester 
linkage. The non-saccharide or aglycone part is called sapogenin. Structural 
variations of saponins mainly lie in the attachment of different saccharide group to 
the sapogenin. Actually saponins can be divided into two categories based on the 
structure of sapogenin. They are triterpene saponins and steroid saponins 
(Hostettmann and Marston, 1995a). 
1.1.3.1 Categories of Saponins 
1.1.3.1.1 Triterpene Saponins 
In the world, most saponins found belong to this category. They have been 
found in many families of plants such as Leguminosae and Araliaceae (Hostettmann 
and Marston, 1995b) (Fig. 1.1 A). 
1.1.3.1.2 Steroid Saponins 
Steroid saponins are relatively less abundant than triterpene saponins. They 
have been found in the family of Liliaceae, Agavaceae as well as Dioscoreaceae 
(Hostettmann and Marston, 1995b). And the herb genera commonly used in China 
that contain steroid saponins as active component include Dioscorea, Paris, 
Polygonatum, Ophiopogon and Allium (Yu and Hui, 20021). They are further 




Chapter 1 Introduction 
； : < 
A 1 I 
I 
B ^ ^ ^ 
HO 
c � 
Fig 1.1 Basic structures of saponins. (A) Triterpene saponin. (B) Spirostan steroid 
saponin and (C) Furostan steroid saponin. 
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1.1.3.2 Monodesmosidic and Bidesmosidic Saponins 
The sapogenin can be linked with one or two saccharide chains, which are 
called monodesmosidic and bidesmosidic saponins (Greek desmos = chain) (Oleszek, 
2000). For the one linked with one saccharide at the C-3 position is known as 
monodesmosidic saponins. While bidesmosidic saponins have two saccharide chains 
with one normally attached at the C-3 position and another at the C-28 position for 
triterpene saponins or at the C-26 position for the furostanol steroid saponins 
(Hostettmann and Marston, 1995a; Oleszek, 2000) (Fig. 1.2). 
The saccharide moiety can be either linear or branched and the most common 
saccharides found are D-glucose, D-galactose, D-glucuronic acid, D-galacturonic acid, 
L-rhaminose, L-arabiose, D-xylose and D-fUrose (Hostettmann and Marston, 1995a). 
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Fig 1.2 Basic structures of monodesmosidic and bidesmosidic saponins. 
(A) Tritepene saponins. (B) Steroid Saponins 
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1.1.4 Biological and Pharmacological Properties of Saponins 
Saponins have a variety of biological and pharmacological activities such as 
anti-microbial, spermdicidal and anti-tumor activity. 
1.1.4.1 Anti-microbial Activity 
Since saponins are widely distributed in plants, it seems that they play a vital 
role in their producer. Researches have found that they protect the plant from 
microbial invasion including fungal, bacterial and viral infections (Hostettmann and 
Marston, 1995d; Hostettmann and Marston, 1995c). The saponin content of the plant 
usually increases in the region under attack. It has been proposed that during 
invasion, the water soluble inactive form of saponin will transports to the infected 
region where it converts into the active form and acts on the microbial (Hostettmann 
and Marston, 1995d). 
1.1.4.1.1 Anti-fungal Activities 
Studies indicated that there are many fungal species respond to the 
anti-fungal activities of saponins such as Phytophthora cinnamoni and Rhizopus 
mucco (Zablotowicz et aL, 1996; Timberkova et al, 1996). The mechanism of how 
saponins kill the fungi has not yet been determined, but it was proposed that saponins 
interact with the fungal membrane components such as sterols, proteins or 
phospholipids and hence destroy the cellular semi-permeability and leading to death 
(Gruiz, 1996; Osboum et al.’ 1996). Recently, scientists have been trying to apply 
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1.1.4.1.2 Anti-bacterial Activities 
Several saponins have anti-bacterial activities. In general, the potency of 
steroid saponins is higher than tritenepene saponins and gram positive bacteria are 
more sensitive than gram negative bacteria (Oleszek, 2000; Hostettmann and 
Marston，1995d). 
1.1.4.1.3 Anti-viral Activities 
It has been found that some saponins can reduce viral infection and possibly 
by acting on one or more steps of the viral replication cycle and inhibit vims-host 
cell attachment (Hostettmann and Marston, 1995d). Enveloped virus is generally 
more sensitive than naked vims (Oleszek, 2000). The viruses, which can be inhibited 
by saponins such as glycyrrhizin (甘草)(Hasegawa et al., 1994), include Herpes 
simplex virus, poliovims (Oleszek, 2000) as well as human immunodeficiency vims 
(HIV) (Oleszek, 2000). 
1.1.4.2 Insecticide Activity 
Reports have shown that some saponins are insecticidal. For example, some 
woods are resistant to termite attack due to the presence of saponins (Hostettmann 
and Marston, 1995d; Tava and Odoardi, 2002). 
1.1.4.3 Molluscicidal Activity 
Some saponins are toxic to the organisms, which use gills for breathing such 
as fishes and frogs. Binding of the saponins to the gill membrane will increase its 
permeability and cause the losses of important physiological electrolytes 
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(Hostettmaim and Marston, 1995d). Besides, some saponins are toxic to mollusk 
such as snails. This property has been made use of to control the schistosomiasis, a 
parasite disease that affects millions of people in South America, Africa and Asia. 
Snail is required as the vector for this parasite (Hostettmaim et al., 2002; Thiilborg et 
al., 2002). By eliminating the vector, the spreading of the parasite can be controlled. 
1.1.4.4 Hypocholestrolemic Activity 
Studies have found that consumption of saponins can reduce the amount of 
cholesterol in circulation and tissues (Hostettmann and Marston, 1995d). They form 
insoluble complex with cholesterol, hence intestinal absorption of both endogenous 
and exogenous cholesterol is prohibited. Besides they form mixed micelles with the 
enterohepatic circulating bile acids and thus inhibit their reabsoiption from the 
terminal ileum (Oakenfull, 2001). A study has shown that the saponin fractions of 
garlic lowered the plasma total cholesterol and LDL-cholesterol levels in a 
hypercholesterolemic animal model and hence reduced the risk of cardiovascular 
disease (Matsuura, 2001). 
1.1.4.5 Anti-ulcer Activity 
Most of the gastric ulcer is emerged when gastric acid or pepsin is 
over-secreted or the protective mucosal lining barrier is weaken. Some saponins 
possess anti-ulcer activity by promoting mucus formation or directly activating the 
gastric membrane protective factors (Hostettmann and Marston, 1995d). For example, 
the saponins isolated from the rhizome of Panax japonicus have been demonstrated 
to have gastro-protective properties (Borrelli and Izzo, 2000). Actually, a patent 
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anti-ulcer tablets contains quillaiasaponins (Hostettmann and Marston, 1995d). 
1.1.4.6 Contraceptive Activity 
Recently, numerous of medicinal plants have been investigated for their 
anti-fertility activity in order to find out a new source of conceptive agents. It has 
been found that some of saponins such as those from Mollugo pentaphylla and 
Acacia auriculiformis are potential contraceptive agents due to their spermicidal and 
sperm immobilizing activity (Garg et aL, 1994; Rajasekaran et aL, 1993; Pakrashi et 
aL, 1991; Dhar^^ aL, 1989). 
1.1.4.7 Immunomodulatory Activities 
It is well known that the immune system plays an important role in 
maintaining health of an organism. For example, patients of human 
immunodeficiency disease (HIV) are far easier to die from complications since their 
immune systems are defective. Therefore, a substance, which is able to improve the 
immune system, is a useful agent and many saponins have found to exhibit 
immunomodulatory activity. 
1.1.4.7.1 Direct Immunostimulation 
In vitro studies have shown that some saponins are able to induce the 
proliferation of both B- and T-lymphocytes directly as well as potentiate the 
mitogenic responses of T cells and B cells toward phytohemagglutinin (PHA), 
concanavalin (ConA) and lipopolysaccharides (LPS) (Chavali et aL, 1987; Calis et 
aL, 1997; Lacaille-Dubois et aL, 1993). One of the saponins isolated from Panax 
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ginseng has been found to induce T-helper cells production (Kenarova et al., 1990) 
and natural killing cell activity (Kenarova et al, 1990; Zhang et al., 1990). Moreover, 
it has been reported that phagocytosis of macrophage and interleukin-1 production 
could be enhanced by saponins (Kenarova et al., 1990; Plohmann et al., 1997). For in 
vivo studies, saponins could promote spleen lymphocytes proliferation in mice (Xu et 
al., 1992) and increase the phagocytotic activities of peritoneal macrophages 
including spreading activity, phagocytosis, lysomal enzyme activity and intracellular 
killing activity (Lacaille-Dubois, 1998). 
1.1.4.7.2 Acting as Immuno-adj uvants 
Apart from direct immunostimulation, saponins can be used as vaccine 
adjuvants. Traditionally, vaccines are made of live-attenuated or inactivated whole 
bacteria or viruses. Although the microorganisms are inactivated, the recipients still 
have the risk of developing side effects and in some rare cases may cause death. 
Immunosuppressed patients are more prone to such risks. Thus, the new generations 
of vaccines are made of antigen subunits either derived from the pathogens or 
prepared by molecular, biological or chemical techniques. These preparations are 
much safer but they are less immunogenic. To solve this problem, immuno-adjuvants 
are used. An immuno-adjuvant is any substance that enhances the immune response 
to an antigen with which it mixed. Saponins are one of the classes of adjuvants used 
nowadays. 
The most well known and widely used saponin-type adjuvant are derived 
from the inner bark of the South American soap tree, Quillaja saponaria 
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(Lacaille-Dubois, 1998). For example, in the presence of Quillaja saponin, rabies 
vaccine stimulates significantly higher serum neutralizing antibody responses than 
orally administered the vaccine alone (Chavali et al, 1988; Chavali and Campbell, 
1987). Also, there was increased T-helper and B cell co-operation and hence 
enhanced antibody production. Moreover, it may act by induction of gamma 
interferon release (Lacaille-Dubois, 1998; Sasaki et al., 1998). 
Besides, saponins are used to synthesize immune stimulating complex 
(ISCOM) by making use of their cholesterol-binding characteristic (Lacaille-Dubois, 
1998). ISCOM is an immuno-adjuvant which is made by mixing cholesterol, 
phospholipids and Quillaja saponins in a ratio of 1 : 1 : 5. The complex forms a 
cage-like structure with hydrophobic inner space. Thus, the hydrophobic part of an 
antigen can be inserted into the structure with hydrophilic part stay outside the 
complex (Lacaille-Dubois, 1998) (Smith et al., 1999). 
1.1.4.8 Anti-tumor Activity 
Apart from the biological functions mentioned in the above paragraphs, the 
anti-tumor activities of saponins have arouse a great interest to scientists since cancer 
is the most leading cause of death in the world. Actually cancer development is a 
complicated process. It involved three main stages, which are initiation, promotion 
and progression. The tumor cannot be reversed once it is established. Thus, 
compounds that can inhibit tumor initiation and promotion are useftil anti-tumor 
agents and are regarded as chemopreventive agents. 
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1.1.4.8.1 Anti-carcinogenesis 
Panax ginseng C. A. Meyer C人參)，which belongs to the Araliaceae family, 
is a famous TCM and is believed to prolong，strengthen life and invigorate bodies. 
Actually it has been reported that ginseng has modulatory effect on central nervous 
system, cardiovascular system, endocrine system and immune system. Recently, 
researchers have found that one of the active components is saponin. The triterpene 
saponins isolated from ginseng exhibit anti-tumor promoting activities as 
demonstrated by the two-stage mouse hepatic carcinogenesis test by using the 
initiator N-nitrosodiethylamine and the promoter phenobarbital (Konoshima et al,, 
1999) as well as in the two-stage mouse skin carcinogenesis test by using 
peroxynitrite as initiator and 12-(9-tetradecanoylphorbor-13-acetate (TPA) as | 
promoter (Konoshima et al., 1999). In addition, ginseng saponins metabolites were 
able to inhibit the tumor initiating activity of the well-known tumor initiator 
benzo[a]pyrene (B[a]P) (Lee et al., 1998). And apart from ginseng saponins, 
saponins from other TCM and natural products also exhibit potent 
anti-carcinogenesis activity. For example, the saponins from leguminous plants 
inhibit cancer development in the two-stage mouse skin carcinogenesis test with 
7,12-dimethylbenz[(2]anthracene as initiator and TPA as promoter (Hanausek et aL, 
2001). And other steroid saponins such as Lilium speciosum (靈糸工鹿子百合)have 
been found to inhibit the promoting activity of the tumor promoter TPA as well 
(Nakamura et aL, 1994). Moreover, the crude extracts of some TCM which are rich 
in saponins such as Paris polyphylla (七葉一枝花）have found to inhibit the 
tumor-initiating activity of B[a]P and picrolonic acid (Lee and Lin, 1988). 
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1.1.4.8.2 Suppression of Tumor Growth 
Nowadays, there are several approaches in treating cancer. They are surgical 
removal of the tumor, radiation and administered of chemotherapeutic drugs to kill 
the cancer cells. Apart from killing the cancer cells, most of the chemotherapeutic 
drugs also exert toxic effects on normal tissues. Thus researchers keep on finding 
substitution and much attention was paid on natural products because they usually 
possess fewer side effects relatively. Many studies have found that some saponins 
have anti-tumor activities (Rao and Sung, 1995). For example, some of the ginseng 
saponins and their metabolites were cytotoxic to several cancer cell lines including 
prostate cancer LNCaP cells, human myeloid leukemia HL-60 cells, pulmonary 
adenocarcinoma PC-14 cells, gastric adenocarcinoma MKN-45 cells and human | 
hepatocellular carcinoma HepG2 cells (Lee et al., 1999). Moreover, they have been 
j 
found to induce apoptosis in hepatocellular carcinoma cell line SK-HEP-1 cells (Kim 
et al., 1999b) as well as brain tumor rat C6 gliomal cells (Kim et al., 1999a). The 
occurrence of apoptosis in saponins-treated cells was demonstrated as morphological 
change, DNA fragmentation, appearance of sub-Gl peak in PI staining of flow 
cytometric analysis (Lee et al., 2000) and the mechanism of apoptosis including 
caspase 3 activation (Lee et al., 2000; Liu et al., 2000; Park et al., 1997)，cytochrome 
c release (Lee et al., 2000) and over-expression of p53 protein (Kim et al., 1999b). 
On the other hand, some studies have found that the bcl-2 protein level was 
down-regulated (Liu et al., 2000) while some studies found that they were bcl-2 
independent (Kim et al, 1999a). Apart from these, soybean saponins and steroid 
saponins from Lilaceae plants also have anti-tumor activity on several cancer cell 
lines including HL-60 cells and human T-lymphocyte leukemia MOLT-4 cells 
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(Hirano et ai, 1996; Qian et al” 1999). Furthermore, two steroid saponins extracted 
from Cordyceps sinensis (冬蟲夏草）inhibited the proliferation of several cancer cell 
lines including HL-60 cells, erythroleukemia K562 cells, T-lymphoblastic Jukat cells, 
malignant melanoma WM1341 cells and multiple myeloma RPMI 8226 cells (Bok et 
al., 1999). 
Besides of inducing apoptosis, some saponins can induce cell cycle arrest. 
The saponins of the bulbs of Ornithogalum saundersiae, a Liliaceae family plant 
j 
have been found to induce cell cycle arrest at the G2 / M phase of HL-60 cells (Lee j 
i 
and Lin, 1988). And ginseng saponins have been found to induce cell cycle arrest at 
i 
the G1 / S phase with down-regulation of cyclins E- and A-dependent kinase | 
activities (Kim et al, 1999b). 
i I 
In the later phase of cancer, the tumor cells may gain invasive power and 
leave the primary tumor site and invade other organs or tissues. This process is 
i 
I 
known as metastasis. Actually metastasis is the major cause of death in cancer 
patients. Thus agents, which can reduce the occurrence of metastasis, can save many 
lives. Recent studies found that several saponins could reduce metastasis both in 
vitro and in vivo (Mochizuki et al., 1995; Shinkai et al., 1996). And they could 
inhibit angiogenesis, formation of new blood vessel, a process that is important for 
the growth of tumor (Shinkai et al., 1996). 
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1.1.5 Anti-tumor Activity of Steroid Saponins 
From these studies, it indicated that some saponins possess anti-tumor 
activities in various respects. And it seems that steroid saponin is a potential 
candidate for cancer treatments. Since they are originated from natural products, 
which are used for medicinal purposes with a long history, most probably have lower 
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合禾斗)are the most abundant sources of steroid saponins (Hostettmann and Marston, j 
li li 丨i 
i I 
1995b). Saponins isolated form these families share the same steroid aglycone called 
diosgenin, which linked with various saccharide side chains. The rhizomes of | 
Dioscorea collettii var. hypoglauca (紛背薯蕷)are used in the TCM “ Fen Bei Bi 
！ 
I 
Xie" for the treatment of cervical carcinoma, carcinoma of urinary bladder and renal 
tumor in China (Hu et aL, 1999). It was included in the Pharmacopoeia of People's 
Republic of China (1990 version). A study has found that the steroid saponins 
isolated from this medicine were anti-neoplastic (Hu et al” 1999). 
1.1.5.2 Hong Kong Compounds 
Diao Xin Xue Kang (地奧乂 L�血康）is a cardioprotective drug commonly used 
in China. From this drug, several diosgenin saponins were isolated and were organic 
synthesized which we named as Hong Kong Compounds (HK) 3, 5 and 9. Under the 
kind co-operation with Professor Yu Biao (俞飈）of the Shanghai Institute of 
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Organic Chemistry, Chinese Academy of Science, a series of HK compounds were 
synthesized based on the structure of the HK compounds found in Dio Xin Xue Kang. 
There are totally fifteen Hong Kong compounds synthesized. All these HK 
compounds share the same diosgenin aglycone linked with various structures of 
saccharide chains (Fig 1.3). 
The HK compounds were total organic synthesized (Deng et al., 1999; Li et 
al., 2001) in the form of powder and were stored at 4®C. They were dissolved in ^ I 
DMSO and then diluted with buffer for studies. The stock solution was kept and used 丨 
within two weeks. In order to study the potency of the HK compounds, 2 |iM of each ； 
HK compounds were used to incubate with HepG2 cells and HL-60 cells for 24 I I hours for screening. Moreover, the HK compounds were incubated with the normal j ：! I 
Lung fibroblast cell line WI-38 cells to study their toxicity. After incubation, MTT [ 
assay was carried out. We have found previously in our laboratory that all the 
saponins were non-toxic against WI-38 cells. And among the derivatives, HKl 8 
I 
possessed the most cytotoxic effects on both cancer cell lines (data not shown). 
Therefore, we chose HKl 8 for further study. 
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1.1.5.3 Hong Kong 18 
Actually HKl8 (scientific name polyphyllin D) can be found in the Chinese 
herbal drug Yunan Bai Yao (雲南白薛）and the Liliaceae family plant Paris 
polyphylla (七葉一枝花）(Deng et al., 1999; Ravikumar et al., 1979) (Fig 1.4). It has 
been found that polyphyllin D was cytotoxic to leukemia P-388, lymphocytic 
leukemia L-1210 and human nasopharynx tumor 9KB cell lines (Ravikumar et al., 
1979). Paris polyphylla was used as folk medicine in China. The rhizome of the 
plant is known as Chong-lou (重樓）and was prescribed to cure mastitis, sore throat, : 
[ 
1 
convulsion and tubeculous meningitis etc. Also, it is used to treat tumors of [ 
I 
respiratory system, digestive tract, liver, pancreas, urinary bladder, brain and i 
leukemia (http:IIwww.healthphone.com). Scientific researches have found that it 丨 
exhibited several pharmacological activities including anti-inflammatory, spermicidal, 
hemostatic, anti-bacterial, sedative, analgesic and anti-tumor activities. In fact, Paris ^ 
i 
polyphylla is commonly used to treat liver cancer as well as nose and throat cancers , 
in China (http://www.brave-souls.com/resQiirces/cancerl3.html). 
i 
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國•丨 
I 
Fig 1.4 Photographs of Paris Polyphylla, 
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The systematic name of polyphyllin D (HKl8) is diosgenyl a 
-L-rhamnopyranosyl-(l 2)-[( a -L-arabinofuranosyl-(l -> 4))- 冷 
-D-glucopyranoside (Fig 1.5). It was synthesized by Professor Yu Biao by the means 
of stepwise glucosylation (Deng et al., 1999; Li et al., 2001). Its molecular formula is 
C44H72O16 and molecular weight is 855.02. Since it is an amphiphilic compound, it is 
not soluble in water but soluble in DMSO and y -cyclodextrin. We made use of 
these solvents to prepare HKl 8 solutions for studying the anti-tumor effect of HKl 8 
on human hepatocellular carcinoma cells. 
/ O H 
o 备 。 ^ ^ 
h � � 1 h 4 � h 
H O - ^ OH 
Fig 1.5 Structure of Hong Kong 18 (polyphyllin D). 
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1.2 Human Hepatocellular Carcinoma (HCC) 
1.2.1 The Incidence of Liver Cancer 
In Hong Kong, the most leading causes of death are malignant cancer, heart 
diseases and cerebrovascular diseases. Among these leading causes, malignant 
cancer is the number one killer, which accounted for around 32 % of mortality. And 
among the different kinds of cancer, liver cancer is the second commonest 
(http://www.ha.org.lik/hesd/nsapi). 
1.2.2 Classification of Liver Cancer 
There are two classes of adult primary liver cancer; they are hepatocellular 
carcinoma ( H C C ) ( 肝 細 胞 癌 ） a n d cholangioma ( 膽 管 瘤 ） 
(http://www.cancerbacup.org.uk/info/liver.htm). Cholangioma is derived from 
intrahepatic biliary epithelial cells which accounted for around 13 % of liver cancer. 
While HCC is originated from liver parenchymal cells (hepatocytes), which accounts 
for around 75 % of liver cancer 
(http://health.yahoo.com/health/cancer—center/acs—crc/liver—cancer/index.html). 
HCC is often extensively invasive or multicentric, hence it is difficult for 
surgical removal And it is positively associated with hepatitis B and C infection, 
liver cirrhosis and exposure to aflatoxin (the toxin produced by the mould of peanuts). 
It causes about one million of deaths worldwide per year. And since the incidence 
rate of hepatitis in Asia is high, the occurrence of HCC in Asia is higher than the 
Western countries. It is no doubt that HCC causes a great loss to us; thus, it is need 
to search new remedies for its treatment. 
- 2 4 -
Chapter 1 Introduction 
1.2.3 Human Hepatocellular Carcinoma Cell Lines 
1.2.3.1 Human Hepatocellular Carcinoma Cell Line HepG2 
In my research project, the human hepatocellular carcinoma cell line HepG2 
was employed for studies. HepG2 cells are epithelial in shape and resemble liver 
parenchymal cells morphologically. Fig 1.6 shows the electron microscopy of the 
cells (Miyazaki and Namba, 1994). 
:I  
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m 
Fig 1.6 Photograph showing the electron microscope of human hepatocellular 
carcinoma cell line HepG2 (Adapted from Miyazaki and Namba，1994). 
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1.2.3.2 Multidrug Resistant Human Hepatocellular Carcinoma Cell Line 
R-HepG2 
Apart from HepG2 cells, multidrug resistant HepG2 cell line (R-HepG2) was 
also used. This cell line was developed in our laboratory by incubating HepG2 cells 
with stepwise increasing concentrations of Doxorubicin as will be introduced in the 
material and method chapter. The established cell population possesses 
over-expressed p-glycoprotein as demonstrated by Northern Blot and Western Blot 
analysis (Chan et al., 2000). Besides, this cell line has shown to become multidrug 
resistant including resistant to the cytotoxic effects of Doxorubicin, Vincristine and 
Methotrexate (Chan et al, 2000). 
Multidrug resistance (MRD) is the avoidance of tumor cells from the actions 
of a numerous chemotherapeutic drugs differing in chemical structures and action 
mechanisms. Treatment of cultured cells with a single anti-tumor drug resulted in the 
establishment of a cell population, which resist to numerous unrelated drugs, i.e. 
cross-resistance (Stavrovskaya, 2000). Table 1.1 listed the families of anti-tumor 
drugs that have been found to be resistant by MDR with their action mechanisms. 
Families of anti-cancer , Example of drugs Action mechanisms drugs 
Anti-cancer antibiotics Doxorubicin Topoisomerase inhibition 
. , 1 Inhibition of enzymes participating in Anti-metabolites Methotrexate DNA and RNA synthesis 
Drugs derivated from Vinca alkaloids , , . . • � Microtubules disassembling plants (Vincristine) 
Table 1.1 Families of anti-tumor drugs and their action mechanisms. 
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1.2.3.2.1 Mechanisms of Multidrug Resistance (MDR) 
The emergence of multidrug resistance (MDR) of tumor cells is the major 
barrier for cancer chemotherapy. Some tumor cells are intrinsic MDR that means the 
cells are already resistant to anti-cancer drugs before treatment. This type of MDR 
may happen in some genetically pre-disposed tumor cells or due to the location of 
the tumor. For example, brain tumors are resistant to chemotherapy due to the 
blood-brain barrier (Stavrovskaya, 2000). 
On the other hand, some tumor cells acquire MDR during anti-cancer 
treatments. There are several mechanisms that cause the cells to become MDR. First 
of all, the detoxification enzymes may be activated such as superoxide dismutase and 
the glutathione detoxification system e.g. glutathione S-transferase. And the genes 
involved in the control of apoptosis such as p53 and Bcl-2 may alter. Moreover, 
alternation of drug targets or enhancement of target repair may occur. For example, 
topoisomerase II inhibitors act on topoisomearse II to prevent DNA replication, 
however, in MDR cells, the topoisomerase II was mutated and so the inhibitors 
cannot act on it. Another example is the enhancement of DNA repairment and hence 
reverses the DNA damaging introduced by anti-cancer drugs (Stavrovskaya, 2000; 
Arced, 2000). Apart from these, another mechanism has been under intensive study, 
is the decrease of drug accumulation in cells by increasing drug efflux. This kind of 
MDR can be achieved by activation of the transmembrane proteins efflux pump such 
as P-glycoprotein (P-gp) (Arced, 2000). 
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1.2.3.2.2 Structure and Characteristics of P-glycoprotein 
P-glycoprotein (P-gp) is a 170 kDa plasma membrane protein encoded by the 
MDR genes which located at the chromosome 7 in human. Only the P-gp encoded by 
MDRl gene accounted for the phenotype of MDR. It is a member of the ABC 
(ATP-Binding Cassette) transporters that means it possesses an ATP binding domain 
and ATP is required for its function. It transverses the plasma membrane twelve 
times and forms a pore across the membrane (Fig 1.7). The pore diameter of hamster 
P-gp has been found to be 5 nm (Rosenberg et al,, 1997). It has a negatively charged 
hydrophobic cavity. It is proposed that cationic lipophilic substrates (including some 
anti-cancer drugs) will be pumped out from intracellular space in the expense of ATP. 
As a result, it reduces the quantity of anti-cancer drugs inside tumor cells and hence 
reduces their anti-tumor activities (Di Pietro et al., 1999; Mickley and Fojo, 1998). 
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Fig 1.7 Schematic diagram of P-glycoprotein (Adapted from Di Pietro et al., 
1999). 
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1.2.3.2.3 Methods in Dealing with P-glycoprotein Over-expressed MDR Cells 
Since some tumor cells may acquire over-expressoion of P-gp during 
chemotherapeutic treatments and once the MDR developed, the patient will become 
irresponsive to a numerous anti-tumor drugs, researchers keep on finding agents 
which can reverse the P-gp-MDR or agents which can by-pass the action of P-gp. 
The most popular P-gp activity inhibitors include cyclosporin A and calcium 
blockers such as verapamil. However, these agents more or less exhibit side effects to 
patients. Thus, the most direct and effective solution is to find out anti-tumor agents 
that can function in P-gp over-expressing cells. 
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1.3 Objectives of the Projection 
1.3.1 Study of the Anti-tumor Activities of Hong Kong 18 on Human 
Hepatocellular Carcinoma Cell Line HepG2 and Unravel the 
Underlying Mechanisms 
In this research project, the anti-tumor activities of the steroid saponin Hong 
Kong 18 (HKl 8), i.e. polyphyllin D, were studied. As mentioned above, some 
saponins were able to induce apoptosis in several cancer cell lines including the 
human hepatocellular carcinoma cell line HepG2, we would like to study the 
apoptotic inducing activities of HKl 8 on HepG2. Besides, the underlying 
mechanisms of HKl 8 induced apoptosis in HepG2 were our interests. 
1.3.2 Study of the Anti-tumor Activities of Hong Kong 18 on 
Multidrug Resistant Human Hepatocellular Carcinoma Cell line 
R-HepG2 and Unravel the Underlying Mechanisms 
In the view of the problem posed by P-gp-MDR on the treatment of cancer 
patients, the potential of HKl 8 on the treatment of multidrug resistant human 
hepatocellular carcinoma cell line R-HepG2 was studied. The apoptotic inducing 
activities and the underlying mechanism would be elucidated. 
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2.1 Materials 
2.1.1 Cell Culture 
2.1.1.1 Cell Lines 
Human Hepatocellular carcinoma cell line HepG2 was purchased from 
American Type Culture Collection (ATCC number HB-8065), which was derived 
from a 15 years old Caucassian male. They are adherent cells with epithelial 
morphology. They were cultured in complete RPMI 1640 medium (GibcoBRL, USA) 
supplemented with 10% (v/v) fetal calf serum (GibcoBRL, USA) and 1% (v/v) 
penicillin-streptomycin (Gibco BRL, USA) as complete medium. The cells were 
maintained at 37°C, 5% carbon dioxide incubator with humidified atmosphere. Cells 
were cultured in 25, 75 or 150 cm tissue culture flasks (Coming / IWAKI) and were 
passed every 3 or 4 days. For each passage, medium was discarded and cells were 
washed with PBS once. Then cell were collected by trypsinization and were 
subjected to centrifugation at 450 x g for 3 minutes. The cell pellet was then 
resuspended in complete medium and cultured in a new tissue culture flask. 
( 
I 
Another cell line, multidrug resistant human hepatocellular carcinoma cell 
line R-HepG2, was developed by our group. To develop R-HepG2 cells, HepG2 cells 
were incubated with 0.1 \xM Doxorubicin (Sigma). Dead non-resistant cells were 
removed and viable cells were further incubated with stepwise increasing 
concentrations of Doxorubicin until 100 i^M. The property of multidrug resistance 
was tested by treating the HpeG2 and R-HepG2 cells with chemotherapeutic drugs 
including Doxorubicin, Vincristine and Methotrexate for 48 hours and MTT assay 
was carried out to determine the percentage survival of cells. The overexpression of 
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p-glycoprotein and upregulation of MDRl gene was confirmed by Western analysis 
and Northern analysis (Chan et al., 2000). The developed resistant cells were 
maintained in complete medium with 1.2 |LIM Doxorubicin and were kept at 37 
5% carbon dioxide humidified incubator. The method of passage of the resistant cells 
was the same as its parental cells. 
2.1.1.2 Culture Media 
RPMI 1640 medium (Roswell Park Memorial Institute tissue culture 
medium 1640) was used for culturing HepG2 and R-HepG2 cells. Each pack of 
RPMI 1640 powder with phenol red, L-glutamine and 0.5 mM HEPES was dissolved 
in 1 L distilled water and two grams of sodium bicarbonate was added and the pH 
was adjusted to 7.2. The medium was then sterilized by filtration with 0.22 |Lim 
bottle-top filter (Millipore). 3 ml of filtered medium was then incubated at 37 
5 % carbon dioxide humidified incubator for 48 hours to check the sterilization. 
, i 
i Sterilized medium was stored at 4 °C. Complete medium was obtained by ‘ 
j i 
supplemented with 10 % (v/v) fetal calf serum and 1% (v/v) penicillin/streptomycin 
(10,000 units/ml) to the sterilized RPMI medium. In some experiments, phenol red 
free RPMI medium was used. Its was prepared by dissolving one pack of phenol red 
free RPMI powder with L-glutamine in 1 L distilled water and two grams of sodium 
bicarbonate was added. The pH was adjusted to 7.2 and was sterilized by filtration as 
described above. 
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2.1.2 Reagents and Buffers 
2.1.2.1 Phosphate Buffered Saline (PBS) 
PBS was prepared by dissolving 136 mM NaCl，2.7 mM KCl, 1.5 mM 
KH2PO4 and 8 mM Na2HP04 in distilled water with pH 7.4. It was then sterilized by 
autoclave and was stored at 4°C. 
2.1.2.2 Reagents and Buffers for DNA Fragmentation 
DNA lysis buffer was prepared by dissolving 200 mM Tris-HCl (pH8.3), 
100 mM EDTA and 1 % SDS in distilled water. 
Tris-EDTA (TE) buffer was prepared by dissolving 10 mM Tris-Cl (pH 8.0) 
and ImM EDTA in distilled water. 
Proteinase K (14 units/mg powder) (Sigma) was dissolved in distilled water 
to prepare a stock concentration of lOmg/ml and was stored at-20°C. 
i 
Ribonuclease A (RNase A) (59 Kunitz units/mg powder) (Sigma) was 
dissolved in TE buffer to prepare a stock concentration of 0.2 mg/ml and was stored 
at-20�C 
Tris-Acetate (TAE) buffer was first prepared as 5OX concentrated stock 
solution. It was composed of 242 g Tris base, 57.1 ml glacial acetic acid and 100 ml 
0.5 M EDTA (pH8.0) in 1 L water. It was then diluted into IX by distilled water 
before use. 
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6X DNA loading dye was prepared by mixing 0.25 % (w/v) bromophenol 
blue, 0.25 % (w/v) xylene cyanol FF and 40% (w/v) sucrose in distilled water. 
100 base pair DNA marker was prepared by mixing 2 |il 100 base pair 
DNA marker (Amersham Pharmacia Biotech Inc.) with 4 jil 6X DNA loading dye 
and 5 |LI1 distilled water. 
2.1.2.3 Reagents and Buffers for Western Analysis 
Lysis buffer for total protein extraction was composed of 2 % SDS, 10 % 
glycerol, 0.0625 M Tris-HCl pH 6.8, p-mercaptoethanol (5 %v/v), 0.002 % 
bromophenol blue. 
Lysis buffer for cytochrome c extraction was prepared by mixing 75 mM 
i ] 
i 
NaCl, 1 mM NaHaPCU, 8 mM Na2HP04 and 250 mM sucrose. The buffer was stored 
at 4�C. 21 |ig/ml aprotinin, 5 ^g/ml leupeptin, 1 mM PMSF and various 
i , 
i concentration of digitonin were added to the buffer just prior use. 
4X lower gel buffer was prepared by dissolving 90.8 g of Tris base and 2 g 
of SDS in 500ml of distilled water. The pH was adjusted to 8.8. 
4X upper gel buffer was prepared by dissolving 30.3 g of Tris base and 2 g 
of SDS in 500 ml of distilled water. The pH was adjusted to 6.8 with HCl. 
lOX SDS running buffer was prepared by dissolving 30.3 g of Tris base, 
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144 g of glycine and 10 g of SDS in 1 L of distilled water. The concentrated stock 
solution was diluted 10-fold with distilled water to give the IX working buffer. 
10% Ammonium Persulfate (APS) was prepared by dissolving 10 % (w/v) 
APS (BioRad) in distilled water and was stored at 4 
2X SDS loading dye was prepared by mixing 10 % (v/v) glycerol, 0.4 % 
(w/v) SDS, 0.05 % (w/v) bromophenol blue, 20 mM EDTA in 0.5 M Tris-Cl with pH 
7.5 and 5 % (v/v) 2-mercaptoethanol and was stored at 4 "^ C. 
Electroblotting buffer (E-Blot Buffer) was prepared by mixing 66.7 ml of 
lOX Tris-glycine (30.3 g of Tris base and 144 g of glycine in 1 L of distilled water) 
(pH 8.3)，100 ml of methanol and 500 ml of distilled water. I 
Commassie Blue staining solution for SDS gel staining was prepared by 
- i } mixing acetic acids, methanol and distilled water in the ratio of 1:3:10 with 0.05 % j 
I 
(w/v) commassie brilliant blue R-250. 
De-staining solution was prepared by mixing acetic acid, methanol and 
distilled water in the ratio of 4:1:5. 
Tris-buffered saline-Tween-20 (TBS-T) lOX TBS stock was prepared by 
dissolving 12.114 g of Tris and 87.66 g ofNaCl in 1 L of distilled water. The pH was 
adjusted to 8. The stock solution was then diluted 10 fold to give the IX working 
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concentration. For 1 L of IX TBS, 1ml of Tween-20 was added. 
2.1.2.4 Reagent and Buffers for Caspases Activities 
Cell lysis buffer was prepared by dissolving 1 % Igepal-CA 630, 150 mM 
NaCl, 50 mM Tris-HCl, 1 mM EDTA and protease inhibitor (1 tablet) in 50 ml 
distilled water. The pH was adjusted to 7.5. 
Reaction buffer was prepared by dissolving 10 mM Hepes-KOH, 40 mM 
glycerophosphate, 50 mM NaCl, 2 mM MgC12, 5 mM EGTA, 0.1 % CHAPS, 
100 |LIG/ ml BSA and 10 mM DTT (add before used). The pH was adjusted to 7.0. 
2.1.2.5 Fluorescent Dyes Used for Flow Cytometry 
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine Iodide 
(JC-1), 5-(and 6-)-carboxy-2',7-dichlorodihydrofluorescein diacetate (DCF) and 
Fluo-3/AM (Molecular Probes) were prepared by dissolving in (DMSO) (excess 
water was absorbed by molecular sieve) to give a concentration of 2.5 mM stock 
solution. Tetramethylrhodamine, ethyl ester, perchlorate (TMRE) was prepared by 
dissolving in DMSO to give a concentration of 125 [iM stock solution. All of the 
fluorescence dyes were stored at -20 
2.1.3 Chemicals 
Hong Kong 18 (HKl 8) is a white solid which is organic synthesized by 
Prof. Biao Yu, Shanghai Institute of Organic Chemistry, Chinese Academy of 
Science (Deng et al., 1999; Li et al., 2001). It was stored at 4 and was dissolved in 
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DMSO to prepare a 50 mM stock solution. 
Doxorubicin (Sigma) was prepared by dissolving in 1 ml autoclaved 
distilled water and was then diluted into 1 mM stock with PBS. It was stored at 
-20 0 �a n d protected from light. 
Vincristine (Sigma) was prepared by dissolved in 1ml autoclaved PBS and 
was stored at -20 and protected form light. 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) 
Solution (Sigma) was prepared by dissolving in PBS at a concentration of 5 mg/ml. 
The solution was filtered by a 0.22 |Lim filter (Kitman) and was stored at 4 
I I j 
i 
I i I 
！ lonomydn (Calbiochem) was prepared by dissolving in DMSO to give a I 
. I I 
1 concentraion of 1 mg/ml stock solution and was stored at -20 
I 
Valinomycin (Calbiochem) was prepared by dissolving in DMSO to give a 
concentration of 1 mM stock solution and was stored at -20 
Bongkrekic acid, Triammonium salt (Calbiochem) was prepared by 
dissolving in 2N NH4OH and diluted with PBS to 1 mM stock solution. It was stored 
at -20°C and protected from light. 
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z-Asp(OME)-Glu(OME)-Val-Asp(OME)-CH2F (z-DEVD-fmk) 
(Calbiochem) was prepared by dissolving in D M S O to give a concentration of 1 m M 
stock solution and was stored at-20 
z-Ile-Glu(OME)-Thr-Asp(OME)-CH2F (z-IETD-fmk) (Calbiochem) 
was prepared by dissolving in D M S O to give a concentration of 10 m M stock 
solution and was stored at -20 
z-Leu-Glu(OME)-His-Asp(OME)-fmk (z-LEHD-fmk) (Calbiochem) was 
prepared by dissolving in D M S O to give a concentration of 10 m M stock solution 




(Sigma) was prepared by dissolving in D M S O to give a concentration of 2 m M stock 
I 
. i ' 





(Ac-IETD-AMC) (Sigma) was prepared by dissolving in D M S O to give a 
concentration of 1 m M stock solution and was stored at -20 °C. 
N-Acetyl-Leu-Glu-His-Asp-7-amido-4-trifluoromethylcoumarin 
(Ac-LEHD-AFC) (Sigma) was prepared by dissolving in D M S O to give a 
concentration of 5 m M stock solution and was stored at —20 
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AMC calibrator (7-amido-4-methylcoumarin) was prepared by 
dissolving in D M S O to give a concentration of 100 |aM stock solution and was stored 
at4°C. 
AFC calibrator (7-amido-4-trifluoromethylcoumarin) was prepared by 
dissolving in D M S O to give a concentration of 80 \xM stock solution and was stored 
at4。C. 
3 % thioglycolate (w/v) was prepared by dissolving 3 g of thioglycolate 
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The name, chemical formula, molecular weight and source of the materials 
used are listed in Table 2.1. 
Table 2.1 List of the chemicals being used in this research project. 
Name and formula of chemical Molecular Source  Weight  
5, 5,, 6, 6，-tetrachloro-l, 1,, 3, 3， 
… n ^ . 」 1 L . 」 • 」 " 〜 、 652 Molecular Probes 
-tetraethylbenzimidazolcarbocyanme iodide (JC-1) 
Ac-DEVD-AMC 






、… "1 … … ， „ . 1 , … . 675.7 Sigma 
N-Ace1yl-Ile-Glu-Thr-Asp-7-amido-4-methylcoumarin 
Ac-LEHD-AFC 
N-Acetyl-Leu-Glu-His-Asp-7-amido-4-trifluoromethyl 765.7 Sigma 
coumarin 
Acrylamide / bis-arcylamide 
(30% solution, mix ratio 37.5:1) Sigma. 
Agarose / Sigma 
Albumin, Bovine / Sigma 
Ammonium persulfate 228.2 Bio-Rad 
Aprotinin 6500 Sigma. 
Bicinchoninic acid solution (BCA) / Sigma 
CHAPS 614.89 USB 
Chloroform / B D H 
Commassie brilliant blue R-250 826.0 USB 
Copper ( n ) sulfate pentahydrate  
(CUSO4 . 5H.0) 249.68 S - a 
Digitonin 
(C22H26N2O4S) 1 遣 0 Merck 
Dimethylsulfoxide (DMSO)  
CH3SQCH3 78.13 Riedel-de-Haen 
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D N A marker (100 base pair) / Invitrogen 
E G T A 380.4 Sigma 
Enhanced chemiluminescence reagents (ECL) / Amersham 
Ethanol 
TT mi、 46.07 Riedel-de-Haen  
(C2H5QH)  
Ethidium bromide 394 Molecular Probes 
Ethylenediaminetetraacetic acid (EDTA)  
(C10H16N2O8) 292.2 Sigma 
Fetal Bovine Serum (FBS) / Invitrogen 
Fluo-3, acetoxymethyl ester Fluo-3/AM 1130 Molecular Probes 
Glycine 
75.07 USB  
(H2NCH2CO2H)  
Hepes-KOH 238.3 Sigma 
Igepal-CA / Sigma 
lonomycin 
_ u r^、 709 Calbiochem  (C41H72Q9)  
Isopropanol / B D H 
Leupeptin 
(C20H38N6O4) 463 Sigma 
Methanol 
( C I W z B D H 
Molecular sieve (potassium, sodium alumino-silicate) 
(normal pore diameter: 3 angstrom) Sigma 
M T T (3-[4，5-dimethylthiazol-2-yl]-2, 
5 -diphenyltetrazolium bromide; thiazoyl 
11 、 414.3 Sigma 
blue) 
(CisHieNsSBr)  
N, N, N'-tetramethyl-ethylene diamine (TMRE) 116.21 Sigma 
Non-fat milk powder / Carnation, Nestle 
Penicillin-streptomyin / Invitrogen 
Phenylmethyl-sulphonyl fluoride (PMSF)  
(C7H7FO2S) 174.2 Sigma 
Potassium phosphate (monobasic anhydrous)  
(KH2PO4) 136.1 Sigma 
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Propidium iodide (PI) 668.4 Sigma 
Protease Inhibitor tablet / Roche 
Proteinase K (16U/mg protein) / Sigma 
Rainbow marker (low range) / Bio-Rad 
Ribonuclease A (RNase) (102 U/mg protein) / Sigma 
Roswell Park Memorial Institute tissue culture medium 
1640 (RPMI-1640) (with phenol red) — g e n 
Roswell Park Memorial Institute tissue culture medium 
1640 (RPMI-1640) (without phenol red) Invitrogen 
Sheath Fluid / USB 
Sodium chloride 
^ 遍 USB 
Sodium dodecyl suphate (SDS)  
(CH3(CH2)nS04Na) 服 38 USB 
Sucrose 
(C12H22O11) 342.3 S - a 
Thioglycolate / Boppard 
Tris base 
_ 2 C ( C H 2 0 H ) 3 ) 121.14 USB 
TRIzol / Invitrogen 
Trysin-EDTA / Invitrogen 
Tween-20 
Polyoxyethylene-sorbitan monolaurate) 8igma 
z-DEVD-fmk (Caspase-3 inhibitor) 
(z-Asp(0ME)-Glu(0ME)-Val-Asp-(0ME)-CH2F) Calbiochem 
z-IETD-fmk (Caspase-8 inhibitor) 
z-Ile-Glu(0ME)-Thr-Asp(0ME)-CH2F) 654.7 Calbiochem 
z-LEHD-fmk (Caspase-9 inhibitor) 
T 广 1 / r ^ T v / r r � T T - A / m / r r … T T T ^ 690.7 CalbiocheiTi 
Leu-Glu(0ME)-His-Asp(0ME)-CH2F 
-glycerophosphate 216 Sigma 
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2.2 Methods 
2.2.1 MTT Assay 
M T T assay was used to assess the cytotoxicity of HKl 8. For HepG2 and 
R-HepG2 cells, 100 ^ il of 1.5 x 10^ cells / ml or 2 x 10^ cells / ml were seeded to 
each well of 96-well flat bottom microliter plates respectively. The plates were 
incubated at 37 5 % CO2 humidified incubator overnight to allow the cells to 
grow. The medium was then removed and 100 |il of various concentrations of HKl 8 
were added to the cells. Medium without drug was added to act as the negative 
control. The cells were incubated for various periods. After treatment, the medium in 
each well was discarded and washed by PBS. Thirty microliters of M T T solution (5 
mg/ml) was added. The plate was incubated at 37 °C for 2 hours. Then, the M T T 
solution was discarded and 100 |LI1 of D M S O was added to dissolve the crystals. The 
plate was allowed to stand for 30 minutes at room temperature. The absorbance at 
540 nm was read by ELISA plate reader (Bio-Rad). Blank was set by adding 100 
of D M S O only. Negative control was set as 100 % of cell survival. 
2.2.2 Determination of Cell Viability 
Tryphan blue exclusion assay was employed to study the viability of HKl 8 
on cells. After treatments, 10 |LI1 of cell suspension was mixed with 10 |LI1 of 0.4 % 
tryphan blue solution (Sigma). 10 [i\ of the mixture was then used for cell counting 
by hemocytometer. Dead cells would be stained blue while viable cell would exclude 
the dye. The amount of unstained viable cells and total cells were counted. 
Percentage of viability can be calculated as follows: 
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% Viability = (no. of viable cells / no. of total cells) x 100 % 
2.2.3 Purification of Macrophages from balb/c Mice 
1.5 ml of 3 % thioglycolate was intra-peritoneally injected into 6 - 8 weeks, 
20 - 25 g balb/c mouse. After 3 days, the mouse was killed and peritoneal cells 
including macrophages were collected by washing the peritoneal cavity with about 
10 ml PBS. Cells pellet was collected by centrifugation at 800 x g for 3 minutes. The 
cells pellet was washed twice with 0.5 X PBS to remove any red blood cells present. 
The cells pellet was then resuspended in complete RPMI. The cell density 
was adjusted into 5 x 10^ cells /ml and were seeded into a 96 well plate for 
cytotoxicity assay. The plate was then incubated at 37 5 % CO2 humidified 
incubator for 3 hours to allow the macrophages to attach to the well bottom. After 3 
hours incubation, the wells were washed with PBS twice and 100 [i\ of complete 
medium or with various concentrations of drugs were added and incubated for 48 
hours. M T T was performed to examine cytotoxicity of drugs. 
2.2.4 Hemolysis Assay 
The hemolytic activity of HKl 8 was studied by red blood cell (RBC) 
hemolysis assay model. Around 12 ml of blood was collected from 300-320 g male 
SD rat from the dorsal vein by vacuum puncture. The blood collected was 
centrifuged at 1,500 x g for 10 minutes at 4 The supernatant (serum) was 
carefully removed. The pellet which contain mostly R B C was then rinsed with 0.15 
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M NaCl and centrifuge at 1,500 x g for 10 minutes at 4 two times. After that, the 
pellet was rinsed again with 0.15 M NaCl and centrifuged at 1,000 x g for 10 minutes 
at 4 The pellet obtained was resuspended in PBS to obtain 20 % R B C suspension. 
0.5 ml of the 20 % R B C suspension was then mixed with 0.25 ml of PBS and 0.25 
ml of various concentration of HK18. 0.25 ml of PBS was used instead of HK18 for 
the negative control. The reaction mixture was incubated at 37 for 3 hours with 
gentle shaking. After incubation, 0.1 ml of each of the reaction mixture was added to 
1.9 ml of distilled water and PBS respectively and were centrifuged at 1,500 x g for 
10 minutes at 4 The supernatant was measured at absorbance 540 nm with a 96 
well plate by ELISA plate reader (Bio-Rad). The percentage of hemolysis was 
directly proportional to the absorbance. The percentage of hemolysis would be 
calculated as follows: 
% Hemolysis = {1- [(Abs of H2O - Abs of PBS) / Abs of H2O] } x 100% 
2.2.5 In vivo Studies of the Toxicity of HK18 
The toxicity of HK18 was examined by in vivo study. Male Balb/c mice 
aged 6 to 8 weeks with 20 to 25 grams were employed in this experiment. The mice 
were divided into 3 groups and 8 mice per group. One group was regarded as control 
group in which saline was administrated. Another group was regarded as solvent 
control group in which 0.4 % 7 -cyclodextrin was administrated. The last group was 
regarded as treatment group in which 342 |ag / kg mice (equivalent to 5 juM of final 
concentration in the circulation of mouse) of HK18 was administrated. Saline, 0.4 % 
cyclodextrin and 5 ^ M HK18 were injected into the mice intravenously via the tail 
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vein every alternate day and lasted for 2 weeks. After treatments, the mice were 
sacrificed and serum was collected. The enzymatic activities of the serum were 
measured by enzymatic diagnostic kits (Sigma). Four enzymes were examined which 
are the indicators of heart tissue or liver damage. They are creatine kinase (CK) and 
lactate dehydrogenase (LDH), which are indicators of heart tissue damage as well as 
alanine transaminase (ALT) and aspartate transaminase (AST), which are indicators 
of liver tissue damage. 
The procedures of measuring the enzymatic activities were according to the 
protocol of the enzymatic kits. In brief, for measuring C K and L D H activities, 20 jul 
and 50 [i\ of serum was mixed with 1 ml of C K reagent or L D H reagent respectively. 
The mixture were then incubated at 30 at dark for 3 minutes or 30 seconds and 
absorbance were taken at 340 nm by spectrophotometer (Beckman) for 2 minutes or 
1 minutes for C K and L D H respectively. For measuring AST and ALT，100 |li1 of 
serum was mixed with 1 ml AST reagent or ALT reagent at 37 at dark for 1 
minute. Absorbance was then taken at 340 nm for 2 minutes. 
The enzymatic activities were calculated as follows: 
Enzymatic activity (U/L) = (AA per min x T V x 1000)/ (6.22 x LP x SV) 
where A A per min = change in absorbance per minute at 340 nm 
T V = total reaction volume (ml) 
LP = light path 
6.22 = millimolar absorptivity ofNADPH at 340 nm 
SV = sample volume 
1000 = conversion of units per ml to per liter 
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thus, C K (U/L) = A A per min x 8200 
L D H (U/L) = A A per min x 3376 
AST (U/L) = A A per min x 1768 
ALT (U/L) = A A per min x 1768 
One unit of activity is defined as the amount of enzyme, which produces 
1 iimole o f N A D H per minute under the condition of assay procedure. 
The mean value of the enzymatic activities of the same group was then 
plotted against the corresponding treatments. The largest and the smallest values 
were eliminated. 
2.2.6 DNA Fragmentation Assay 
D N A fragmentation assay was used to examine apoptosis. 3 ml of 1.5 x 
10^ cells/ml or 2 X 10^ cells/ml of HepG2 or R-HepG2 cells were seeded in 60 m m 
culture dish respectively. Cells were allowed to grow overnight at 37 5 % CO2 
humidified incubator. Medium was then removed and various concentrations of 
HKl 8 were added. The cells were incubated for various periods. After treatment, 
cells were harvested and washed twice with PBS. Cells at 1 x 10^ were lysed with 
400 \x\ of D N A lysis buffer. The mixture was vortexed until no cell debris was left. 
Twenty microliter of proteinase K (10 mg/ml) was added and incubated at 37 for 
at least 2 hours. After cooling down the sample to room temperature, 150 jul of 
saturated NaCl was added and the sample was shaken vigorously. The 
microcentrifuge tubes were centrifliged at 6,500 x g for 15 minutes. The supernatant 
was collected and 1 ml of cold absolute ethanol was added. The mixture was then 
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subjected to centrifugation at 15,000 x g for 20 minutes. One ml of cold 75 % 
ethanol was used to wash the pellet. After centrifuge at 7,000 x g for 5 minutes, the 
pellet was allowed to dry. Finally, 20 |li1 of RNase A (0.2 mg/ml) was added to each 
sample and further incubated at 37 for 90 minutes. The dissolved D N A was then 
subjected to electrophoresis on 1.5 % (w/v) agarose gel (Sigma). 
2.2.7 Detection of Apoptotic and Necrotic / Late Apoptotic Cells by 
Flow Cytometry with Annexin V-FITC/PI 
T A G S ™ Annexin V-FITC kit (Trevigen) was used to examine early 
apoptosis and necrosis / late apoptosis of HKl 8 treated cells. 10 ml of 1.5 x 10^ 
cells/ml or 2 X 10^ cells were seeded in 100 m m tissue culture dish. Cells were 
incubated at 37 5 % CO2 humidified incubator overnight. Medium was then 
removed and various concentrations of HKl 8 were added and medium without drug 
was added as negative control. The cells were incubated for various periods. After 
treatment, both floating dead cells and adherent cells were harvested and washed 
twice with plain non-phenol red containing RPMI. Cells at 1 x 10^ were used for the 
assay. 2 mg/ml of digitonin was added to permeabilize the plasma membrane of 
untreated cells to serve as positive control. 100 [i\ of Annexin V incubation reagent 
including 10 [i\ of lOX binding buffer, 10 \x\ of PI, 2 }il of Annexin-V conjugate and 
78 of distilled water was added and the sample was incubated in the dark at 37 
for 15 minutes. Then, 400 ^ il of IX binding buffer was added to the sample and the 
sample was analyzed by FACSort flow cytometry (Becton Dickison) by using ‘Cell 
Quest’ software. The cell population was chosen by forward scatter (FSC) light and 
side scatter (SSC) light. The signal was detected by FLl channel for the detection of 
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Annexin V-FITC and FL3 channel for PI with log scale. 
2.2.8 Detection of Mitochondrial Membrane Potential by JC-1 
Fluorescent Dye 
The mitochondrial membrane potential (cpm) was examined by flow 
cytometry with fluorescent JC-1 dye. 2 ml of 1.5 x 10^ cells/ml or2x 10^ cells/ml of 
HepG2 or R-HepG2 cells respectively were seeded to each well of a 6 well plate. 
Cells were incubated at 37 5 % CO2 humidified incubator overnight. Medium 
was removed and various concentrations of HKl 8 were added and medium without 
drug was added as negative control. 500 n M of Valinomycin was added to act as the 
positive control. The cells were incubated for various periods. After treatment, 
floating dead cells were discarded; adherent cells were harvested and washed twice 
with plain non-phenol red containing RPMI. Cells at 0.25 x 10^ were resuspended in 
500 |il of medium with 10 |LIM JC-1. The samples were incubated in the dark at 37 °C 
for 15 minutes and then were analyzed by FACSort flow cytometry (Becton Dickison) 
by using "Cell Quest' software. The cell population was chosen by FSC light and 
SSC light. The signal was detected by FLl and FL3 channels in log scale. 
2.2.9 Detection of Intracellular Ca^ ^ Level by Flow Cytometry with 
Fluo-3 Fluorescent Dye 
， 
The intracellular concentration of Ca was examined by flow cytometry 
with fluorescence dye Fluo-3. 2 ml of 1.5 x 10^  cells/ml or 2 x 10^ cells/ml of HepG2 
or R-HepG2 cells respectively were seeded to each well of a 6 well plate. Cells were 
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incubated at 37 5 % CO2 humidified incubator overnight. Medium was removed 
and various concentrations of HKl8 were added and medium without drug was 
added as negative control. The cells were incubated for various periods. After 
treatment, floating dead cells were discarded; adherent cells were harvested and 
washed twice with plain non-phenol red containing RPMI. Cells at 0.25 x 10^ were 
used for analysis. 40 |ag/ml lonomydn was added to untreated cells for 15 minutes to 
act as the positive control. The cells were resuspended in 500 jiil of medium with 10 
jiiM Fluo-3. The samples were incubated at 37 for 30 minutes in dark and then 
were analyzed by flow cytometry by using "Cell Quest' software. The cell 
population was chosen by FSC light and SSC light. The signal was detected by FLl 
channel in log scale. 
2.2.10 Detection of Intracellular Hydrogen Peroxide Level by Flow 
Cytometry with DCF Fluorescent Dye 
The intracellular hydrogen peroxide level was examined by flow cytometry 
with fluorescence dye DCF. 2 ml of 1.5 x 10^ cells/ml or 2 x 10^ cells/ml of HepG2 
or R-HepG2 cells respectively were seeded to each well of a 6 well plate. Cells were 
incubated at 37 5 % CO2 humidified incubator overnight. Medium was removed 
and various concentrations of HKl 8 were added and medium without drug was 
added as the negative control. Cells were incubated for various periods. After 
treatment, floating dead cells were discarded; adherent cells were harvested and 
washed twice with plain non-phenol red containing RPMI. Cells at 0.25 x 10^ were 
resuspended in 500 of medium with 10 |LIM DCF. The samples were incubated at 
37 °C for 30 minutes in dark and then were analyzed by flow cytometry by using 
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"Cell Quest' software. The cell population was chosen by FSC light and SSC light. 
The signal was detected by FLl channel in log scale. 
2.2.11 Simultaneous Detection of Mitochondrial Membrane Potential 
and Intracellular Ca^ ^ or Mitochondrial Membrane Potential and 
Intracellular Hydrogen Peroxide 
Change of mitochondrial membrane potential (cpm) could be analyzed with 
change of intracellular Ca or hydrogen peroxide level simultaneously by flow 
cytometry with T M R E and Fluo-3 or DCF. 2 ml of 1.5 x 10^ cells/ml or 2 x 105 
cells/ml of HepG2 or R-HepG2 cells respectively were seeded to each well of a 6 
well plate. Cells were incubated at 37 5 % CO2 humidified incubator overnight. 
Medium was removed and various concentrations of HKl 8 were added and medium 
without drug was added as negative control. Cells were incubated for various periods. 
After treatment, floating dead cells were discarded; adherent cells were harvested 
and washed twice with plain non-phenol red containing R P M L Cells at 0.25 x 10^ 
were resuspended in 500 of medium with 500 n M T M R E and 10 )liM Fluo-3 or 10 
I^M DCF. The samples were incubated at 37 for 30 minutes in dark and then were 
analyzed by flow cytometry by using "Cell Quest' software. The cell population was 
chosen by FSC light and SSC light. The signal was detected by FL-3 channel for 
T M R E and FL-1 channel for Fluo-3 or DCF in log scale. 
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2.2.12 Western Analysis 
2.2.12.1 Total Protein Extraction 
• Protein Extraction 
10 ml of 1.5 X 105 cells/ml or 2 x 10^ cells/ml HepG2 and R-HepG2 cells 
were seeded in a 100 m m tissue culture dish and incubated at 37 °C，5 % CO2 
humidified incubator overnight. Medium was removed and various concentrations of 
HK18 were added. Cells were incubated for various periods. After treatment, both 
floating dead cells and adherent cells were collected and were washed twice with 
PBS. 100 III of lysis buffer (2% SDS, 10% glycerol, 0.0625 M Tris-HCl pH 6.8， 
P-mercaptoethanol (5 % v/v), 0.002 % bromophenol blue) was added and was 
allowed to stand in ice for 1 hour. Subsequently, samples were boiled for 10 min. The 
extracts were then centrifuged at 11,000 x g for 10 minutes at 4 After 
centrifugation, supernatant was collected and stored at -70 
• Determination of Protein Amount 
The amount of total protein extracted by SDS lysis buffer was determined 
by B C A protein assay. 1 |LI1 of each sample was mixed with 9 |LI1 PBS in a 96 well 
plate. A standard bovine serum albumin (BSA) curve was obtained as 0, 2, 4, 6，8 
and 10 mg/ml BSA in the 96 well plate. Both protein samples and BSA standard 
were done in triplicate. B C A mixture was composed of mixing B C A (bicinchoninic 
acid) solution and CUSO4 . 5H2O solution in the ratio of 50:1. 200 fil of B C A mixture 
was added to each well and incubate at 37 for 30 min. B C A mixture only was 
used as blank. Fig 2.1 showed a standard BSA curve. 
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Fig 2.1 BSA protein standard curve used for protein concentration 
determinat ion. 
• SDS Polyacrylamide Gel Electrophoresis 
The apparatus of 3D vertical electrophoresis system (BioRad) was set 
rcfcmng to the slops in user manual. 
According to the molecular weight of the target protein, dilTcrcnt 
pcrccniagcs of Macking and separating gel were used. The composition uas as 
follows: 
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Separating gel Stacking gel 
8 % 12 % 15% 4.5 % 
Distilled water 1.9 ml 1.375 ml 0.975 ml 1.2 ml 
30% Acrylamide 1.07 ml 1.6 ml Yml 0.3 ml 
4 X lower gel buffer 1 ml 1 ml 1 ml / 
4 X upper gel buffer / / / 0.5 ml 
T E M E D 4.65 ^ 4 . 6 5 |LI1 4.65 |LI1 2.65 |LI1 
1 0 % APS 2 M 2 M 20^11 
Table 2.2 The compositions of various percentage of SDS gel. 
According to the BSA standard curve, equal amount of protein samples 
(25-50 |ag) were used for electrophoresis. Protein samples were mixed with equal 
amount of 2 x SDS loading dye and boiled for 10 minutes. Then samples were 
loaded to the well of the polyacrylamide gel with rainbow low range marker 
I 
I 
(Amershan). The gel was run under constant voltage of 100 V for 2-3 hours. 
• Electroblotting of Protein 
The apparatus of Semi-Dry Electrophoretic Transfer Cell (semi-dry blotter, 
Bio-Rad) was set referring to the steps in manual. 
0.45 )am PVDF (polyvinylidene fluoride) membrane (Immobilon, Millipore) 
was used for electroblotting. The dry PVDF membrane was soaked in absolute 
methanol for re-hydration. Membrane was then put in the electroblotting buffer 
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(E-blot buffer) for 15 minutes. 3 pieces of blotter paper were soaked in E-Blot buffer 
and put onto the platinum anode. The membrane was put onto the blotter papers 
following with the acrylamide gel (the upper stacking gel was cut and removed). Air 
bubbles were excluded by rolling. Another 3 pieces of E-blot buffer-soaked blotter 
paper were put onto the gel. The proteins were transferred at constant current at 
150 m A for 2 gels for 20-50 minutes. After blotting, the gel was stained with 
commassie blue staining solution and destaining solution to check the completeness 
of transfer. 
• Probing of Proteins with Antibodies 
The membrane was then soaked in 10 % non-fat milk (in TBS-T) at 4 
overnight for non-specific blocking. It was washed with TBS-T for 10 minutes 3 
times. Then, primary antibody in 10 % non-fat milk was added for probing at room 
temperature for 1 hour. After that, the membrane was washed with TBS-T for 10 
minutes 3 times and probes with second antibody (conjugated with horseradish 
peroxidase) at room temperature for 1 hour. The membrane was washed again with , 
TBS-T for 10 minutes 3 times and it was ready for ECL detection. The anti-bodies 
which had been used in this project were listed at Table 2. 3. 
• Enhanced Chem Hum in escen ce (ECL) Assay 
After probing antibody, the target protein can be detected by using ECL 
assay. Reagent 1 and 2 and ECL (Amersham) were mixed in the ratio of 1:1 and the 
membrane was immersed in the mixture for 90 seconds. Then the membrane was 
wrapped and put into the Hypersensitive film cassette (Amersham) following with 
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Fuji Medical x-ray film (Super Rx, Fuji) at dark with various exposure period. The 
film was developed by a film processor (M35 X-OMAT, Kodak) and the band 
intensity was analyzed by ImageQuaNT software (Molecular Dynamics). 
Molecular weight of 
Anti-bodeis the target protein Ratio Company 
Aiiti-/3-actin 42 1 : 1000 Sigma 
Anti-AIF ^ 1 : 1 0 0 0 S a n t a Cruz 
‘ Anti-Bcl-2 ^ 1 : 1000 Santa Cruz 
Anti-cytochrome c 15 1:1000 Santa Cruz 
Anti-PARP 116，85 1 : 1000 Santa Cruz 
~Anti-Pro-caspase 3 35 1 : 1000 Santa Cruz 
Anti-mouse-HRP 1 1 : 1000 Z Y M E D 
Anti-rabbit-HPR 1 1 : 1000 Santa Cruz 
i 
• t: Table: 2.3 List of the anti-bodies used in this project with the corresponding 
{ target protein molecular weight, dilution ratio and purchasing companies. 
I 
. ' a -
2.2.12.2 Extraction of Cytosolic Proteins 
• Extraction of Protein 
20 ml of 1.5 X 105 cells/ml or 2 x 10^ cells/ml of HepG2 or R-HepG2 
cells were seeded into a 75 cm^ tissue culture flask and incubated at 37 5 % CO2 
humidified incubator overnight. Medium was discarded and various concentrations 
of HKl 8 were added and medium without drug was added as the negative control. 
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Cells were incubated for various periods. After treatment, cells were harvested and 
washed with plain medium 2 times. 4 x 10^ cells of each sample were used for assay. 
50 111 of lysis buffer (75 m M NaCl, 1 m M NaHzPO*，8 m M NazHPO*, 250 m M 
sucrose, 21 |ig/ml aprotinin, 5 [ig/m\ leupeptin, 1 m M P M S F and various 
concentration of digitonin) was added to 4 x 10^ cells and vortexed vigorously for 30 
seconds following with centxifugation at 8,000 x g for 1 minute at room temperature 
immediately. The supernatant was collected and mixed with equal volume of 2X 
SDS loading dye and boiled for 10 minutes. Then, the samples were subjected to 
centrifugation at 11,000 x g for 7 minutes at 4 (Single et al., 1998). The 
supernatant collected was used to run SDS electrophoresis or store at -70 For 
running electrophoresis, the samples were boiled for 5 minutes and 20 jal of each 
sample was loaded to the well of a 12 % SDS gel. The following procedures of 
electrophoresis were as same as total protein extraction mentioned above. 
• Determination of the Dosage of Digitonin 
Since digitonin was used to cause plasma membrane permeabilzation, the { 
dosage of digitonin was very critical. Insufficient amount of digitonin may lead to 
incomplete plasma membrane permeabilzation while in excess digitonin may lead to 
disruption of mitochondrial membrane and release of mitochondrial proteins and 
hence lead to incorrect and misleading result. Thus, the dosage of digitonin was 
determined first with untreated cells. Various concentrations of digitonin (12.5, 25, 
50, 100，200 and 400 |ig / 4 x 10^ cells) were used to lyse cells and the extracts were 
subjected to SDS electrophoresis. From the film (Fig 2.2), the band intensity of 
cytochrome c was similar for 12.5, 25, 50 and 100 |ig digitonin / 4 x 10^ cells while 
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the band intensity of 200 and 400 |ig digitonin was much higher. This indicated that 
200 and 400 )ig digitonin did not only permeabilize the plasma membrane but also 
permeabilize the outer mitochondrial membrane and hence release the cytochrome c 
of mitochondrial inter-membrane space. From the gel (Fig 2.2), at 12.5 and 
25 |Lig / 4 X 10^ cells, the total protein amount was less than other digitonin 
concentrations. This indicated that these two concentrations of digitonin could not 
permeabilize the plasma membrane of all cells. Thus, 50 ^ ig digitonin / 4 x 10^ cells 
was chosen to be used which was able to permeabilize the plasma membrane fully 
but did not affect mitochondrial membrane. 
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Digitonin ( | L i g / 4 x 10^ cells) 
I 1 
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Fig 2.2 Determinat ion of digitonin concentration. 4 X 1 0 ^ untreated HepG2 cells 
were lysed with 50 |il lysis buffer in the presence of 12.5, 25, 50, 100 or 200 fig 
digitonin. The protein extracts obtained were mixed with equal volume of 2 X SDS 
loading dye and 20 |il of each sample was loaded to SDS gel electrophoresis. One of 
the gel was stained with Commassie brilliant blue while another was transferred and 
probed with anti-cytochrome c anti-bodies. 
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2.2.13 Determination of Caspases Enzymatic Activity 
• Extraction of proteins 
20 ml of 1.5 X 105 cells/ ml or 2 x 10^ cells/ ml ofHepG2 or R-HepG2 
cells were seeded to a 75 cm^ tissue culture flask and incubated at 37 5 % CO2 
humidified incubator overnight. Medium was removed and H K l 8 was added. Cells 
were incubated for various periods. After treatment, both of the floating dead cells 
and adherent cells were collected and were washed twice with plain medium. Cells 
were counted and were centrifuge at 400 x g for 10 minutes to collect cell pellet. The 
pellet can be store at -70 for later use. 50 jiil of chilled lysis buffer was added to 
each 2 X 106 cells in order to resuspend and lyse the cell pellet. The cells were 
allowed to stand on ice for 10 minutes. Then the cell lysate was centrifuge at 
11，000 X g for 3 minutes at 4。C to precipitate cell debris (Mack et aL, 2000). The 
supernatant was collected for use. The protein concentration of each sample was 
determined by B C A assay as mentioned above. 
！ 
• Assessment of caspases enzymatic activities 
Caspase-3 activity 
50 |ig of protein of each sample was used for measuring caspase-3 
activity. 90 ^il of reaction buffer supplemented with 10 m M D T T were added to wells 
of a 96 well plate. In order to confirm that the increase of substrate signal is due to 
caspase-3 activity, caspase-3 specific inhibitor z-DEVD-fmk was added before 
addition of substrate. Lysate containing 50 |ag of protein sample was added and 1 |li1 
of 1 m M z-DEVD-fmk was added to the wells and incubated at 37 °C for 30 minutes 
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at dark. During this incubation period, the other lysate were kept on ice. After 
incubation, lysate containing 50 |Lig of protein was added to wells. Then 0.5 [i\ of 2 
m M fluorescent A M C conjugated caspase-3 specific substrate Ac-DEVD-AMC was 
added to each well (including the wells with inhibitor) and the plate was incubated at 
37 for 1 hour at dark. A well without cell lysate but containing reaction buffer and 
substrate was set to act as blank. A standard curve of A M C was set as the following 
concentrations 0, 0.625, 1.25, 2.5 and 5 After incubation, the fluorescent 
intensity was measured by a fluorescence microplate reader (CytoFluo™, Millipore). 
The excitation and emission filters were 390 nm and 460 nm respectively. The 
sensitivity of the scanning was maximized. According to the standard A M C 
fluorescent curve (Fig 2.3), the amount of A M C released from the conjugated 
substrate can be calculated. 
Caspase-8 activity 
For measuring caspase-8 activity, 100 |Lig of protein was used. Similarly, 
90 \x\ of reaction buffer supplemented with 10 m M DTT were added to wells of a 96 ‘ 
well plate. In order to confirm the increase of substrate signal is due to caspase-8 
activity, caspase-8 specific inhibitor z-IETD-fmk was added before addition of 
substrate. Lysate containing 100 |Lig of protein sample was added and 2 ]x\ of 10 m M 
z-IETD-fmk was added to the wells and incubated at 37 °C for 30 minutes at dark. 
During this incubation period, the other lysate were kept on ice. After incubation, 
lysate containing 100 )ig of protein was added to wells. Then 5 jul of 1 m M 
fluorescent A M C conjugated caspase-8 specific substrate Ac-IETD-AMC was added 
to each well (including the wells with inhibitor) and the plate was incubated at 37 
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for 1 hour at dark. A well without cell lysate but containing reaction buffer and 
substrate was set to act as blank. A standard curve of A M C was set as the following 
concentrations: 0, 0.625, 1.25, 2.5 and 5 jiiM. After incubation, the fluorescent 
intensity was measured by a fluorescence microplate reader (CytoFluo™, Millipore). 
The excitation and emission filters were 390 nm and 460 nm respectively. The 
sensitivity of the scanning was maximized. According to the standard A M C 
fluorescent curve (Fig 2.3), the amount of A M C released from the conjugated 
substrate can be calculated. 
Caspase-9 activity 
For measuring caspase-9 activity, 200|ig of protein was used. Similarly, 90 |il 
of reaction buffer supplemented with 10 m M DTT were added to wells of a 96 well 
plate. In order to confirm the increase of substrate signal is due to caspase-9 activity, 
caspase-9 specific inhibitor z-LEHD-fmk was added before addition of substrate. 
Lysate containing 100 |ag of protein sample was added and 2 \x\ of 10 m M 
z-LEDH-fmk was added to the wells and incubated at 37 for 30 minutes at dark. 1 
During this incubation period, the other lysate were kept on ice. After incubation, 
lysate containing 100 i^g of protein was added to wells. Then 5 of 1 m M 
fluorescent AFC conjugated caspase-9 specific substrate Ac-IETD-AFC was added 
to each well (including the wells with inhibitor) and the plate was incubated at 37 
for 1 hour at dark. A well without cell lysate but containing reaction buffer and 
substrate was set to act as blank. A standard curve of AFC was set as the following 
concentrations: 0 , 0 . 5 , 1, 2 and 4 |LIM. After incubation, the fluorescent intensity was 
measured by a fluorescence microplate reader (CytoFluo™, Millipore). The 
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excitation and emission filters were 400 nm and 505 nm respectively. The sensitivity 
of the scanning was maximized. According to the standard A F C fluorescent curve 
(Fig 2.3), the amount of AFC released from the conjugated substrate can be 
calculated. 
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Fig 2.3 Standard curves of AMC and AFC for the determination of caspases 
enzymatic activities. 
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2.2.14 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
2.2.14.1 RNA Extraction by TRIzol Reagent 
1.5 X 10^ cells of HepG2 or2x 10^ cells of R-HepG2 were seeded to 6 wells 
plate and incubated at 37°C, 5 % CO2 humidified incubator overnight. The cells were 
then treated with HKl 8 or medium with various time periods. After treatment, 
medium was discarded and 1 ml TRIzol reagent (Invitrogen) was added to each well 
and was incubated at room temperature for 5 minutes. The lysate was then 
transferred to 1.5 ml micro-centrifuge tube and 200 of chloroform was added. The 
mixture was mixed by vortex vigorously for 15 seconds and stand at room 
temperature for 2 to 3 minutes. The mixture was then centrifiiged at 12,000 x g for 
15 minutes at 4 After centrifugation, 3 layers: a lower red phenol-chloroform 
layer, an interphase layer and a colorless upper aqueous layer were observed. R N A 
remains exclusively in the aqueous layer. The upper aqueous layer was transferred to 
I ly 
a new micro-centrifuge tube on ice. 0.5 ml isopropanol was added and incubated at ！ 
. i 
room temperature for 10 minutes for R N A precipitation. After that, the sample was 
pi 
centrifuge at 12,000 x g for 10 minutes at The supernatant was discarded and :: 
1 ml of 75 % EtOH was added to wash the pellet. The sample was further centrifuge 
at 7,500 X g for 5 minutes at 4°C and the supernatant was discarded. The pellet was 
allowed to air-dry for 5 to 10 minutes and then 20 - 30 |LI1 of DEPC-treated dlfcO 
was added to dissolve the pellet. The R N A samples were then stored at -80°C. The 
purity of the R N A samples was then checked by measuring O D at 260 and 280 nm 
by UV-visible spectrophotometer (UV-1601, Shimadzu). 1 |li1 of R N A sample was 
diluted with 499 DEPC-treated dHiO for measurement. The ratio of O D 260/280 
should be within 1.6 — 1.8. The concentration of R N A (}ig/|Lil) was calculated by (OD 
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at 260 nm / 0.1) x (4 / 1000) x (500 /I). Besides, the R N A samples were subjected to 
gel electrophoresis to check integrity. One |al of R N A samples were mixed with 1 jLil 
2 X R N A loading dye and incubated at 65 for 5 minutes. The mixture was then 
loaded to 1 % agarose gel for electrophoresis. 
2.2.14.2 Reverse Transcription 
The R N A samples were then subjected to reverse transcription by 
ThermoScript™ RT-PCR kit (Invitrogen) for c D N A synthesis. 3 jiig of each R N A 
sample was mixed with 1 |il of oligo(dT) primer (50 |LIM), 2 |LI1 dNTP ( 1 0 m M ) and 
DEPC-treated dH20 was added to adjust the volume to 12 jul in a 0.5 ml 
micro-centrifuge tube. The mixture was incubated at 65 for 5 minutes and then 
placed on ice for R N A and primer denaturation to take place. After that, 8 jiil of 
reaction mixture (composed of 4 |LI1 of 5 X cDNA Synthesis Buffer, 1 |LI1 of 0.1 M 
DTT, 1 [i\ of40U/ |Lil RNasOUT™, 1 DEPC-treated dHzO and 1 |LI1 of 15 units / 
[i\ ThermoScript™ RT) was added. RT reaction was carried out in a thermal cycler at 
I 
50°C for 60 minutes and terminated at 85°C for 5 minutes. Then 1 jiil of RNase H ” 
was added and incubated at 37°C for 20 minutes. The cDNA synthesized was diluted 
5 folds with autoclaved dHiO and can be stored at -20。C or used for PGR 
immediately. 
2.2.14.3 Polymerase Chain Reaction 
For polymerase chain reaction, 5 |LI1 of diluted cDNA was mixed with 45 |il 
reaction mixture which composed of 5 j^l of lOX PGR buffer. 5 of dNTP (2 mM), 
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5 [i\ of forward primer (2.5 F^M), 5 |il reverse primer (2.5 |LIM), 28.5 |LI1 autoclaved 
dH20 and 0.5 of Taq polymerase (1.25 units). The sample mixture was then 
subjected to PGR in a thermal cycler (Progene). The initial denaturing temperature 
was 94 °C for 3 minutes and the final elongation temperature was 72 for 10 
minutes. While the cycling conditions were set according to the nature of the primer 
pairs. After finishing the PGR reaction, 2 |LI1 of the PGR product was then mixed with 
10 |al of 6X D N A loading dye and then subjected to 1 % agarose gel electrophoresis 
along with 100 bp D N A marker. Table 2.4 showed the primer sequences used in this 
project with the corresponding sizes of PGR product as well as the conditions used. 
' I 
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广 ^ . Size of PGR 
Gene Sequence / Conditions 
Product (bp) 
Forward: 5'ACCACAGTCCATGCCATCAC3 ‘ 
Reverse: 5'TCCACCACCCTGTTGCTGTA3 ’ 
Denature: 95。。，1 minute 
G A D P H ‘ 400 
Annealing: 50 C, 1 minute 
Amplification: 72。。，1 minute 
27 cycles 
Forward: 5'AGCTGCACCTGACGCCCTT3 ‘ 
Reverse: 5 ' C A G C C A G G A G A A A T C A A A C A G A G G 3’ 
Denature: 94 45 seconds 293 
bcl-2 。 
Annealing: 65 C，45 seconds 
Amplification: 72 2 minute 
27 cycles 
Forward: 5'TGGCAACCCATCCTGGCACCT3' 
Reversel 5 ' A C T G A A G A G T G A G C C C A G C A G A A C 3 ’ 
、， Denature: 95 45 seconds 
bcl-x 。 538 
Annealing: 61 C, 45 seconds 
Amplification: 72 1 minute 
27 cycles 
Forward: 5 G C C C A G G A C A C A G A G G A G G T T T T C 3 ’ 
Reversel 5 , A A A C T G G C C C A A C A G A A C C A C A C C 3 ’ 
, , Denature: 95 45 seconds 
bak ^ 528 “ 
Annealing: 61 C，45 seconds 
Amplification: 72 1 minute 
27 cycles 
Table 2.4 List of the sequences of primers used in this project and their 
corresponding PCR conditions and size of PCR products. 
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2.3 Statistic Analysis 
All experiments were performed in triplicate unless otherwise noted. The 
results were expressed as mean 土 standard derivation. Student's T-test was 
performed in the experiment indicated and p < 0.05 or p < 0.001 was considered as 
statistically significant. 
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3 Cytotoxicity of HKl 8 
3.1 Cytotoxicity of HKl8 on HepG2 Cells 
First of all, the cytotoxicity of HKl 8 on the human hepatocellular 
carcinoma cell line HepG2 was studied by M T T and tryphan blue exclusion assays. 
3.1.1 Study of the Cytotoxic Activity of HK18 on HepG2 Cells by 
MTT Assay 
HepG2 cells were incubated with HKl 8 with the following concentrations: 
0, 1, 2, 3, 4, 5, 6，7, and 10 [iM. From Fig. 3.1a, HKl8 was found to have cytotoxic 
effect on HepG2 cells. The percentage of survival decreased when concentrations of 
H K 1 8 increased. Most of the HepG2 cells died at the concentration around 1 0 |LIM 
for 24 hours incubation while most of the cells died at the concentration around 
7 |iM for 48 hours incubation. The IC50 of HKl 8 on HepG2 cells were around 
3.5 |aM and 2.5 |aM for 24 hours and 48 hours respectively. Thus, HKl8 was 
cytotoxic to HepG2 cells in a dose and time dependent manner. A solvent control 咖' 
was carried out to check whether D M S O itself could induce cytotoxic effect. At 10 
I^M of HKl 8, the solvent content was 0.02 %. W e found that at 0.02 % D M S O , there 
was around 100 % survival, so the cytotoxic effect was contributed by HKl 8. 
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Fig 3.1 Study of cytotoxicity of HK18 and DOX on HepG2 cells for 24 and 48 
hours by MTT assay. 1.5 x 10^  cells / ml were incubated with various 
concentrations of HKl 8 or D O X in a 96 well plate for 24 or 48 hours. After 
treatment, M T T assay was carried out. Percentage of survival was plotted against 
concentration of drug added, (a) Percentage survival of HepG2 upon various 
concentration of HKl 8. (b) Percentage survival of HepG2 upon various 
concentration of DOX. Percentage survival was calculated relative to the control that 
is expressed as 100 %. Mean marked with (*) are significantly (*P<0.001) lower than 
the control. 
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As mentioned before, HepG2 is a hepatocellular carcinoma (HCC) cell line. 
Doxorubicin (DOX) is a commonly prescribed chemotherapeutic drug for treating 
H C C . Thus, M T T assay was also carried out to study the cytotoxic effect of D O X on 
HepG2 cells so that it can be used to compare with HKl8. Various concentrations 
were used to incubate with HepG2 cells for 24 and 48 hours. As shown in Fig 3.1b, 
the percentage of survival decreased with increasing concentrations of D O X . Most of 
the cells died at the concentration 25 [xM and 12.5 |iM for 24 and 48 hours 
incubation respectively. The IC 50 were around 4.5 jiM and 1 \iM for 24 and 48 hours. 
Thus, D O X also possesses cytotoxic effect on HepG2 cells in a dose and time 
dependent manner. And our data also indicated that HKl8 was a high potency 
anti-tumor drug and had a comparable IC50 with this promising chemotherapeutic 
drug, D O X . The following tabic summarizes the IC50 of HKl8 and D O X on HcpG2 
cells with difTcrent incubation time intervals. 
HKI8 DOX 
24 hours 3.5 f.iM 4.5 }.iM 
48 hours 2.5 V^ lM 
Table 3.1 S u m m a r y of the I C 5 0 of HK18 and DOX on HepG2 cells treating for 
24 and 48 hours by M T T assay. 
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3.1.2 Study of the Cytotoxic Activity of HK18 on HepG2 Cells by 
Tryphan Blue Exclusion Assay 
Apart from M T T assay, tryphan blue exclusion assay was also performed to 
study the cytotoxicity of HK18 on HepG2 cells. After treating HepG2 cells with 
various concentrations of HK18 for 24 and 48 hours, cells were collected and loaded 
with tryphan blue and cell counting was performed. As indicated in Fig 3.2, HK18 
was shown to have cytotoxic effect on HepG2 cells in a dose and time dependent 
manner. 
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Fig 3.2 Study of the cytotoxicity of HKl8 on HepG2 cells by tryphan blue 
exclusion assay. 1.5 x 10^  cells / ml of HepG2 cells were seeded into a 6 well plate i 
and incubated with 0, 3, 5, 7 and 1 0 |LIM of HKl 8 for 24 and 48 hours respectively. 二 
After treatments, cells were collected and loaded with tryphan blue then cell counting 
was performed. Cells stained blue were dead cell while cells remain unstained were 
regarded as viable cells. Data are from a representative of three separate experiments. 
Percentage viability was calculated as: no. of viable cells / no. of total cells x 100 % 
and was plotted against concentration of HKl 8. 
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3.2 Cytotoxicity of HKl8 on R-HepG2 Cells 
R-HepG2 cells were derived from HepG2 cells incubated with stepwise 
increased concentrations of D O X . They have acquired the over-expression of 
P-glycoprotein and thus are multidrug resistant. In this research project, the activities 
of HKl 8 on R-HepG2 cells were studied. First of all, its cytotoxicity on R-HepG2 
cells were studied by M T T assay and tryphan blue exclusion assay. 
3.2.1 Study of the Cytotoxic Activity of HK18 on R-HepG2 Cells by 
MTT Assay 
jj 
Various concentrations of HKl 8 were incubated with R-HepG2 cells for 24 
and 48 hours. The concentrations used were 0, 1，2, 3，4, 5, 6，7, and 10 jiM. As | 
.丨 
shown in Fig 3.3 a, HKl8 was cytotoxic to R-HepG2 cells in a dose and time [I 
i 
\ 
dependent manner. Most of the cells died at the concentration 6 |LIM and 10 |LIM for ; 
24 and 48 hours respectively. The IC50 was around 3.5 jiiM for 24 hours treatment 
and 2.5 [iM for 48 hours treatment. There was around 100 % survival for 0.02 % 
；!j 
.瑰 
D M S O solvent control. 
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Fig 3.3 Study of cytotoxicity of HKl8 and DOX on R-HepG2 for 24 and 48 
hours by M T T assay. 2 x 10^ cells / ml were incubated with various concentration 
of HKl 8 or D O X 
in a 96 well plate for 24 or 48 hours. After treatment, M T T assay 
was carried out. Percentage of survival was plotted against concentration of drug 
added, (a) Percentage survival ofR-HepG2 upon various concentration of HKl 8. (b) 
Percentage survival of R-HepG2 upon various concentration of DOX. The 
percentage of survival was calculated as relative to the control that is expressed as 
100 o/o. Mean marked with (*) are significantly (*P<0.001) lower than the control. 
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Besides, the cytotoxic effect of D O X was also examined on R-HepG2 cells 
by M T T assay. Various concentrations of D O X (up to 250 juM) were used for 24 and 
48 hours treatment. Since there was over-expression of p-glycoprotein in R-HepG2 
cells, they are more resistant to the action of D O X . As shown in Fig 3.3 b, D O X was 
cytotoxic to R-HepG2 cells in a concentration and time dependent manner. However 
the IC50 were much higher than its parental cells HepG2. The IC50 of D O X on 
R-HepG2 cells were around 68 |aM for 48 hours and greater than 250 ^ M for 24 
hours treatment. The IC50 of HKl 8 and D O X on R-HepG2 cells with different 
incubation time intervals was summarized in Table 3.2. 
24 hours 3.5 jiM > 250 ^iM ； 
illillllillltliill?^  j 
48 hours 2.5 |LIM 68 |IM 
L 1 J I 
Table 3.2 Summary of the IC50 of HK18 and DOX on R-HepG2 cells treating for 
24 and 48 hours by MTT assay. 
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3.2.2 Study of the Cytotoxic Activity of HKl8 on R-HepG2 Cells by 
Tryphan Blue Exclusion Assay 
Tryphan blue exclusion assay was also carried out to study the cytotoxicity 
of HKl8 on R-HepG2 cells. The following concentrations of HKl8: 3，5, 7 and 
10 [iM were used to incubate with R-HepG2 cells for 24 and 48 hours. As shown in 
Fig 3.4，HKl8 was cytotoxic to R-HepG2 cells on a dose and time dependent 
manner. 
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Fig 3.4 Study of the cytotoxicity of HK18 on R-HepG2 cells by Tryphan blue j 
exclusion assay. 2 x 10^ cells / ml of R-HepG2 cells were seeded into a 6 well plate 
and incubated with 0, 3, 5, 7 and 10 jiiM of HKl8 for 24 and 48 hours respectively. 
After treatments, cells were collected and loaded with tryphan blue and then cell 
counting was performed. Cells stained blue were dead cells while cells remain 
unstained were regarded as viable cells. Data are from a representative of three 
separate experiments. Percentage viability was calculated as: no. of viable cells / no. 
of total cells x 100 % and was plotted against concentration of HKl 8. 
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3.3 Cytotoxicity of HKl8 on Macrophages 
The cytotoxicity of HKl 8 on normal primary cells, using macrophages as a 
model, was also studied. Macrophages ( M O ) were collected from balb/c mice as 
mentioned in the chapter of Materials and Methods. M O obtained were seeded to a 
96 well plate and 2.5 |LIM and 5 [iM of HKl 8 were added for 48 hours incubation. 2.5 
[iM was used since the IC50 obtained from M T T assay for HepG2 and R-HepG2 cells 
for 48 hours treatment were 2.5 [iM. Apart from 2.5 ^ iM, 5 |LIM was used since it 
induced around 80 % cytotoxicity on both cell lines for 24 hours treatment. This 
concentration, 5 [iM would further used for the mechanistic studies of HKl8 on 
HepG2 and R-HepG2 cells. After treatment, M T T assay was carried out. The 
percentage survivals were plotted against the concentration of HKl8. Along with 
I 
M O , the percentage survivals of HepG2 and R-HepG2 cells against 2.5 |LIM and 5 
\ 
|LIM of HKL8 were also plotted for comparison. As shown in Fig 3.5, the percentage ( 
survivals o f M O , HepG2 and R-HepG2 cells upon 2.5 |LIM HKl 8 were around 90 %, 
52 % and 48 % respectively. While at 5 |LIM HKl 8, the percentage survival were ' 
around 70 %, 10 % and 12 % for M O , HepG2 and R-HepG2 cells respectively. 
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Fig 3.5 Comparison of the cytotoxicity of HK18 on macrophages, HepG2 and 
R-HepG2 cells. Macrophages collected from balb/c mice, HepG2 and R-HepG2 
cells were incubated with 2.5 and 5 |LIM of HKl 8 for 48 hours. After treatment, M T T 
assay was carried out. Percentage survival was calculated as relative to the control 
that is expressed as 100 % and was plotted against concentration of HKl 8 according 
to the cells. 
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3.4 Hemolytic Activity of HKl8 
As mentioned in the Introduction chapter, hemolysis is a common feature 
of saponins. Thus, the hemolytic ability of H K l 8 was studied. H K l 8 was used to 
incubate with red blood cells collected from SD rat with the concentrations of 3, 5, 7, 
10，20, 40, 80 and 120 ^ M . From Fig 3.6, it showed that HKl8 induce hemolysis in a 
dose dependent manner with LD50 around 70 |aM and about 80 % hemolysis at the 
concentration of 1 2 0 |LIM. However, only a small proportion of red blood cells were 
lysed (< 3 % ) at the concentration of IC50 (i.e. 3.5 ^ M for 24 hours) obtained from 
the M T T assay on HepG2 cells as well as R-HepG2 cells and around 7 % hemolysis 
observed at the maximum concentration (10 juM) applied on HepG2 cells and 
R-HepG2 cells for studies. 
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Fig 3.6 Study of the hemolytic activity of HK18. Red blood cells were collected 
from 200-220 g SD rat and were incubated with various concentrations of HKl 8. 
After incubation, absorbance was measured by spectrometer. The readings indicated 
the extent of hemolysis. The percentage of hemolysis was plotted against the 
concentration of HKl 8. 
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3.5 In vivo Study of the Toxicity of HKl8 
The toxicity of HKl 8 was further investigated by in vivo study. 342 jag / kg 
of HKl 8 which is equivalent to 5 \xM final circulation concentration was injected to 
a group of balb/c mice via intravenous injection. In parallel with HKl 8, a group of 
mice were treated with saline only as control and 0.4 % 7 -cyclodextrin as solvent 
control. 7 -cyclodextrin was used instead of D M S O as solvent since 
r -cyclodextrin is a commonly used clinical solvent. The treatments last for two 
weeks with intravenous injection applied every alternative day. After treatments, the , 
i 
mice were sacrificed and serum was collected. The enzymes levels were then ： 
measured to examine tissues damage. Creatine kinase (CK) and lactate 
dehydrogenase (LDH) are the biomarkers of heart tissue damage while aspartate 
！ i： 
transaminase (AST) and alanine transaminase (ALT) are the hallmarks of liver | \ 
damage. The enzyme levels are directly proportional to the degree of corresponding ； 




It has been found that 342 fig / kg of H K 18 was non-toxic to both heart and 
liver tissues since the levels of all the four enzymes were more or less similar to the 
control and solvent control (Fig 3.7 and 3.8).. 
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Fig 3. 7 In vivo studies of the toxicity of HKl8 by measuring the heart tissue 
specific enzymes CK and LDH. 3 groups of mice were treated with saline, 0.4 % 
r -cyclodextrin or 342 \xg / kg HKl8 via intravenous injection every alternate day 
for 2 weeks. After treatments, mice were killed and serum was collected. The serum 
enzyme levels were then measured based on their enzymatic activities, (a) C K 
enzymatic activity, (b) L D H enzymatic activity. n = 6. 
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Fig 3. 8 In vivo studies of the toxicity of HKl8 by measuring the liver tissue 
specific enzymes AST and ALT. 3 groups of mice were treated with saline, 0.4 % 
r -cyclodextrin or 342 jig / kg HKl8 via intravenous injection every alternate day 
for 2 weeks. After treatments, mice were killed and serum was collected. The serum 
enzyme levels were then measured based on their enzymatic activities, (a) AST 
enzymatic activity, (b) ALT enzymatic activity, n = 6. 
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4 Mechanistic Study of HKl8 on HepG2 Cells 
4.1 Hallmarks of Apoptosis Induced by HKl 8 on HepG2 
Cells 
Nowadays, there are several approaches in treating cancer. One of them is 
the induction of cell cycle arrest. Tumor cells are cells undergoing uncontrollable cell 
division. Thus an agent, which obstructs the cell cycle progression, can be used for 
cancer treatment. Besides, the induction of cell differentiation is another approach. 丨 
The principle of this approach is the induction of active proliferating progenitor cells j 
into non-proliferating or less active proliferating cells such as promyelocytic \ 
leukemia cells into monocytic cells. Apart from cell cycle arrest and cell 
differentiation, induction of apoptosis is another important approach. Since HKl8 ’ 
i 
i 
was found to be cytotoxic to HepG2 cells, its apoptotic inducing ability was 〜 
investigated in this project. 
There are several hallmarks observed during apoptosis, such as : 
morphological changes including chromatin condensation, cellular shrink and 
apoptotic bodies formation. Biochemical changes also resulted including plasma 
membrane alternation as indicated by extemalization of phosphatidylserine (PS), 
D N A fragmentation and caspases activation (Webb et aL, 1997). 
4.1.1 Induction of Phosphatidylserine Extemalization by HK18 on 
HepG2 Cells 
Phosphatidylserine (PS) is a phospholipid normally restricted to the inner 
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leaflet of the plasma membrane. However, during apoptosis, PS usually flipped from 
the inner to the outer membrane. This extemalization property is one of the 
biochemical events occur during apoptosis and is usually precedes other 
morphological changes. It is a critical property for the maintenance of homeostasis of 
an organism. It is because exposure of PS on cell surface is a stigma for phagocytosis 
by macrophages. Thus, the dying cells can be removed before they lose membrane 
integrity and leakage of cellular substances into surrounding and cause inflammation 





This property can be made use to study early apoptosis and necrosis / late ； 
丨)i 
apoptosis in the combination of FITC conjugated Annexin V and propidium iodide 丨 
(PI). Intact cell membrane of viable and early apoptotic cells can exclude a number 
I 
of substances such as PL On the contrary, necrotic and late apoptotic cells usually ‘ 
\ 
lose membrane integrity and thus allow PI to enter. Annexin V binds tightly with PS \ 
in the presence of calcium. Thus fluorescence FITC conjugated Annexin V can be 
used to stain the PS existing in the outer leaflet of plasma membrane of apoptotic 
cells (Spactor et al” 1998)(Fig 4.1 a). 
By combining these changes of membrane integrity and PS localization, 
early apoptosis and nercosis / late apoptosis can be distinguished by using flow 
cytometry. Annexin V-FITC intensity can be detected at the FL-1 channel while PI 
intensity can be detected at the FL-3 channel. For normal viable cells, both 
fluorescence dyes are excluded from the cells. Therefore, both of the Annexin V and 
PI intensity were low which can be observed at the lower left quadrant of the density 
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plot ofFL-1 against FL-3 (Fig 4.1 b). While during early apoptosis, Annexin V binds 
to the exposed PS but PI was excluded. This was indicated as a cell population at the 
lower right quadrant. On the other hand, for cells undergoing necrosis or late 
apoptosis, the cells will be stained with both dyes, which appeared as a cell 
population at the upper right quadrant. The percentage of cell populations in each 
quadrant can be analyzes and so it allows quantification of apoptosis. 
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Fig 4.1 Quantification of apoptosis by Annexin V-FITC conjugate and PI by 
flow cytometry, (a) Schematic diagram showing the binding of Annexin V-FITC 
and PI to apoptotic or necrotic cells, (b) The density plot can be divided into four 
quadrants for distinguish and quantification of viable, early apoptotic and later 
apoptotic / necrotic cells. 
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Extemalization of PS of HKl 8 treated HepG2 cells were studied by 
Annexin V 一 FITC and P I staining, in this assay, 3, 5 and 7 |LIM of HKl 8 were used 
to incubate with HepG2 cells for 24 hours. From the density plots (Fig 4.2), two 
additional cell populations were observed in the lower right and upper right 
quadrants of HKl 8 treated cells. The percentage of cells in the lower left quadrant, 
which represent the percentage of viable cells, decreased from 86.6 % of control to 
53.7, 40.6 and 36.3 % of treatments at 3，5 and 7 [xM of HKl8 respectively. On the 
other hand, the percentage of cells in the lower right quadrant, which indicate the , 
percentage of early apoptotic cells, increased from 7.9 % of control to 28.4, 34.7 and 
I' 
38 .9 % for treatments of 3, 5 and 7 |LIM of HKl 8 respectively. The folds of increase f 
were 3.6, 4.4 and 4.9 folds respectively. The percentage of cells in the upper right ( 
quadrant also increased from 5.3 % of control to 16.2, 21.3 and 19 % for 3, 5 and 7 
；I 
I^M of HKl 8 which indicate the percentage of necrotic / late apoptotic cells. ; 
Therefore, HKl 8 could induce apoptosis in a dose-dependent manner. At the 
concentration of 7 fiM, the percentage of D M S O was 0.014 % and it was used to 
incubate with HepG2 cells as a solvent control. The density plot of solvent control 
was similar to the control one; thus, the changes of distribution of cells for HKl 8 
treated HepG2 cells were contributed by HKl 8 solely. Besides, a positive control 
was performed to verify this experiment, by adding 20 mg/ml digitonin which binds 
with cholesterol of plasma membrane and hence increase cell permeability. From the 
result，most of the cells of the positive control were located at the necrotic / late 
apoptotic region. 
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Fig 4.2 Phosphatidylserine extemalization induced by HKl8 on HepG2 cells. 
1.5 X 10^  cells / ml ofHepG2 cells were seeded into a 6 well plate and 3, 5 and 7 jiM 
of HKl 8 were added to incubate for 24 hours. After treatment, cells were collected 
and loaded with Annexin V-FITC and PI for staining and followed by flow 
cytometric analysis. 20mg / ml digitonin was added to act as a positive control. Data 
are from a representative of five separate experiments. 
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4.1.2 Induction of DNA Fragmentation by HK18 on HepG2 Cells 
D N A fragmentation is a common feature of apoptosis in most, though not 
all，cell types. During apoptosis, endonuclease was activated which cleave the 
genomic D N A first into large fragments of 30-50 kilobases and further cleave at the 
linker regions between nucleosomes (Webb et al., 1997). The resulted 
oligonucleosomal fragments can be detected as multiples of 180 - 200 base pairs, 
which can be assessed by agarose gel electrophoresis. The fragmented D N A would 
appear as a ladder after electrophoresis and so this method is called DNA-ladder 
development (Spactor et a l , 1998). 
The ability of HKl 8 to induce D N A fragmentation on HepG2 cells was 
studied. HepG2 cells were incubated with various concentrations of HKl 8 as 1，3, 5, 
7 and 10 [iM for 24 and 48 hours. Cells without HKl 8 and with 0.02 % D M S O were 
also carried out to act as medium control and solvent control respectively. From the 
result of 24 hours incubation, D N A ladder developed at the concentration of 5, 7 and 
1 0 [iM but not in the control, solvent control, 1 and 3 |LIM of HKl 8 (Fig 4.3). This 
indicated that HKl 8 could induce D N A fragmentation at the concentration above 5 
[iM after 24 hours incubation. For 48 hours, D N A ladder was observed at a lower 
concentration of 3 |aM apart from 5, 7 and 10 |LIM. Thus, HKl8 could induce D N A 
fragmentation in a time dependent maimer. However, since D N A fragmentation only 
gives a qualitative assessment, we cannot conclude HKl 8 induce D N A 
fragmentation of HepG2 cells in a dose-dependent manner. 
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Fig 4.3 Induction of DNA fragmentation in HKl8 treated HepG2 cells. 
1.5 X 10' cells/ ml of HepG2 cells were seeded into a 6 well plate and various 
concentrations of HKl8 were added for 24 or 48 hours incubation. After treatments, 
cells were collected and D N A was extracted and subjected to gel electrophoresis. 
(a) 24 hr incubation. Lane 1: 100 base pairs marker. Lane 2: Medium control. Lane 3: 
0.02 % D M S O solvent control. Lanes 4 - 8 : 1, 3, 5, 7 and 10 ^ M of HKl8. 
(b) 48 hr incubation. Lane 1: 100 base pairs marker. Lane 2: Medium control. Lanes 
3 -7: 1, 3，5，7 and 10 fiM HK18. Lane 8: 0.02 % D M S O solvent control. Data are 
from a representative of five separate experiments. 
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4.2 Study of the Underlying Mechanisms of HKl8 Induced 
Apoptosis in HepG2 Cells 
From the above assays, it can be concluded that HKl 8 was able to induce 
apoptosis in HepG2 cells. After that, the mechanisms of its apoptosis-inducing ability 
were studied in this research project. 
4.2.1 The Role of Mitochondria in HK18 Induced Apoptosis of 
HepG2 Cells 
Recently, more and more studies have given evidences that mitochondria 
play an important role in regulating apoptosis. Mitochondrial permeability transition 
(MPT) plays an active role in apoptosis (Zamzami et a l , 1996; Marchetti et al.’ 1996; 
Green and Reed, 1998). The proposed M P T pore composed of several components, 
which form a complex, spans both the inner and outer mitochondrial membrane. 
They are the voltage-dependent anion channel (VDAC) (located at outer membrane), 
the adenine nucleotide translocator (ANT) (located at the inner membrane), the 
peripheral benzodiazepin receptor (located at the outer membrane), cyclophilin D 
(located at the matrix), creatine kinase (located at the intermembrane space) and 
hexokinase (located at the outer surface of outer membrane) (Kroemer and Reed, 
2000; Crompton, 1999). The proposed schematic diagram of M P T pore complex was 
shown in Fig 4.4 (Costantini et al., 2000). 
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Fig 4.4 Proposed schematic diagram of MPT pore complex. VDAC: voltage 
dependent anion channel; ANT: adenine nucleotide translocator; PBR: 
peripheral benzodiazepin receptor; HK: hexokinase, Bcl-2 and Bax: anti-apoptotic 
and pro-apoptotic Bcl-2 family proteins; CK: creatine kinase; Cyp-D: cyclophilin 
D; SH: thiol group and ¥ m : mitochondrial membrane potential. (Modified from 
(Costantini et a l , 2000)). 
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There are several well known conditions, which are able to induce MPT. 
They are oxidative stress, high intracellular calcium concentration, low ATP, high 
ADP, high pH and mitochondrial membrane potential depolarization (Lemasters et 
al., 1998; Crompton, 1999). Once the M P T pores open, solute with molecular weight 
smaller than 1,500 Da will escape from the boundary of mitochondria into cytoplasm 
and the mitochondrial membrane potential may be collapsed (Crompton, 1999). 
It was proposed that during MPT, the highly folded mitochondrial inner 
membrane was allowed to expand. Since the surface area of the inner membrane is 
greater than the outer membrane, such expansion was thought to cause membrane 
rupture and release of intermembrane apoptogenic protein such as cytochrome c and 
apoptosis inducing factor (AIF) to trigger apoptosis. There are many researches 
proving that cytochrome c and AIF are released into cytosol before apoptotic 
alternation observed. And studies have found that inhibition of M P T would inhibit 
apoptosis (Kroemer and Reed, 2000; Crompton, 1999). 
In view of this, the involvement of mitochondria in HKl 8-induced HepG2 
cells apoptosis was carried out in this research project. 
4.2.1.1 HK18 Induced Mitochondrial Membrane Depolarization in HepG2 Cells 
Mitochondria are regarded as the powerhouses of a cell. Under normal 
physiological conditions, the transmembrane potential difference is around 180 m V 
with negative charge on the matrix side and positive charge on the cytosolic side. 
The maintenance of potential difference is contributed by the proton gradient across 
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the membrane, which is critical for energy production (Stryer, 1995b). However, 
during apoptosis, the mitochondrial membrane potential ( ¥ m ) may collapse . 
To measure the potential difference, cationic lipophilic fluorescent dyes can 
be used. In this project, JC-1 was used. The uptake of this dye by mitochondria is 
driven by the negative charge. They will aggregate to form dimer in the inner 
mitochondrial membrane and give out red fluorescence (Cossarizza et al., 1993; 
Reers et al., 1995), which can be measured by flow cytometry at the FL-3 channel. 
However, when the mitochondria become depolarize, the dimerized JC-1 dye will 
break down into monomer and give out green fluorescence as measured at the FL-1 
channel. Thus, increase of green fluorescence with decrease of red fluorescence 
implies depolarization. 
Effect of HKl 8 on the mitochondria potential of HepG2 cells was studied. 
As shown in Fig .4.5, 3，5 and 7 |liM of HKl 8 were used to incubate with HepG2 cells 
for 12 and 24 hours. The x-axis of the contour plot shows the green fluorescence of 
monomelic JC-1 while the y-axis shows the red fluorescence of dimeric JC-1. The 
contour plots were divided into two regions. The region R1 indicated the cell 
population with higher green but lower red fluorescence which reflect W m 
depolarization. For 12 hours incubation, the cell population in R1 increased from 9.3 
% of control to 22.6 % and 23.5 % for 5 and 7 j^M of HKl8 respectively. The 
increment was more significant for 24 hours incubation. The cell population in R1 
increased to 22.4，35.6 and 41.3 % for 3, 5 and 7 |iM respectively which were around 
2.4，3.8 and 4.4 folds of the control. Therefore, it was obvious that HKl 8 was able to 
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induce W m depolarization in a dose and time dependent manner. Besides, a solvent 
control (0.014 % D M S O ) and a positive control (500nM Valinomycin) were 
performed. Valinomycin is a chemical, which could induce M P T (Furlong et al., 
1998). For the solvent control, the percentage in the R1 region is similar to the 
control one. Thus the W m depolarizing activity was attributed to HKl8. For the 
positive control, almost all cells fell in the region R1. 
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Fig 4.5 Induction of mitochondrial membrane potential depolarization in HK18 
treated HepG2 cells. 1.5 x 10^  cells / ml were seeded into a 6 well plate and various 
concentrations of HKl 8 were added as indicated for 24 and 48 hours. After 
treatments, cells were loaded with JC-1 and fluorescence intensity was recorded by 
flow cytometry, (a) and (b) control and 0.014 % D M S O solvent control, (c) 500 n M 
valinomycin as positive control. Plots (d)-⑴ 3, 5 and 7 i^M H K 18 for 24 hr 
incubation. Plots (g)-(i) 3, 5 and 7 juM of HKl 8 for 48 hr incubation. Data are from a 
representative of five separate experiments. 
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4.2.1.2 Addition of Bongkrekic Acid Reduced HK18 Cytotoxicity on HepG2 cells 
To study the requirement of M P T in HKl 8 treated-apoptotic cells, M P T 
inhibitors were added. The most widely used M P T inhibitors are cyclosporin A and 
Bongkrekic acid (Crompton, 1999; Zamzami et al., 1996; Marchetti et al., 1996). 
Bongkrekic acid (BA) is an unsaturated fatty acid produced by 
Pseudomonas cocovenans on partially defatted coconut. Its name has been derived 
from "bongkreck", a moulded coconut product from Banjoemas (Indonesia) 
(Lijmbach et a l , 1970). 
B A was used to study M P T since it is an M P T inhibitor via binding with the 
adenine nucleotide translocator (ANT), one of the components of the M P T pore 
complex. A N T is the transporter, which transports A D P / ATP across the 
mitochondria membrane. When binding with its substrate, it oscillates between two 
conformations in which the A D P / ATP binding site is either on the matrix side or on 
the cytosolic side. By such conformational change, the A D P and ATP will be 
transported across the membrane. However, when A N T is binding with its ligand, 
which stabilizes the matrix-side conformation, M P T will be prohibited (since it has 
been found that the cytosolic-side conformation is critical for MPT). B A is the ligand 
which stabilizes the matrix-side conformation, thus it can inhibit M P T (Crompton, 
1999; Zamzami et al., 1996; Marchetti et al； 1996). 
In order to study whether M P T was involved in HKl8 induced HepG2 cells 
apoptosis, HKl 8 was added in the presence of B A and then M T T assay was 
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performed. For 24 hours incubation, 5 [iM of HKl 8 induced around 80 % 
cytotoxicity on HepG2 cells from M T T assay. Thus, 5 |LIM of HKl 8 was used for 
study. 
In this experiment, 5 |LIM of HKl 8 was used to incubate with HepG2 cells in 
the presence or absence of 50 B A for 24 hours. 50 fiM B A alone was also 
incubated for 24 hours to study its effect on HepG2 cells. After incubation, M T T 
assay was performed. The result was shown as Fig 4.6. 
From the result, it has been found that addition of B A could reduce the 
cytotoxicity of HKl 8 on HepG2 cells. The percentage survival rose from around 
15.8 % to 42.2 % in the presence of B A which was significantly higher (p< 0.001) 
than the cells under 5 [iM HKl 8 alone (Fig 4.6 a). Actually, B A has shown to have a 
dose-dependent inhibitory effect on HKl 8 induced apoptosis in HepG2 cells. As 
demonstrated by incubating HepG2 cells with 5 |LIM HKl 8 in the presence of 25, 50 
and 100 [iM of B A (Fig 4.6 b). From the result of this experiment, M P T has been 
shown to play an important role in HKl 8 induced apoptotic cell death. 
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Fig. 4.6 Addition of BA would reduce the cytotoxicity of HKl8 toward HepG2 
cells. 1.5 X 10^ cells / ml of HepG2 cells were seeded to a 96 well plate for 24 hours 
treatment, (a) Cells were treated with 5 jiM of HKl 8 in the presence or absence of 
5 0 | L I M B A for 2 4 hours, (b) Cells were treated with 5 |iM H K L 8 with 0, 25, 50 or 
100 [iM B A for 24 hours. After treatments, M T T assay was carried out to find out 
the percentage of survival. The percentage survival was calculated as relative to the 
control that is expressed as 100 %. Mean marked with (*) indicated that the value is 
significantly higher (* p<0.001) than the percentage survival of 5 j^M HKl 8 
treatment. 
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4.2.1.3 Elevation of Intracellular Hydrogen Peroxide Level in HK18 Treated 
HepG2 Cells 
There are increasing studies showing that intracellular free radicals level is a 
modulator of apoptosis. Mitochondria are the most abundant source of reactive 
oxygen species (ROS). During oxidative phosphorylation, electrons are transferred 
through the electron transport chain, which localized in the inner mitochondrial 
membrane. In most circumstances, four electrons are funneled into one O2 molecule 
to completely reduce it into H2O and concomitantly pump protons from the matrix to 
the cytosolic side of the inner mitochondrial membrane (Stiyer, 1995b). 
However, a small amount of superoxide anion O2 ' is unavoidable to form if 
only one electron was funneled to a O2 molecule. This superoxide anion is highly 
destructive, thus must be removed. Our bodies have developed some defense 
mechanism to work against the accidentally formed ROS. The defense system can be 
divided into enzymatic dependent and independent systems. For the enzymatic 
dependent system, several enzymes are included. Superoxide dismutase (SOD) 
which exists as two isoforms: mitochondrial SOD (Mn-SOD) and cytosolic SOD 
(Cu-dependent SOD). They scavenge two superoxide anions into one hydrogen 
peroxide H2O2 and one O2 molecule. The H2O2 formed will then scavenged by 
another enzyme, namely catalase, into a water and oxygen molecule or being 
converted into H2O by the action of glutathione peroxidase. 
The non-enzymatic defense system includes water soluble agents such as 
glutathione (GSH), ascorbate, uric acid and plasma proteins as well as lipid soluble 
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agents including a -tocopherol, /5 -carotene and bilirubin. Despite of these, still 
some of these R O S escape from the defense systems and leak out from the 
mitochondria and cause damages to the macromolecules including lipids, proteins 
and D N A of cells. Therefore, increased intracellular ROS will lead to necrosis of 
cells. 
Although ROS is harmful, recent studies have found that these ROS play an 
important role in mediating apoptosis (Kroemer and Reed, 2000; Crompton, 1999; 
Lemasters et al., 1998). But how cells react with ROS for different consequences is 
still an open question. It has been proposed that a very high intracellular H2O2 (>500 
I^M) will lead to necrosis while medium intracellular H2O2 (25-500 |iM) will end up 
with apoptosis. On the other hand, low H2O2 (<25 |LIM) may induce cell proliferation. 
Some tumors have transformed to over-produce ROS (Pervaiz and Clement, 2002). 
Actually the aroused interest towards the apoptotic mediating activity of 
ROS is due to the discovery of anti-oxidative activity of the anti-apoptotic Bcl-2 
protein. Up to now, the mechanisms of ROS induced apoptosis are under elucidation. 
One of the proposed mechanisms is that the ROS enhance the cytosolic Ca^^ (Suzuki 
et al, 1997) and stimulate some transcriptional factors such as NF n B, AP-1 and p53, 
which may up -regulate death proteins or produce inhibitors of survival proteins 
(Suzuki et aL, 1997; Chandra et al., 2000). Another proposed mechanism is that the 
released H2O2 will act on mitochondria to cause M P T and W m depolarization and 
subsequently cytochrome c release (Pervaiz and Clement, 2002; Chandra et al., 
2000). And studies have found that oxidation of the M P T pore complex under 
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mitochondrial oxidative stress was able to induce M P T (Costantini et aL, 1996). The 
suspected oxidative modification site was located at the A N T component (Costantini 
et aL, 1996). 
In view of this, intracellular H2O2 level of HKl 8 treated HepG2 cells was 
measured by flow cytometry with fluorescence dye, carboxy-HiDCFDA. The 
non-fluorescent carboxy-HiDCFDA passively diffused into cells, where the acetates 
are cleaved by intracellular esterases into carboxy-HiDCF. Oxidation of 
carboxyl-HzDCF occurs almost exclusively in cytosol and produces a fluorescent 
carboxyl-DCF (Cathcart et aL, 1983). 
In this experiment, 5 jiM of HKl 8 was used to treat HepG2 cells for 12 
and 24 hours while 0.01 % D M S O was used as a solvent control. It was found that 
HKl 8 was able to induce H2O2 accumulation in a time-dependent manner. The 
maker M l of the histograms (Fig. 4.7) indicated the percentage of cells with higher 
DCF intensity (i.e. higher H2O2 level). The higher the intracellular H2O2 level, the 
greater the shift of the fluorescence peak. From the histograms, 0.01 % D M S O had 
similar M l percentage with control (11.5 % vs 11.2 % ) while at 12 and 24 hours, the 
percentage of cells with higher H2O2 was 23.9 and 35.3 % respectively. That meant 
the intracellular H2O2 level for 12 and 24 hours treatment were around 2 and 3 folds 
of the control. 
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Fig 4.7 Intracellular H2O2 level of HepG2 cells was enhanced by HK18. 1.5 x 10^ 
cells / ml of HepG2 cells were seeded into a 6 well plate with 5 ^ M of HKl 8 for 12 
or 24 hours incubation. After treatments, cells were collected and loaded with DCF. 
The marker Ml showed the percentage of cells with higher DCF intensity, which 
reflects cells with higher intracellular H2O2 level, (a) Histogram plotting control 
against 0.01% D M S O solvent control, (b) Histogram plotting control against 5 ^ iM of 
HK18 for 12 hours, (c) Histogram plotting control against 5 jiM of HK18 for 24 
hours, (d) The table summarizes the percentage of cells in Ml. The data are from a 
representative of five separate experiments. 
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As it was proposed that increased intracellular level of R O S would induce 
W m depolarization (Chandra et al,, 2000), the changes of both H2O2 and ¥ m were 
measured simultaneously by flow cytometry with two compatible fluorescence dyes 
T M R E for and DCF for H2O2. T M R E is a positively charged fluorescence dye 
and is uptaken by the negatively charged The fluorescence intensity would 
decrease when the cells become depolarized. 
Similarly, 5 |LIM of HKl 8 was used to incubate with HepG2 cells for 1 2 and 
24 hours and 0.01 % D M S O was used as solvent control. The x-axis of the contour 
plot (Fig. 4.8) shows the green fluorescence of DCF while the y-axis shows the red 
fluorescence of T M R E . The region R2 indicates the percentage of cells having higher 
DCF but lower T M R E fluorescence (i.e. higher H2O2 level but lower membrane 
potential). From the result, treating HepG2 cells with 5 ^iM HKl 8 for 12 hours 
would increase the percentage of cells in the R2 from 11.8% of control to 28.6 % (i.e. 
around 2.4 folds). The percentage of cells in the R2 region further increased to 35.7 
%, which is around 3 folds of the control at 24 hours. The percentage of cells in R2 
of solvent control was similar to the control one. Therefore, HKl 8 was able to induce 
intracellular H2O2 level accumulation with declined membrane potential 
simultaneously in a time dependent manner. 
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Fig 4.8 Study of the intracellular H2O2 level and Wm simultaneously of HK18 
treated HepG2 cells. 1.5 x 10^ cells / ml ofHepG2 cells were seeded into a 6 well 
plate and 5 |LIM HKl 8 was added for 12 and 24 hours incubation. After treatments, 
cells were collected and loaded with both DCF and TMRE. Fluorescence intensity of 
DCF was measured at the x-axis while T M R E was measured at the y-axis. (a) 
Control, (b) 0.01 % D M S O solvent control, (c) 5 | L I M HKl 8 for 12 hours and (d) 5  
jiM for 24 hours. Region R2 indicated the cells with higher DCF but lower T M R E 
intensity. Data are from a representative of five separate experiments. 
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4.2.1.4 Elevation of Intracellular Ca^ ^ Level in HK18 Treated HepG2 Cells 
Recently, studies have found that intracellular Ca^^ homeostasis was upset 
during apoptosis. It is well known that Ca^ "^  is an important physiological ion since it 
is a key intracellular messenger in many eukaryotic signaling pathways and is a 
mediator of many metabolic pathways. Thus, maintaining its homeostasis is very 
important. In a normal resting cell, the cytosolic Ca^^ level is maintained at around 
100 n M while the Ca^^ in extracellular, endoplasmic reticulum and mitochondria is 
maintained at the milimolar level (Stryer, 1995a). To maintain the low cytosolic Ca^^ 
level against the electrochemical gradient to ensure normal cell functions, several 
transporting systems exist for exclusion of Ca〗. from the cytosol. They are the 
ATP-dependent Ca^^ pump located in the plasma, ER and mitochondrial membranes 
I 2 1 
as well as the Na / Ca exchanger located in plasma and mitochondrial membranes. 
2+ 
Another one is the Ca uniporter located in mitochondrial membrane (Suzuki et al, 
1997). Mitochondria and ER are the major stores of intracellular Ca^^. The large 
electrochemical gradient favors the influx of Ca^^ from extracellular space or outflow 
of Ca from internal stores thermodynamically. 
Studies have found that increased intracellular ROS may act on the 
mitochondria, ER and plasma membranes. It has been proposed that increase of 
intracellular ROS will enhance cytosolic Ca〗. level, which come from intracellular 
and / or extracellular stores (Suzuki et al., 1997). It has been found that ROS would 
2 j 
induce Ca release from sarcoplasmic reticulum (SR) of smooth muscle cells by 
inhibiting the ATP-dependent Ca^^ pump and hence Ca^^ ions were able to passively 
diffiise from the SR into cytosol (Suzuki et al., 1997). Besides, it have been found 
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that oxidation of mitochondrial pyridine nucleotide including N A P H (due to the 
increase of mitochondrial ROS) would induce Ca^ "" release from mitochondria into 
cytosol (Suzuki et aL, 1997; Chakraborti et al., 1999). The elevated cytosolic Ca^^ 
• 2+ 
stimulates the Ca -dependent catabolic enzymes such as endonuclease and 
subsequently leads to apoptosis (Chakraborti et al., 1999; McConkey and Orrenius, 
1997). On the other hand, the elevated cytosolic Ca^^ would enhance mitochondria to 
take up Ca2+ (Smaili et al., 2000). The resulted mitochondrial Ca2+ overload would 
induce M P T opening and apoptosis (Crompton, 1999; Lemasters et al., 1998; Smaili 
et al., 2000; Bemardi et a l , 1999). 
Since there was elevation of intracellular ROS level in HKl 8 treated HepG2 
cells, the intracellular Ca concentration was also studied in this project by using 
flow cytometry with a fluorescence dye, Fluo-3/AM (Fluo-3). On binding with Ca^ "", 
the fluorescence intensity would increase (Fluo-3 is non-fluorescent until binding 
with Ca2+) which can be recorded at the FL-3 channel. 
In this experiment, 5 |iM of HKl 8 was used to incubate with HepG2 cells 
for 12 and 24 hours. The marker M l of the histograms indicated the cell population 
with higher Fluo-3 intensity, which meant higher intracellular Ca〗. level. As shown 
in the histograms (Fig 4.9), intracellular Ca^^ level was enhanced by HKl8. The 
percentage of M l increased from 8.4 % of control to around 36 % of 12 and 24 hours 
treatments, which was approximately 4 folds of the control. However, the rise was 
not time dependent since both of the time points showed similar percentage of 
increment. A positive control with 40 \ig/m\ ionomycin was performed for 
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verification. Inomycin would increase the permeability of biological membrane to 
divalent ions, especially Cd^^. Most of the cells (92 % ) of the positive control 
exhibited higher intracellular Ca^^ level. 
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Fig 4.9 Intracellular Ca2+ level of HepG2 cells was enhanced by HK18. 
1.5 X 10^ cells / ml of HepG2 cells were seeded into a 6 well plate and 5 juM of 
HKl 8 was added for 12 and 24 hours incubation. After treatment, cells were 
collected and loaded with Fluo-3. The marker M l showed the percentage of cells 
with higher Fluo-3 intensity, which reflects cells with higher intracellular Ca〗. level, 
(a) Histogram plotting control against 0.01% D M S O solvent control, (b) Histogram 
plotting control against the positive control (40 jug / ml Ionomycin). (c) Histogram 
plotting control against 5 |iM of HKl 8 for 12 hours, (d) Histogram plotting control 
against 5 of HKl 8 for 24 hours, (e) The table summarizes the percentage of cells 
within Ml. Data are from a representative of five separate experiments. 
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Recent studies have found that Ca2+ is one of the triggers of M P T and W m 
depolarization. (Crompton, 1999; Lemasters et a l , 1998; Smaili et al., 2000; 
Bemardi et al., 1999). Thus, effects of HKl8 on ¥ m and intracellular Ca]. level 
were measured simultaneously with T M R E and Fluo-3. 
In this experiment, 5 )iM of HKl 8 was incubated with HepG2 cells for 12 
and 24 hours. The x- and y-axis of the contour plots showed the Fluo-3 and T M R E 
fluorescence intensity respectively (Fig 4.10). The region R2 indicated the cells with 
higher Fluo-3 but lower T M R E intensity implied that the treated cells having higher 
Ca level but with collapsed W m . Therefore HKl 8 could induce intracellular Ca^ "^  
level elevated from 8.7 % of control to 25.8 % and 29.5 % of 12 and 24 hours 
treatments respectively, which was around 3 folds of the control. 
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Fig 4.10 Study of the intracellular Ca^ ^ level and ¥ m simultaneously of HK18 
treated HepG2 cells. 1.5 x 10^ cells / ml ofHepG2 cells were seeded into a 6 well 
plate and 5 |aM HKl 8 was added for 12 and 24 hours incubation. After treatments, 
cells were collected and loaded with Fluo-3 and TMRE. Fluorescence intensity of 
Fluo-3 was measured at the x-axis while T M R E was measured at the y-axis, (a) 
Control, (b) 0.01 % D M S O solvent control, (c) Positive control (40 jug/ml 
ionomycin), (d) 5 ^iM HKl 8 for 12 hours and (e) 5 jiiM of HKl 8 for 24 hours. 
Region R2 indicated the cells with higher Fluo-3 but lower T M R E intensity. Data are 
from a representative of five separate experiments. 
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4.2.1.5 HK18 Induced Cytochrome c and AIF Released from 
Mitochondria of HepG2 Cells 
Recent studies have found that during early stage of mitochondrial 
dependent apoptosis, a variety of mitochondrial intermembrane space proteins will 
be released. These include cytochrome c, apoptosis inducing factor (AIF), adenylate 
kinase-2 and Smac/DIABLO (Loeffler and Kroemer, 2000; Kohler et al., 1999; 
Verhagen et a l , 2000; Du et al., 2000). Release of these proteins into cytosol will 
trigger cellular catabolic destruction. 
Cytochrome c is a 15 kDa protein which normally located at the inner 
mitochondrial membrane. It is encoded by nuclear D N A . The protein is synthesized 
as the precursor apocytochrome c in cytosol and is then translocated to mitochondria 
spontaneously, which does not require membrane potential or general translocation 
machinery (Evans and Scarpulla, 1988; Mayer et al., 1995). Inside mitochondria, the 
precursor incorporates with a heme group and then refolded into functional 
cytochrome c molecule. Cytochrome c plays an important role in energy production. 
It transports electrons through the complex III to complex IV of respiratory chain. 
And most recent studies have found that release of cytochrome c into cytosol would 
induce caspases activation and subsequent apoptosis (Liu et al., 1996). 
Apoptosis inducing factor (AIF) is another apoptogenic protein being 
released from mitochondria into cytosol (Susin et aL, 1996). AIF is a 57 kDa 
flavoprotein encoded by the gene located on the X chromosome. It is synthesized in 
the cytosol and then transported into mitochondria and confined in the 
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intermembrane space (Daugas et al” 2000a). During apoptosis, AIF redistributed 
from the mitochondria into cytosol and nucleus. In isolated nuclei, addition of AIF 
would induce chromatin condensation as well as large scale D N A fragmentation (i.e. 
50 kbp D N A fragmentation) (Susin et al., 1996). Besides, AIF could induce PS 
extemalization to outer plasma membrane, collapse of ¥ m and release of 
cytochrome c (Susin et al., 1999). And its activities have been found to be 
caspases-independent. That means AIF mediate apoptosis in a different mechanism 
from cytochrome c (Loeffler et al., 2001; Daugas et al., 2000b). 
In this research project, the release of cytochrome c and AIF from 
mitochondria was examined. HepG2 cells were treated with 5 [iM of HKl 8 for 12 
and 24 hours. After treatment, protein was collected as mentioned in the chapter of 
Materials and Methods. The protein collected was then subjected to SDS 
electrophoresis and then probed with anti-cytochrome c or anti-AIF antibodies. Since 
the amount of protein loaded per sample was normalized by cell numbers, 
anti- - actin antibody was used to check the degree of normalization. 
As illustrated in Fig 4.11, cytochrome c was being released from 
mitochondria into cytosol after treating with 5 ^ iM of HKl 8 for 12 and 24 hours. The 
amount of cytochrome c released at 24 hours was greater than that at 12 hours. Apart 
from this, AIF was also being released from mitochondria into cytosol after treating 
with 5 |liM of HKl 8 for 24 hours. 
- 1 2 1 -
Chapter 5 Mechanistic Study of HKl 8 on R-HepG2 Cells 
1 2 3 4 





Fig 4.11 HKl8 induce mitochondrial cytochrome c and AIF release of HepG2 
cells. 1.5 X 10^  cells / m l ofHepG2 cells were seeded into 75 cm〗 culture flask. Cells 
were then treated with medium (lane 1), 0.01 % D M S O (lane 2), 5 ^ M HKl8 for 12 
hours (lane 3) or 5 i^M HKl 8 for 24 hours (lane 4). After treatment, cells were 
collected and cytosolic fraction was extracted as mentioned in the chapter of 
Materials and Methods. The cytosolic proteins were then subjected to Western 
analysis and were probed with anti-cytochrome c, anti-AIF or anti- -actin 
antibodies. Data are from a representative of three separate experiments. 
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4.3 Downstream Biochemical Changes Induced by HKl8 on 
HepG2 Cells 
Caspases activation is a common biochemical change occurred in most, 
though not all, apoptotic cells. Activated caspases will act on their substrates, which 
will then participate in apoptosis to destruct the cells (Zimmermann et al., 2001). 
4.3.1 Activation of Caspase 3 of HepG2 Cells by HK18 as 
Demonstrated by Western Blot 
First of all, the participation of caspase 3 was examined by Western blotting. 
Various concentrations of HKl 8 were used to incubate with HepG2 cells for 24 and 
48 hours. As illustrated in the film, the level of procaspase 3 protein (35 kDa) 
decreased when the concentration of HKl 8 increased (Fig 4.12). Thus, HKl 8 was 
able to induce caspase 3 activation in a dose-dependent manner. 
Besides, the level of PARP (poly(ADP-ribose)polymerase), one of the 
substrates of catalytically active caspase 3，is regarded to play a role in D N A repair 
(de Murcia et aL, 1997; Soldani and Scovassi, 2002) was also studied. Various 
concentrations of HKl 8 were used to treat HepG2 cells for 24 and 48 hours. As 
indicated in the film (Fig 4.12), the levels of uncleaved intact PARP (116 kDa) 
decreased while the cleaved PARP (85 kDa) increased when concentration of HKl 8 
increased. 
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Fig 4.12 Activation of caspase 3 and induction of PARP cleavage by HKl 8 on 
HepG2 cells. Cells were treated with various concentrations of HKl 8 for 24 and 48 
hours and were then subjected to Western analysis, (a) Probed with anti-pro-caspase 
3 (35 kDa) antibodies, (b) Probed with anti-PARP (116 kDa for intact PARP and 85 
kDa for cleaved PARP) antibodies. Data are from a representative of three separate 
experiments. 
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4.3.2 Induction of Caspases Activities of HepG2 Cells by HK18 as 
Demonstrated by Enzymatic Activity Assays 
Apart from studying the protein levels of caspase 3 by Western blot analysis, 
the enzymatic activity of caspase 3 was also studied. 5 |LIM of HKl 8 was used to treat 
HepG2 cells for 12 and 24 hours, and then protein was extracted. The protein extract 
was incubated with caspase 3 specific fluorescent A M C conjugated substrate 
Ac-DEVD-AMC. The amount of fluorescent A M C (}iM) released from the substrate 
by the action of caspase 3 was plotted against various treatments, which is directly 
proportional to its enzymatic activity. To confirm the correlation between the 
fluorescence signal and caspase 3 activity, caspase 3 specific inhibitor z-DEVD-fmk 
was added to the protein extract before addition of substrate. In the presence of 
inhibitor, the increased fluorescence intensity was prohibited. As shown in the bar 
chart (Fig 4.13), HKl 8 induced caspase 3 activity in a time dependent manner. The 
caspase 3 activities were around 6.05 folds and 10 folds of the solvent control for 12 
and 24 hours respectively. 
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Fig 4.13 Caspase 3 enzymatic activity of HepG2 cells was enhanced by HK18. 
1.5 X 105 cells / ml of HepG2 cells were seeded into 75 cm^ flask and medium, 
0.01 % D M S O control or 5 ^ iM of HKl 8 was added for 12 or 24 hours incubation. 
After treatment, cells were collected and lysed. The protein extracts were incubated 
with caspase-3 specific substrate Ac-DEVD-AMC in the presence or absence of 
caspase-3 specific inhibitor z-DEVD-fmk. The fluorescence intensity of A M C 
released was measured and the amount was calculated according to the standard 
curve. Data are means of three separate experiments. The folds of change of 
treatments were calculated as relative to the solvent control that is expressed as 1 
fold. Mean marked with (*) is significantly (* P < 0.05) higher than the solvent 
control. 
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In addition of caspase 3 enzymatic activity, activities of caspase 8 and 9 
were also studied. For measuring caspase 8 activity, caspase 8 specific substrate 
Ac-IETD-AMC was used instead. Similarly, the fluorescence intensity should be 
directly proportional to caspase 8 activity and caspase 8 specific inhibitor 
z-IETD-fmk was added before substrate addition for verification. As observed from 
the bar chart (Fig 4.14 a), there were no significant increase of caspase 8 activity for 
the HKl 8 treated HepG2 cells for 12 hours and 24 hours compared with the solvent 
control. 
On the other hand, caspase 9 specific fluorescent A F C conjugated substrate 
Ac-LEHD-AFC was employed to measure caspase 9 enzymatic activity in the 
presence or absence of caspase 9 specific inhibitor z-LEDH-ftnk. As illustrated in the 
bar chart (Fig 4.14 b), HKl 8 would induce caspase 9 activity. The activity of caspase 
9 was around 1.5 fold and 1.4 fold of that of solvent control for 12 and 24 hour 
treatments respectively. 
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Fig 4.14 Caspase 9 enzymatic activity of HepG2 cells was enhanced by HK18 
but not caspase 8. 1.5 x 10^ cells / ml of HepG2 cells were seeded into 75 cm^ flask 
and medium, 0.01 % D M S O control or 5 |iM of HKl 8 was added for 12 or 24 hours 
incubation. After treatment, cells were collected and lysed. (a) The protein extracts 
were incubated with caspase 8 specific substrate Ac-IETD-AMC in the presence or 
absence of caspase 8 specific inhibitor z-IETD-fmk. (b) The protein extracts were 
incubated with caspase 9 specific substrate Ac-LEHD-AFC in the presence or 
absence of caspase 9 specific inhibitor z-LEHD-fmk. The fluorescence intensity of 
A M C or AFC released was measured and the amount was calculated according to the 
standard curve. Data are means of three separate experiments. The folds of change of 
treatments were calculated as relative to the solvent control that is expressed as 1 
fold. Mean marked (*) is significantly (* p < 0.05) higher than the solvent control. 
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4.4 Down-regulation of Anti-apoptotic Bcl-2 Family 
Members of HepG2 Cells by HK18 
It is well known that the Bcl-2 family members play an important role in 
apoptosis. Bcl-2 (homologue to CED-3 of C. elegens) was first identified from B cell 
lymphomas, where chromosomal translocations activate its expression at 
inappropriate high level (Reed, 1997). Overexpression of Bcl-2 has been detected in 
a wide variety of cancer. Actually Bcl-2 family members can be divided into two 
groups as anti-apoptotic such as Bcl-2, B C 1 - X L , Bcl-w and Mcl-l as well as the 
pro-apoptotic such as Bax, Bcl-Xs, Bak, Bid and Bad. These proteins interact with 
each other to form homodimers or heterodimers, which decide the fate of the cells. 
For instant, Bcl-2 can heterodimerize with Bax and their ratio is important for 
apoptosis. In fact, the anti-apoptotic function of Bcl-2 is depend on, at least in part, 
of its ability in interacting with pro-apoptotic members especially Bax and inhibiting 
their apoptotic inducing activities (Reed, 1997). 
Therefore, the protein expression level of Bcl-2 of HKl 8 treated HepG2 
cells was examined. HepG2 cells were treated with 3, 5 and 7 |LIM of HKl 8 for 1 2  
and 24 hours. It was found that HKl 8 inhibited Bcl-2 expression in a dose and time 
dependent manner (Fig 4.15). 
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Fig 4.15 Down-regulation of Bcl-2 expression of HepG2 cells by HK18. HepG2 
cells were treated with 3, 5 and 7 |iM HKl8 for 12 and 24 hours. The protein 
extracted was subjected to Western blot and probed with anti-Bcl-2 antibodies. Lane 
1: medium control, lane 2: 0.014 % D M S O , lanes 3 - 5: 12 hours with 3, 5 or 7 juM 
HKl8, lanes 6-8: 24 hours with 3, 5 or 7 |LIM HK18. Data are from a representative 
of two separate experiments. 
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On the other hand, the R N A levels of bcl-2, bcl-XL and bak genes were 
studied in order to examine the effect of HKl 8 at the transcriptional level. 5 |LIM of 
HKl 8 was used to treat HepG2 cells for 12 and 24 hours. Then total R N A was 
extracted and was subjected to RT-PCR with bcl-2, bcl-XL or bak primers. It was 
found that the amount of bcl-2 m R N A of HKl 8 treated HepG2 cells decreased to 
around 75 % and 80 % of the control for 12 and 24 hours treatments (Fig 4.16). On 
the other hand, the amount of bcl-XL reduced to around 52 % and 68 % of the control 
for 12 and 24 hours treatments. However, it did not affect the transcription of the 
pro-apoptotic gene bak. 
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Fig 4.16 Down-regulation of bcl-2 and bcl-Xt genes transcription of HepG2 cells 
b y H K 1 8 . HepG2 cells were treated with 0.01 % D M S O solvent control or 5 iiM 
HKl8 for 12 or 24 hours. The R N A extracted was subjected to RT-PCR with primers 
of bcl-2, bcl-XL, bak or GADPH. Data are from a representative of two separate 
experiments. 
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5 Mechanistic Study of HK18 on R-HepG2 
Cells 
5.1 Hallmarks of Apoptosis Induced by HK 18 on R-HepG2 
Cells 
It has been found that HKl 8 was cytotoxic to R-HepG2 cells as 
demonstrated by M T T assay and tryphan blue exclusion assay. Thus, emerge of 
apoptosis hallmarks were studied to see whether HKl 8 induces R-HepG2 cell death 
via apoptosis or not. 
5.1.1 Induction of Phosphatidylserine Extemalization by HK18 on 
R-HepG2 Cells 
First of all, extemalization of phosphatidylserine (PS) induced by HKl 8 on 
R-HepG2 cells was measured and quantified by flow cytometry with Annexin V -
FITC and PI staining. In this experiment, 3，5 and 7 jLiM of HKl 8 were used to 
incubate with R-HepG2 cells for 24 hours. The density plot was divided into 4 
quadrants. Cells in the lower left quadrant are viable cells while the cells at lower 
right quadrant are early apoptotic cells. Necrotic and late apoptotic cells are located 
at the upper right quadrant. 
As shown in the density plots of Fig 5.1, the percentage of viable cells 
decreased from 82.8 % to 49.8 %, 29.2 % and 16.4 % upon 3, 5 and 7 ^ iM of HKl 8 
respectively. On the other hand, the percentage of cells at the early apoptotic 
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quadrant increased from 8.6 % to 24.6 %, 44.2 % and 57.7 % upon treatments of 3, 5 
and 7 |LIM of HKl 8 respectively. That was around 2.9 folds, 5 . 1 folds and 6.7 folds of 
the control respectively. A solvent control with 0.014 % D M S O was performed and 
the resulted density plot was similar to the control. Besides, 2 mg/ml digitonin was 
used as positive control and large proportion of cells were located at the necrotic / 
late apoptotic quadrant. 
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Fig 5.1 Induction of phosphatidylserine extemalization by HK18 on R-HepG2 
cells. 2 X 10^ cells / ml of R-HepG2 were seeded into a 6 well plate and 3, 5 and 7 
I^M of HKl 8 were added to incubate for 24 hours. After treatment, cells were 
collected and loaded with Annexin V-FITC and PI for staining and followed by flow 
cytometric analysis. 20mg / ml digitonin was added to act as positive control, (a) 
Control, (b) 0.014 % D M S O . (c) 20 mg/ml digitonin. (d) 3 jiM HKl 8. (e) 5 ^ M 
HKl 8. (f) 7 |iM HKl 8. Data are from a representative of four separate experiments. 
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5.1.2 Induction of DNA Fragmentation by HK18 on R-HepG2 Cells 
Moreover, the D N A of HK18 treated R-HepG2 cells were extracted and 
subjected to gel electrophoresis to check the occurrence of D N A fragmentation. 
R-HepG2 cells were incubated with various concentrations of HKl 8 as 1, 3，5, 7 and 
10 |iM for 24 hours. Samples without HKl 8 and with 0.02 % D M S O were used as 
medium control and solvent control respectively. After 24 hours incubation, D N A 
ladder developed in the cells treated with 3, 5, 7 and 10 jaM of HKl 8 but not in the 
control cells, solvent control cells and cells treated with 1 |iM of HKl8 (Fig 5.2). 
This indicated that HKl8 could induce D N A fragmentation at the concentrations 
above 3 _ after 24 hours incubation. 
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Fig 5.2 Induction of DNA fragmentation in HK18 treated R-HepG2 cells. 
2 X 105 cells / ml of R-HepG2 cells were seeded into a 6 well plate and various 
concentrations of HKl 8 were added for 24 hours incubation. After treatments, cells 
were collected and D N A was extracted and subjected to gel electrophoresis. Lane 1: 
100 base pairs marker. Lane 2: Medium control. Lanes 3-7: 1, 3, 5, 7 and 10 [iM of 
HK18. Lane 8: 0.02 % D M S O solvent control Data are from a representative of five 
separate experiments. 
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5.2 Study of the Underlying Mechanisms of HK18 Induced 
Apoptosis in R-HepG2 Cells 
As HKl 8 could induce PS extemalization as well as D N A fragmentation, it 
seems that HKl 8 could induce R-HepG2 cells to undergo apoptosis. Therefore, the 
mechanisms of how HKl 8 induce R-HepG2 cells to undergo apoptosis were studied 
in the following sections. 
5.2.1 The Role of Mitochondria in HK18 Induced Apoptosis of 
R-HepG2 Cells 
5.2.1.1 HK18 Induced Mitochondrial Membrane Depolarization in R-HepG2 
Cells 
First of all, the effect of HKl 8 on the mitochondrial membrane potential (W 
m) of R-HepG2 cells was studied. In this experiment, R-HepG2 cells were treated 
with 3, 5 and 7 |LIM of HKl 8 for 1 2 and 24 hours. After treatment, the cells were 
collected and loaded with JC-1 dye for flow cytometric analysis. The results were 
shown in Fig 5.3. The density plot was divided into two regions. Cells which fell in 
the region R2 were those with collapsed ¥ m . The percentage of cells in R1 
increased from 14.3 % of control to 26.3 %, 30.8 % and 35.8 % of 3, 5 and 7 ^ M for 
12 hours incubation of HKl 8 respectively. There were around 1.8 folds, 2.2 folds and 
2.5 folds of the control. The percentage of cells in R2 further increased to 31.9 %, 
32.1 % and 57.4 % of 3, 5 and 7 |iM for 24 hours incubation of HKl 8 respectively, 
which were about 2.2 folds, 2.2 folds and 4 folds of the control. Thus, HKl 8 could 
induce mitochondrial membrane depolarization in a concentration and time 
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dependent manner. 
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Fig 5.3 Induction of mitochondrial membrane potential depolarization in HK18 
treated R-Hep2 cells. 2 x 10^ cells / ml were seeded into a 6 well plate and various 
concentrations of HKl 8 were added for 24 and 48 hours incubation. After treatments, 
cells were loaded with JC-1 and fluorescence intensity was recorded by flow 
cytometry, (a) and (b) control and 0.014 % D M S O solvent control, (c) 500 n M 
valinomycin as positive control, (d)-(f) 3, 5 and 7 p M H K 18 for 24 hr incubation. 
(g)-(i) 3, 5 and 7 juM of HKl 8 for 48 hr incubation. Data are from a representative of 
four separate experiments. 
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5.2.1.2 Addition of Bongkrekic Acid Reduced HK18 Cytotoxicity on R-HepG2 
Cells 
To see whether M P T involve in HKl 8 induced R-HepG2 cells death, 
Bongkrekic acid (BA) was added to treat R-HepG2 cells with HKl8. In this 
experiment, R-HepG2 cells were incubated with 5 |LIM HKl 8 with or without 25 [iM 
B A for 24 hours. Then M T T assay was performed to obtain the percentage survival. 
As shown in Fig 5.4, HKl8 induced about 85 % cell death in R-HepG2 cells. 
However, in the presence of 25 |LIM B A , the percentage of survival aroused to around 
50 % of the control and it was significantly higher (p< 0.001) than that under 5 jiiM 
HKl 8 treatment. 
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Fig 5.4 Addition of Bongkrekic acid (BA) reduced HK18 cytotoxicity on 
R-HepG2 cells. 2 x 10^  cells / ml ofR-HepG2 cells were seeded to a 96 well plate. 
5 [iM of HKl 8 was added in the presence or absence of 25 |LIM B A . After 24 hours, 
M T T 
assay was performed to obtain the percentage of survival. Percentage of 
survival was calculated as relative to the control that is expressed as 100 %. The 
mean marked with (*) indicated the value is significantly higher (*p< 0.001) than the 
value in cells under 5 jiiM HKl 8. 
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5.2.1.3 Elevation of Intracellular Hydrogen Peroxide Level in HKl 8 Treated 
R-HepG2 Cells 
The intracellular hydrogen peroxide (H2O2) level of HKl 8-treated R-HepG2 
cells was then studied. R-HepG2 cells were treated with 5 |LIM HKl 8 for 12 and 2 4  
hours and were then loaded with DCF which detects the intracellular H2O2 level. 
Flow cytometric analysis was then performed and the change of DCF fluorescence 
intensity (the fluorescence peak shift to right hand side implied cells having higher 
intracellular H2O2 level and vice versa) was recorded and plotted as histogram. The 
results were shown in Fig 5.5, and the marker M l showed the cells with higher 
fluorescence intensity. After 12 and 24 hours, R-HepG2 cells included in M l region 
increased from the basal level of control 8 % to 43.8 % and 34.3 % respectively 
which is around 5.5 folds and 4.3 folds of the control. The fluorescence intensity of 
the 0.01 % D M S O solvent control coincided with the control. 
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Fig 5.5 Intrace l lu lar n：^)： level of R - l k p ( ; 2 cells w a s e n h a n c e d by IIK18. 
2 X cells / ml of R-}lcpG2 cells were seeded into a 6 well plate with 5 |.iM of 
I IK 18 for 12 or 24 hours incubation. A tier treatments, cells were collcclcd and 
loaded with DCF. The marker M l showed ihc pcrccntagc o f cells with higher I ) ( ,F 
inlcnsily, which rctlcctcd cells wiih higher inlraccllular IhO： level, (a) Histogram 
plotting control against 0.01 % D M S O sohem control, (b) Histogram plotting control 
against 5 ^ M o f H K l 8 for 1 2 hours, (c) Histogram plotting control against 5 ^.Vl o f 
H K l 8 for 24 hours, (d) I he lablc summarizes the pcrccntagc ( " cells in M 1 region. 
Data arc from a representative o f three separate experiments. 
- 1 4 5 -
Chapter 5 Mechanistic Study of HKl 8 on R-HepG2 Cells 
5.2.1.4 Elevation of Intracellular Ca^ ^ Level in HK18 Treated R-HepG2 Cells 
Moreover, the change of intracellular Ca^^ level of R-HepG2 cells upon 
HKl8 was studied. R-HepG2 cells were treated with 5 juM of HKl 8 for 12 and 24 
hours and were then loaded with Fluo-3. Flow cytometric analysis was carried out 
and the alternation of fluorescence intensity was recorded. Cells with higher 
fluorescence intensity indicated higher intracellular Ca^ "^  level and were appeared as 
a shift of the fluorescence peak into right hand side of the histogram. As observed in 
Fig 5.6, cells having higher fluorescent intensity (as indicated by M l region) 
increased from 8.5 % of control to 31.5 % and 23.1 % of 12 and 24 hours treatments, 
which were around 3.7 folds and 2.7 folds of the control. The fluorescence peak of 
the 0.01 % D M S O solvent control coincided with the control. Besides, a positive 
control with 40 [ig/m\ ionomycin was performed and most of the cells fell in M l 
region. 
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Treatn^ent � % of Ml 
Control 8.46 
0.01% D M S O 7.13 
12hr 5uM 31.46 
24hr 5uM 23.12 
4Qug/ml Ionomycin 97.28 
Fig 5.6 Intracellular Ca^ ^ level of R-HepG2 cells was enhanced by HK18. 
2 X 10^ cells / ml of R-HepG2 cells were seeded into a 6 well plate and 5 jiiM of 
HKl 8 was added for 12 and 24 hours incubation. After treatment, cells were 
collected and loaded with Fluo-3. The marker M l showed the percentage of cells 
with higher Fluo-3 intensity, which reflected cells with higher intracellular Ca^^ level. 
(a) Histogram plotting control against 0.01% D M S O solvent control. 
(b) Histogram plotting control against the positive control (40 |ig / ml Ionomycin). 
(c) Histogram plotting control against 5 ^ M of HKl 8 for 12 hours, (d) Histogram 
plotting control against 5 ^ iM of HKl 8 for 24 hours, (e) The table summarizes the 
percentage of cells within M l region. Data are from a representative of four separate 
experiments. 
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5.3 Downstream Biochemical Changes Induced by HKl 8 on 
R-HepG2 Cells 
5.3.1 Activation of Caspase 3 of R-HepG2 Cells by HK18 as 
Demonstrated by Western Blot 
The activity of HKl 8 on the activation of caspase 3 of R-HepG2 cells was 
analyzed by Western blot. R-HepG2 cells were treated with 3，5 and 7 jiM of HKl 8 
for 24 hours. As shown in Fig 5.7 a, HKl8 activated caspase 3 in a dose dependent 
manner as the pro-caspase 3 level (35 kDa) decreased when the concentrations of 
HKl 8 increased. 
Furthermore, the protein level of PARP was also elucidated. Fig 5.7 b 
indicated that HKl 8 induced the cleavage of PARP in a dose dependent manner. The 
protein level of intact PARP (116 kDa) decreased with the cleaved PARP fragment 
(85 kDa) increased when the concentration of HKl 8 increased. 
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Fig 5.7 Activation of caspase 3 and induction of PARP cleavage by HKl8 on 
R-HepG2 cells. R-HepG2 cells were treated with various concentrations of HKl 8 
for 24 hours and were then subjected to Western analysis, (a) Probed with 
anti-pro-caspase 3 (35 kDa) antibodies, (b) Probed with anti-PARP (116 kDa for 
intact PARP and 85 kDa for cleaved PARP) antibodies. Data are from a 
representative of three separate experiments. 
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5.3.2 Induction of Caspases Activation of R-HepG2 Cells by HK18 as 
Demonstrated by Enzymatic Activity Assays 
Caspases enzymatic activities were then analyzed in H K l 8 treated R-HepG2 
cells. R-HepG2 cells were treated with 5 |iM H K l 8 for 12 and 24 hours, then total 
protein was extracted. After that the protein samples were incubated with caspase 3 
specific substrate that had been conjugated with fluorescent A M C . Cleavage of the 
substrate Ac-DEVD-AMC will release the fluorescent A M C which can be measured 
by fluorescence spectrometer. Amount of A M C being released is directly 
proportional to the activity of caspase 3 present in the protein extract. 
It was found that caspase 3 activity has been enhanced by HKl 8 as shown in 
Fig 5.8. The caspase activities of medium control and 0.01 % D M S O solvent control 
were similar. However, in the presence of HKl8，the caspase activity was 8.6 folds 
and 3.6 folds of the solvent control for 12 and 24 hours incubation. To check whether 
the increment was due to the enhanced caspase activity, caspase 3 specific inhibitor 
z-DEVD-fmk was added. In the presence of z-DEVD-fmk, the amount of A M C 
released was prohibited. 
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Fig 5.8 Caspase 3 enzymatic activity of R-HepG2 cells was enhanced by HKl8. 
2 X 10^ cells / ml of R-HepG2 cells were seeded into 75 cm〗 flasks and medium, 
0.01 % D M S O control or 5 [iM of HKl 8 was added for 12 or 24 hours incubation. 
After treatment, cells were collected and lysed. The protein extract were incubated 
with caspase-3 specific substrate Ac-DEVD-AMC in the presence or absence of 
caspase-3 specific inhibitor z-DEVD-fmk. The fluorescence intensity of A M C 
released was measured and the amount was calculated according to the standard 
curve. Data are means of three separate experiments. The folds of change of 
treatments were calculated as relative to the solvent control that is expressed as 1 
fold. Mean marked with (*) is significantly (* p < 0.05) higher than the solvent 
control. 
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Besides, the enzymatic activities of caspase 8 and 9 were also examined. To 
measure caspase 8 activity, caspase 8 specific substrate conjugated with fluorescent 
A M C Ac-IETD-AMC was used. The amount of A M C being released is directly 
proportional to the activity of caspase 8. And the caspase 8 specific inhibitor 
z-EETD-fmk was used for verification. As shown in Fig 5.9 a, there were no 
significant different between the control, 0.01 % D M S O solvent control and 5 |iM of 
HKl 8 for 12 hours incubation. However, the caspase 8 activity was reduced in cells 
under 5 \xM HKl 8 for 24 hours incubation. 
On the other hand, for measuring the enzymatic activity of caspase 9, 
caspase 9 specific substrate conjugated with fluorescent A F C Ac-LEHD-AFC was 
used. The amount of fluorescent AFC being released was directly proportional to the 
activity of caspase 9. Caspase 9 specific inhibitor z-LEHD-fmk was used for 
verification. As illustrated in Fig 5.9 b, the caspase 9 activity was enhanced which 
was around 2.05 folds of the solvent control for 12 hours treatment. However, the 
activity after 24 hours treatment was lower than the solvent control. 
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Fig 5.9 Caspase 9 enzymatic activity of R-HepG2 cells was enhanced by HK18 
but not caspase 8. 2 x 10^ cells / ml of R-HepG2 cells were seeded into 75 cm^ 
flasks and medium, 0 . 0 1 % D M S O control or 5 | l i M of HKl 8 was added for 1 2 or 2 4  
hours incubation. After treatment, cells were collected and lysed. (a) The protein 
extract were incubated with caspase 8 specific substrate Ac-IETD-AMC in the 
presence or absence of caspase 8 specific inhibitor z-IETD-fmk. (b) The protein 
extract were incubated with caspase 9 specific substrate Ac-LEHD-AFC in the 
presence or absence of caspase 9 specific inhibitor z-LEHD-fmk. The fluorescence 
intensity of A M C or AFC released was measured and the amount was calculated 
according to the standard curve. Data are means of three separate experiments. The 
folds of change of treatments were calculated as relative to the solvent control that is 
expressed as 1 fold. 
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5.4 Down-regulation of the Anti-apoptotic Bcl-2 Protein of 
R-HepG2 Cells by HK18 
The effect of HKl 8 on the Bcl-2 protein expression of R-HepG2 cells was 
studied. R-HepG2 cells were treated with 3，5 and 7 juM of HKl8 for 12 and 24 
hours. The Bcl-2 level decreased as concentrations of HKl 8 increased. Thus HKl 8 
could lower the Bcl-2 level in a concentration and time dependent manner as 
illustrated in Fig 5.10. 
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Fig 5.10 Down-regulation of Bcl-2 expression of R-HepG2 by HK18. 
R-HepG2 cells were treated with 3, 5 and 7 |liM HKl 8 for 1 2 and 24 hours. The 
protein extracted was subjected to Western blot and probe with anti-Bcl-2 antibodies. 
Bcl-2 is a 25 kDa protein. Data are from a representative of two separate 
experiments. 
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5.5 HK18 Was Not a Substrate of P-glycoprotein 
R-HepG2 cells were derived from HepG2 cells with the addition of D O X as 
mentioned in the chapter of Materials and Methods. Overexpression of 
p-glycoprotein (P-gp) and its encoding gene MDR-1 were proven by Western Blot 
and Northern Blot. In order to sustain the expression of P-gp, the presence of its 
substrates such as D O X , vincristine and other multidrug resistant substances is 
required. For the R-HepG2 cells, 1.2 |LIM of D O X is added to culture the cells to 
maintain the expression of P-gp (Chan et aL, 2000). Since HKl8 was cytotoxic to 
R-HepG2 with a dosage much lower than D O X (2.5 j i M of HKl8 vs 68 |LIM of 
DOX), it seems that HKl 8 is not a substrate of P-gp. 
In view of this, HKl 8 was used to treat R-HepG2 cells for a month and the 
expression of P-gp was examined in a time course manner. Along with HKl 8, 
R-HepG2 cells were treated with D O X or vincristine or without D O X . The results 
were shown in Fig 5.11, it showed that the P-gp level was substantially high within 
the period of treatment in the presence of D O X or vincristine as compared to the 
level of HepG2 cells. On the other hand, the P-gp level decreased gradually for 
treating with HKl 8 or withdrawal of D O X . 
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Fig 5.11 HKl8 was not a substrate of P-glycoprotein. RHepG2 cells were cultured 
in the absence of D O X or in the presence of 1.2 |iM of HKl 8 or vincristine for 28 
days. Protein was extracted every 7 days to check the expression of P-glycoprotein. 
Proteins of HepG2 and R-HepG2 cells, which were being maintained in 1.2 |iM 
D O X , were extracted for comparison. 
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6. Discussion 
6.1 Cytotoxicity of HK18 
6.1.1 HKl8 was Cytotoxic to the Human Hepatocellular Carcinoma 
Cell Line HepG2 and Multidrug Resistant Human Hepatocellular 
Carcinoma Cell Line R-HepG2 
First of all, the cytotoxicities of HKl 8 on the human hepatocellular 
carcinoma cell line HepG2 and its derivative, the multidrug resistant cell line 
R-HepG2 were studied. R-HepG2 cells were derived from HepG2 cells by prolong 
culturing HepG2 cells in the presence of stepwise increased concentrations of 
Doxorubicin (DOX), one of the multidrug resistant compounds. After a period of 
time, the cells have gained to over-express P-gp, which actively pumps out a series 
of intracellular anti-tumor drugs and hence forbids the accumulation of the drugs. 
The overexpression of P-gp in R-HepG2 cells were assessed by Western Blot to 
examine the protein expression level and assessed by Northern Blot to examine the 
transcriptional level of the MDR-1 gene, which encoded the P-gp (Chan et al., 2000). 
It is well known that multidrug resistance has posed a great barrier in anti-tumor 
treatments, thus it is of value to invest on the exploitation of new anti-tumor agents， 
which can kill multidrug resistance cancer cells. 
By the aid of M T T assay and tryphan blue exclusion assay, HKl8 have 
found to exhibit cytotoxic effect in both HepG2 (Fig. 3.1 and 3.2) and R-HepG2 cell 
lines (Fig. 3.3 and 3.4) in a concentration and time dependent manner. The IC50 of 
HKl8 obtained from M T T assay on HepG2 cells and R-HepG2 cells were 3.5 j^M 
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and 2.5 for 24 and 48 hours treatment respectively. And it was found that HKl8 
has a comparable IC50 with D O X on HepG2 cells (4.5 )LIM and 1 \xM for 24 and 48 
hours treatments) (Fig 3.1) and far more potent on R-HepG2 cells (IC50 of D O X : > 
250 |LIM and 68 |LIM for 24 and 48 hours treatments) (Fig 3.3). 
6.1.2 Study of the Toxicity of HK18 
Apart from HepG2 and R-HepG2 cells, the cytotoxicity of HKl 8 was 
examined on the primary cell macrophages ( M O ) in order to study the toxic effect of 
HKl8 on normal cells. 2.5 ^ M and 5 \xM of HKl8 was used to treat M O for 48 
hours. It have been found that 2.5 jiM of HKl 8 induce around 10 % cell death on 
M O while around 50 % cell death on HepG2 and R-HepG2 cells (Fig 3.5). On the 
other hand, 5 [iM of HKl8 induce around 30 % cell death on M O and around 80 % 
on HepG2 as well as R-HepG2 cells. Thus, HKl 8 exerted more potent cytotoxic 
effects on the two tumor cell lines than on the normal cell, at least M O . Pilot studies 
in our laboratory also demonstrated that HKl8 is non-toxic to the lung fibroblast cell 
line, WI-38 (data not shown). 
Since induction of hemolysis is a common feature of saponins, the 
hemolytic ability of HKl 8 was checked. It has been found that HKl 8 could induce 
hemolysis in high concentrations. The percentage of hemolysis for 3.5 |LIM and 10 
\iM was only around 3 % and 7 % respectively (Fig 3.6). 
The toxic effect of HKl 8 on normal tissues was further studied by in vivo 
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study. 342 |ig /kg (equivalent to 5 jiM final concentration) of HKl 8 was 
administered to mouse via intravenous injection for every alternative days for 2 
weeks. The liver and heart tissue enzymatic levels (AST and ALT for liver and C K 
and L D H for heart) were then monitored. And it has shown that there was no 
elevation of neither one of the enzymes (Fig 3.7 and 3.8). 
6.2 Mechanistic Studies of the Cytotoxic Effects of HKl8 on 
HepG2 Cells 
6.2.1 Apoptotic Cell Death Induction of HKl8 on HepG2 Cells 
As shown by M T T and tryphan blue exclusion assays, HKl 8 has found to 
induce cell death of HepG2 cells. The death mode of HepG2 cells was then examined 
by phosphatidylserine (PS) extemalization assay and D N A fragmentation assays, 
which are the frequently used biochemical assays for detection of apoptosis. 
Phospholipids distributed across the plasma membrane asymmetrically, 
with phosphatidylcholine and sphingomyelin localized primarily in the extracellular 
surface while PS and phosphatidylethanolamine restricted almost exclusively to the 
intracellular surface under physiological conditions (Stryer, 1995). Upon apoptosis, 
the PS will flip from inner membrane into outer membrane, which is an important 
biochemical change for the removal of the dying cells by macrophages to prevent 
inflammation. PI is a D N A intercalating dye. It cannot get access to D N A in intact 
cells. However, it can stain the D N A of necrotic and late apoptotic cells since their 
plasma membrane was disrupted. Therefore, in the combination of PS flipping and 
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plasma membrane disruption, one can distinguish between viable, early apoptotic 
and necrotic / late apoptotic cells (Spactor et al” 1998). 
D N A fragmentation is another prevalent apoptotic biochemical changes 
(although not found in all apoptotic cells). During apoptosis, the activated caspases 
will activate endonuclease, which cleave D N A in the linker region between 
nucleosomes to produce oligonucleosomal D N A fragments. The D N A fragments can 
be detected as multiples of 180 - 200 bp and can be demonstrated as a ladder 
appearance upon gel electrophoresis. Results shown that HKl 8 induced PS 
extemalization in a dose dependent maimer for 24 hours treatment (Fig 4.2) and 
D N A fragmentation in a time dependent manner for 24 and 48 hours treatments (Fig 
4.3). 
6.2.2 Studies of the Underlying Mechanisms of HK18 Induced 
Apoptosis of HepG2 Cells 
There were two main apoptotic pathways. One of them involved the death 
receptor and ligand binding. Binding of ligand molecules to the death receptors will 
induce cluster of the death domains of receptors. An adaptor protein FADD 
(Fas-associated death domain) then binds to the clustered receptor death domain via 
the death domain of the FADD. FADD also contain a death effector domain (DED), 
which then interact with the D E D of pro-caspase 8. More than one molecules of 
pro-caspase 8 are being recruited to the death receptors. Such induced proximity of 
the pro-caspase will lead to auto-activation of pro-caspase 8 into catalytically active 
caspase 8 which then participate in apoptosis and activate pro-caspase 3 (Ashkenazi 
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and Dixit, 1998; Hengartner, 2000). 
Mitochondria are involved in another apoptotic pathways. It is well known 
that mitochondria are responsible to produce energy for maintaining life of cells for a 
long history. However, recent discoveries have found that mitochondria also play an 
active role in apoptosis. In the mitochondrial dependent apoptotic pathway, a variety 
of apoptotic triggers such as oxidants and Ca^^ converge to mitochondria. This will 
lead to mitochondrial permeability transition (MPT) due to the opening of the M P T 
pore complex. The precise structure and components of the M P T pore complex is 
still under investigation. However, several components are believed to be involved. 
They are voltage dependent anion channel (VADC) (i.e. porin) located in the outer 
mitochondrial membrane; adenine nucleotide translocator (ANT) located in the inner 
mitochondrial membrane; peripheral benzodiazepin receptor located in the outer 
mitochondrial membrane; creatine kinase located in intermembrane space; 
cyclophilin D located in the matrix and attached to ANT; hexokinase located in the 
cytosolic face of outer mitochondrial membrane and attached to V D A C as well as the 
Bcl-2 family members including Bcl-2 and Bax (Fig 4.4) (Arced, 2000; Kroemer 
and Reed, 2000). Opening of the M P T pores will allow small solutes (<1.5 kDa) 
diffuse out from mitochondria into cytosol non-specifically. Mitochondrial 
membrane potential ( W m ) depolarization usually accompanied with M P T (Arced, 
2000; Kroemer and Reed, 2000; Crompton, 1999; Lemasters et al., 1998). 
The opening of M P T pores can be measured directly by confocal 
fluorescence microscopy (Halestrap，1999). Calcein, a neutral green fluorophore will 
retain in cytosol when loaded to a normal viable cell. While tetramethylrhodamine 
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methylester (TMRM), a cationic red fluorophore will accumulate in negatively 
charged mitochondria. As a result, the viable cell will appear as red fluorescence dots 
(mitochondria) against green fluorescence background (cytosol). During MPT, M P T 
pore opening allow the entry of calcein into mitochondria and leakage of red 
fluorescence from the potential difference dissipated mitochondria and hence red 
dots disappear (Halestrap, 1999). 
There are several well known conditions, which are able to induce MPT. 
They are oxidative stress, high intracellular calcium concentration, low ATP, high 
ADP, high pH and mitochondrial membrane potential depolarization (Lemasters et 
al., 1998; Crompton, 1999). On the other hand, onset of M P T can be inhibited by 
M P T inhibitor. The widely used M P T inhibitors are cyclosporin A (CsA) and 
Bongrekrekic acid (BA). By the aid of these inhibitors, the role of M P T in apoptosis 
can be studied. CsA is a ligand of cyclophilin D, one of the components of M P T pore 
complex. Binding of CsA wilf induce conformational change of the cyclophilin D 
and inhibit its binding with the M P T pore complex and hence M P T is being inhibited. 
The inhibitory activity of B A is through another mechanism. B A is a ligand of the 
ANT, another component of M P T pore complex. Its binding will stabilize the A N T 
in a conformation that is unable to participate in M P T pore opening (Crompton, 1999; 
Zamzami et al., 1996; Marchetti et aL, 1996). 
Onset of M P T will lead to release of mitochondrial intermembrane 
apoptogenic proteins. However, how the release of these apoptogenic proteins takes 
place is controversial. One hypothesis is that opening of M P T pores allows water and 
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sucrose influx into matrix and hence causes matrix swelling. Since the inner 
mitochondrial membrane is highly folded so its surface area is greater then the outer 
membrane. Upon matrix swelling, inner mitochondrial membrane expanding will 
disrupt the outer membrane physically. Consequently, apoptogenic proteins will leak 
out from the boundary of outer membrane into cytosol and elicit apoptosis (Arced, 
2000; Kroemer and Reed, 2000; Crompton, 1999; Lemasters et al., 1998). 
Another hypothesis involves the participation of Bcl-2 family proteins. It 
has been found that the three dimensional structure of B C 1 - X L is similar to the pore 
forming bacterial toxin (Muchmore et al., 1996). Thus it is thought that Bcl-2 family 
members may form pores in the mitochondrial outer membrane. The pro-apoptotic 
member Bax may oligomerize and insert into outer mitochondrial membrane to form 
ion-conducting channels or it may interact with V D A C to form large channels. 
Therefore, proteins can pass through the membrane freely (Gottlieb, 2000). 
Up to now, several apoptogenic proteins have been found to release from 
mitochondria during mitochondria-dependent apoptosis. These include cytochrome c, 
apoptosis inducing factor (AIF), adenylate kinase-2 and Smac/DIABLO (Loeffler 
and Kroemer, 2000; Kohler et al., 1999; Verhagen et a l , 2000; Du et al” 2000; 
Scarlett and Murphy, 1997). Release of these proteins into cytosol will induce 
cellular catabolic destruction. 
Smac (second mitochondria-derived activator of caspase) or also called as 
DIABLO (direct LAP binding protein with low pi) is a novel discovered apoptogenic 
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protein. They are released from mitochondria during apoptosis to promote caspase 9 
activaion by binding to the lAPs (inhibitor of apoptosis proteins) (Verhagen et al” 
2000; Du et al., 2000). lAPs are inhibitors of caspase 3, 7 and 9 (Shi, 2002). 
Activated caspase 9 will expose its LAP-binding domain and hence lAP can bind and 
inhibit its enzymatic activities. The binding of LAP will further degrade the activated 
caspase 9 and hence apoptotic catabolic changes are inhibited. Therefore, lAPs must 
be removed for ensuring the caspase 9 activities (Wang, 2001). Smac / DIABLO is 
responsible for removing the lAPs by binding with them (Verhagen et al., 2000; Du 
et al., 2000; Zimmermann et al., 2001; de Murcia et al., 1997). 
Cytochrome c is a 15 kDa protein which is involved in the electron transport 
chain for energy production. It is one of the apoptogenic proteins being released from 
mitochondria during apoptosis and they are important in the activation of procaspase 
9 (Liu et al., 1996; Yang and Cortopassi, 1998). Cytochrome c is bound to the inner 
membrane by anionic phospholipids, primarily cardiolipin. Actually, there are two 
pools of cytochrome c. The small pool (accounted for around 10 - 15 %) located at 
the mitochondrial intermembrane space via electrostatic interaction between the 
positively charged lysine residues of cytochrome c and negatively charged phosphate 
groups of cardiolipin (Bemardi et al., 1999; Ott et al., 2002; Shen et al., 2001). The 
large pool is tightly bound to the inner membrane via hydrophobic interaction with 
the cardiolipin (Ott et al., 2002). The loosely bound small pool will be released when 
ionic strength or pH change. For releasing the tightly bound pool, oxidation of the 
mitochondrial membrane especially the cardiolipin is needed (Shidoji et al., 1999; 
Ott et a l , 2002). 
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AIF (apoptosis inducing factor) is a 57 kDa flavoprotein which being 
released from mitochondria during apoptosis. It can induce large scale D N A 
fragmentation, PS extemalization and ¥ m depolarization in a caspase independent 
manner (Susin et al., 1996; Susin et al., 1999; Loeffler et aL, 2001; Daugas et al., 
2000). 
Studies have found that some saponins such as the saponins isolated from 
Acacia victoriae could induce apoptotic cell death via mitochondrial dependent 
pathway. Thus, the involvement of mitochondria in HKl 8 induced apoptosis of 
HepG2 cells was studied. 
From the result, incubation of HKl 8 with HepG2 cells induced 
mitochondrial membrane depolarization in a dose and time dependent manner (Fig 
4.5). M P T always induce W m depolarization, however not all W m depolarizations 
are caused by M P T (Lemasters et aL, 1998). Thus, the occurrence of M P T was 
further studied by the addition of M P T inhibitor BA. As shown in Fig 4.6, addition 
of B A could reduce the cytotoxicity of HKl 8 on HepG2 cells. Since B A is an 
inhibitor of MPT, it is obvious that M P T is pivotal to HKl 8 induced HepG2 cells 
apoptotic cell death. 
As mentioned above, onset of M P T leads to apoptogenic proteins release 
from mitochondria although the releasing mechanism is still uncertain. The release of 
apoptogenic proteins were examined for HKl8 treated HepG2 cells. It has been 
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found that HKl 8 could induce cytochrome c release (Fig 4.11). The amount of 
cytochrome c released at 12 hours treatment was smaller than 24 hours treatment. 
This might due to the cytochrome c released at 12 hours treatment was come from 
the loosely bound small pool cytochrome c. While at 24 hours treatment, the tightly 
bound large pool of cytochrome c also being released. In such mode of cytochrome c 
release, the ATP production via the electron transport chain might be allowed. Since 
it is well known that ATP is needed for the catabolic degradation during apoptosis, 
maintenance of ATP production is important. On the other hand, the release of AIF 
was also studied in HKl 8 treated HepG2 cells. As observed in Fig 4.11, AIF was 
induced to release for 24 hours treatment. 
There are several M T P inducers so far identified such as mild oxidative 
I  
stress, increase of intracellular Ca level, reduced ATP level, and elevated pH 
(Crompton, 1999; Lemasters et al., 1998). Among them, oxidative stress and 
^ I 
elevated Ca are most important and under intensive studies. 
Although it has been found that apoptotic cell death can be carried out in 
anaerobic conditions, more studies provide evidences that ROS play an important 
role in the induction of apoptosis. It has been found that exposure of cells with 
oxidizing agents such as hydrogen peroxide and 胁"Butylhydroperoxide would 
induce apoptotic cell death (Lemasters et al., 1998). Moreover, it has been found that 
increase of intracellular ROS production was observed in apoptotic cell death 
induced by non-oxidative agents such as ionizing radiation and chemotherapeutic 
drugs (Chandra et al., 2000; Hampton et al., 1998). For example, addition of 
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selenium, an essential trace element with potent chemopreventive effect against 
cancer, to HepG2 cells would elicit intracellular R O S production followed by 
cytochrome c release, ¥ m depolarization, caspase 3 activation and D N A 
fragmentation (Shen et al., 2001). Another example was etoposide induced apoptosis. 
Etoposide is a semisynthetic derivative of podophyllotoxin and is an anti-tumor agent 
used currently in treating a variety of hematopoietic and solid tumor. Etoposide has 
been found to induce apoptosis by interacting directly with macromolecular targets 
or by generating ROS. And its cytotoxicity has been reported to mediate by 
mitochondria including cytochrome c release, W m depolarization, M P T and caspase 
3 and 9 activation as well (Custodio et al., 2002). Moreover, it has been found that 
the apoptotic inducing activities of these agents could be blocked by the addition of 
anti-oxidants A^ -acetylcysteine (NAC) (Shen et al., 2001; Custodio et al., 2002) and 
glutathione (Custodio et al., 2002). Therefore, ROS seems to play an important role 
in apoptosis, though may not in all cases. 
The mechanisms of how ROS induce apoptosis are still under investigation. 
But there were evidences that ROS induce apoptosis by acting on the M P T pore 
complex (Costantini et a l , 1996). It has been found that there was a cysteine residue 
in the A N T (one of the component of M P T pore complex), which is sensitive to 
oxidizing stress. Oxidation of this cysteine residue will lead to thiol cross-link 
between A N T molecules. The resulted A N T dimer would induce M P T pore opening 
(Costantini et al., 2000a). Besides, ROS will cause elevation of intracellular Ca 
level. The enhanced Ca^^ level can either come from extracellular space or internal 
I 
stores. It has been found that ROS could act on the Na / Ca exchanger which 
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normally exclude Ca^^ from cytosol into extracellular space or organelles. However, 
R O S could reverse the action of the exchanger to pump Ca^^ into cytosol instead 
(Suzuki et al, 1997). Moreover, ROS would oxidize mitochondrial pyridine 
nucleotides NAD(P)H which would stimulate the release of Ca^ "^  from mitochondria 
(Suzuki et al., 1997; Chakraborti et a l , 1999). The enhanced cytosolic Ca2+ level 
• 2+ 
would then activate Ca dependent catabolic enzymes such as proteases and 
endonucleases (Chakraborti et aL, 1999; McConkey and Orrenius, 1997). Besides, 
Ca2+ is also an inducer of M P T with unknown mechanism (Kroemer and Reed, 2000). 
Moreover, ROS may also activate nuclear transcriptional factors such as NF /c B, 
AP-1 and p53 which may up-regulate death proteins or produce inhibitors of survival 
proteins (Suzuki et al., 1997; Chandra et aL, 2000). 
On the other hand, besides serving as the inducer of M P T and apoptosis, 
ROS also has found to be the consequence of MPT. It is because during MPT, W m 
usually collapsed. Thus oxidative phosphorylation was uncoupled and the electron 
transport chain was disturbed. As a result, ROS production increases especially when 
cytochrome c was being released from mitochondria. Thus, they form a positive 
amplification feedback loop between ROS production and M P T (Costantini et al., 
2000b). 
In view of the apoptosis and M P T inducing activities of ROS and Ca^^, the 
participation of them were investigated in this research project. HepG2 cells were 
treated with HKl 8 for 12 and 24 hours and followed by flow cytometric analysis to 
measure the intracellular H2O2 and Ca^ "^  level. It has been found that HKl 8 enhanced 
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intracellular H2O2 in a time dependent manner (Fig 4.7). Since ROS level is related 
to the occurrence of MPT, the intracellular H2O2 level was further measured with 
¥ m simultaneously. As shown in Fig 4.8, HKl8 could induce elevation of 
intracellular H2O2 level with collapsed W m simultaneously in a time dependent 
manner. 
Apart from measuring intracellular H2O2 level, intracellular Ca^^ level was 
also examined. It has been found that HKl 8 could enhance intracellular Ca^ "^  level 
(Fig 4.9). However, the increment was not in a time dependent manner. It may be due 
to the optimal Ca release was reached at 12 hours treatment; further longer 
treatment period did not affect the Ca^^ level anymore. Similarly, intracellular Ca^^ 
level was examined with ¥ m simultaneously. As shown in Fig 4.10, HKl 8 
enhanced intracellular Ca level with decreased W m . And the increment at 12 and 
24 hours were more or less the same. 
It is well known that the Bcl-2 family proteins play an important role in 
apoptosis. Bcl-2 (homologue to CED-3 of C. elegans) was first identified from B cell 
lymphomas, where chromosomal translocations activate its expression at 
inappropriate high level (Reed, 1997). Bcl-2 family members can be divided into two 
groups as anti-apoptotic such as Bcl-2, BC1-XL, Bcl-w and Mcl-l as well as the 
pro-apoptotic such as Bax, Bcl-Xs, Bak, Bid and Bad. The locations of the Bcl-2 
family members vary from cytosol to intracellular compartments including nucleus, 
endoplasmic recticulum and mitochondria. In non-apoptotic normal cells, 
anti-apoptotic members including Bcl-2 and BC1-XL are localized at the 
- 1 7 1 -
Chapter 6 Discussion 
mitochondrial outer membrane while most of the pro-apoptotic members such as Bax 
and Bid are localized in cytosol. Upon apoptotic stimuli, they will redistribute in the 
cells. For example, the pro-apoptotic members including Bax and Bid will 
translocate to mitochondria to interact with the anti-apoptotic members or exert their 
effect on the mitochondria directly. There were evidences that Bax is able to form 
oligomer across the mitochondria membrane to form a non-specific pores, which has 
been proposed to be responsible for apoptogenic proteins release from mitochondria 
during apoptosis (Muchmore et al., 1996; Gottlieb, 2000). 
The Bcl-2 family members of HKl 8 treated HepG2 cells were studied. First 
of all, the protein expression level of the anti-apoptotic Bcl-2 was examined by 
Western blot analysis. It has been found that treating HepG2 cells with HKl 8 for 12 
and 24 hours would suppress the Bcl-2 protein level in a dose and time dependent 
manner (Fig 4.15). The gene transcriptions of the bcl-2 family members were further 
investigated by RT-PCR. It has been found that treating HepG2 cells with HKl 8 for 
12 and 24 hours would suppress the m R N A level of the anti-apoptotic bcl-2 and 
bcl-XL. However, there was no change in the m R N A level of the pro-apoptotic bak. 
The suppression of HKl8 on the m R N A of bcl-2 and bcl-XL was not in a time 
dependent manner as to the protein expression did. This may be due to the effect of 
HKl8 on transcription was optimal at 12 hours but not on the translation level. 
Studies of development in the nematode Caenorhabtidis elegans (C elegans) 
have led to the discovery of genes whose function is critical for programmed cell 
death. There are three pivotal apoptotic genes: ced-3, ced-4 and ced-9, which encode 
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the proteins CED-3, CED-4 and CED. It was found that mutation of ced-3 and ced-4 
would result in cell survival and differentiation even the cells should be removed 
normally (Ellis and Horvitz, 1986; Yuan and Horvitz, 1990). The ced-3 gene was 
cloned and was found to be similar to the interleukin-1 /3 -converting enzyme of 
mammals. And it has been found that the C E D protein acts as a cysteine protease to 
initiate programmed cell death in C. elegans (Yuan et al., 1993). Later, It was found 
that CED-4 physically interacts with both CED-3 and CED-9 to form a multiple 
protein complex (Chinnaiyan et al., 1997; Irmler et al., 1997). Upon binding with 
CED-4 in the presence of dATP / ATP, CED-3 will be activated and its activity is 
critical for cells to undergo apoptosis. On the other hand, binding of CED-9 to the 
complex would inhibit apoptosis (Seiffert et al., 2002; Hengartner, 1999). 
Since apoptosis is an evolutionarily conserved biochemical process, 
understanding of the apoptotic processes of C. elegans helps to learn and infer how 
the apoptotic processes work in mammalian cells. It has been found that mammals 
have counteipartners of the three apoptotic related proteins of C. elegans. The 
mammalian interleukin-1 -converting enzyme proteases or also known as caspases 
are homologous to the CED-3 protein (Yuan et al., 1993). Besides the mammalian 
apoptotic protease activating factors -1 (Apaf-1) is homologous to the CED-4 
(Hengartner, 1999) and the anti-apoptotic bcl-2 protein is homologous to the CED-9 
(Chinnaiyan et al., 1997; Spector et al., 1997). Although human shares some of the 
apoptotic mechanisms with the C. elegans, the apoptotic mechanisms of human are 
much more complicated. 
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Up to now, 14 mammalian caspases have been identified and 7 of them have 
found to participate in apoptosis while the remaining are involved in inflammation 
(Shi, 2002). They share similarities in amino acid sequence, structure and substrate 
specificity (Eamshaw et al., 1999). Actually apoptotic caspases can be divided into 
two categories, initiator caspases including caspase 2, 8, 9 and 10 as well as the 
effector caspases including caspase 3, 6 and 7. All caspases are synthesized as 
catalytically inactive precursor zymogens with three major domains: N-terminal 
prodomain, large subunit containing the active site and C-terminal small subunit. The 
prodomain varies in length and sequence, which is important in distinguish between 
initiator and effector caspases. Usually initiator caspases consist of a long prodomain 
and contain a sequence that promotes their interaction with activator molecules, 
either caspase recruitment domain (CARD) present in caspase 2 and 9 as well as the 
death effector domain (DED) present in caspase 8 and 10 (Zimmermann et al., 2001; 
Shi, 2002; Eamshaw et al.，1999). 
For converting the zymogens into the active caspases, two proteolytic 
clevages are required. The first clevage divides the zymogen into large and small 
subunits while the second clevage aimed to remove the prodomain. An active 
caspase is a tertramer of two large and two small subunits with two active sites 
(Eamshaw et al., 1999). Activation of initiator caspases is mediated by several 
activator molecules, which subsequently lead to auto-activation of the initiator 
caspases via induced proximity. There are two major mechanisms for activating 
initiator caspases. One of them involves death receptor and another involves 
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mitochondria. As mentioned above, the activation of procaspae 8 requires the 
participation of death receptor, ligand of death receptor, F A D D and several 
procaspase 8 molecules. (Ashkenazi and Dixit, 1998; Hengartner, 2000). 
On the other hand, for the mitochondria dependent apoptosis, activation of 
procaspase 9 requires the formation of apoptosome. Apoptosome is formed by the 
interaction of apoptotic protease activating factors -1 (Apaf-1), cytochrome c and 
pro-caspase 9 in the presence dATP / ATP (Liu et a l , 1996). Apaf-1 is a 130 kDa 
protein which contains a C A R D sequence (Li et al., 1997). On binding with dATP / 
ATP (dATP is prefer over ATP for 1000 folds) (Li et al., 1997)，the Apaf-1 undergo 
conformational change which then allow cytochrome c binding. ATP hydrolysis is 
required since binding of non-hydrolysable ATP- j would completely abolish the 
binding of cytochrome c (Li et al” 1997; Hu et al., 1999). Binding of cytochrome c 
induces further conformational change. This allows oligomerization of Apaf-1 
molecules and causes the exposure of C A R D of Apaf-1. As a result, procaspase-9 
molecules are recruited to the complex via C A R D - C A R D interaction to form 
apoptosome. The induced proximity of the pro-caspase 9 molecules leads to its 
auto-activation into catalytically active caspase 9 (Hu et al., 1999; Srinivasula et a l , 
1998; Li et al., 1997; Cai et al., 1998). After that, pro-caspase 3 will be recruited to 
the apoptosome and is being activated by the activated caspase 9 (Hu et al., 1999). 
Activated caspase 3 will then cause proteolytic cleavage of a series of substrates, 
which will then lead to the biochemical and morphological changes observed in 
apoptosis (Zimmermann et al., 2001; Shi, 2002). 
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Actually, the apoptotic pathways mediated by death receptor and 
mitochondria can be cross-linked. It has been found that activated caspase 8 will 
cleave the cytosolic pro-apoptotic Bid. The truncated Bid will then translocate to 
mitochondria and induce cytochrome c release and subsequently apoptosome 
formation (Hengartner, 2000; Engels et al., 2000; Gottlieb, 2000). By such 
mechanism, the apoptotic responses induced by caspase 8 will be amplified. 
It is well known that caspases are the effector molecules. Their activities are 
critical for the occurrence of apoptotic biochemical alternations. It is particularly true 
for caspase 3. Caspase 3 is the most abundant caspase inside cells. No matter which 
apoptotic pathways is induced by the apoptosis inducing agent, the final destination 
usually directed to the activation of pro-caspase 3 (Zimmermann et al., 2001). The 
activated caspase 3 will then act on a wide array of substrates which responsible for 
the catabolic degradation of cells. For example, murine caspase-activated DNase 
(CAD) (i.e. D N A fragmentation factor, DFF of human) is activated by caspase 3. 
C A D is synthesized in the complex with its inhibitor ICAD (inhibitor of CAD). 
Activated caspase 3 in apoptotic cells will act on the complex to release the ICAD 
and hence restore the endonuclease activity of C A D (Nagata, 2000). 
There are numerous caspase substrates including structural components 
(such as actin and nuclear lamin), proteins involved in D N A metabolism and repair 
(such as DNA-depedent protein kinase and poly(ADP-ribose) polymerase) and 
inhibitors of deoxyribonuclease (such as caspase-activated DNase) etc. 
(Zimmermann et al., 2001; Eamshaw et al., 1999). Caspases are specific proteases, 
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which recognize at least four contiguous amino acids and cleave after the C-terminal 
of an Aspartic acid residue only. Each caspase recognize a specific amino acid 
sequence. Such substrate specific property can make use for study the caspase 
activity. By the aid of fluorescence or chromogen conjugated artificially constructed 
amino acids sequence, which consist the substrate recognition site, the activity of the 
caspase can be studied. The fluorescence or chromogen intensity is directly 
proportional to the caspase activity (Mack et al., 2000). 
The caspases activating activities of HKl 8 on HepG2 cells were studied. 
First of all, the protein expression level of caspase 3 was studied by Western blot 
analysis. As shown in Fig 4.12, incubation of HepG2 cells with HKl 8 reduced the 
protein level of pro-caspase 3 in a dose and time dependent manner. The reduced 
pro-caspase 3 was supposed to be converted into active caspase 3. It was then 
confirmed by examine the substrate of active caspase 3, PARR It was found that the 
intact PARP decreased while the fragmented PARP increased when the concentration 
of HKl 8 increased (Fig 4.12). 
The caspases activities were then examined by measuring their enzymatic 
activities. Caspase 3, caspase 8 and caspase 9 specific substrates were used. The 
substrates were conjugated with fluorescent materials. Upon cleavage by the caspase, 
the fluorescent material will be released which can be measured by fluorescent 
spectrometer. The fluorescence intensity is directly proportional to the caspase 
activity. It has been found that HKl 8 could induce the activities of caspase 3 of 
HepG2 cells in a time dependent manner (Fig 4.13). HKl 8 also induce the enzymatic 
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activity of caspase 9 of HepG2 under 12 hour and 24 hours treatments (Fig 4.14), 
however the activation was not time dependent. The activity of caspase 9 at 24 hours 
was slightly lower than 12 hours treatment. This may due to the caspase 9 activity 
was optimal at 12 hours. As mentioned above, active caspase 9 will activate 
pro-caspase 3, which is pivotal for the apoptotic degradation. Once procaspase 3 
have been activated, the cell will undergo apoptotic degradation. Thus, apoptosis 
might also occur even the activity of caspase 9 decreased in longer time treatment. 
Furthermore, the effect of HKl 8 on the activity of caspase 8 was also examined. It 
has been found that the activity of caspase 8 remained unchange upon 12 hours 
HKl 8 treatment (Fig 4.14). Thus, activation of caspase 8 seems not involved in the 
apoptotic pathway of HKl 8 induced cell death. The caspase 8 activity decreased 
after 24 hours treatment. This may because at that treatment period, large proportion 
of the cells died out and hence the intracellular enzymes lost their activities and even 
lower than the basal level. The enzymatic activities of caspase 3 and caspase 9 might 
also being affected. 
Summarize of the above results, it can be concluded that HKl 8 could induce 
HepG2 cells to undergo apoptosis. M P T was induced by HKl 8, which may be due to 
the elevated intracellular ROS and Ca^^ levels. The anti-apoptotic protein Bcl-2 and 
B C 1 - X L were reduced by H K L 8 . Apoptogenic proteins cytochrome c and AIF were 
released from mitochondria while the release of Smac remained to be elucidated. 
Cytochrome c released would then interact with Apaf-1 and pro-caspase 9 to form 
apoptosome. This leaded to pro-caspase 9 activation and subsequent pro-caspase 3 
activation. The activated caspases would then activate an array of substrates, which 
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contributed to catabolic degradation of HepG2 cells. D N A fragmentation and PS 
extemalization were resulted. Fig 6.1 summarizes the possible action mechanisms of 
HKl 8 exerting on HepG2 cells. 
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Fig 6.1 Summary of the possible action mechanisms ofHKlS exerted on HepG2 
cells. 
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6.3 Mechanistic Studies of the Cytotoxic Effects of HKl 8 on 
R-HepG2 Cells 
6.3.1 Apoptotic Cell Death Induction of HKl8 on R-HepG2 Cells 
Similar to the study of HepG2 cells, the cell death mode of H K l 8 on 
R-HepG2 cells was examined by PS extemalization and D N A fragmentation. It has 
been found that treating R-HepG2 cells with H K l 8 could induce PS extemalization 
in a dose dependent manner (Fig 5.1). Besides, as shown in Fig 5.2, HKl8 could 
induce D N A fragmentation on R-HepG2 cells after 24 hours treatment. By these two 
typical apoptotic cell death assays, H K l 8 has been proven to induce apoptosis in 
R-HepG2 cells. 
6.3.2 Studies of the Underlying Mechanisms of HK18 Induced 
Apoptosis of R-HepG2 Cells 
After proving the apoptotic inducing activities of H K l 8 on R-HepG2 cells, 
the underlying mechanisms of how H K l 8 induces apoptosis on R-HepG2 cells were 
investigated. First of all, the MPT-inducing activity of H K l 8 was examined. As 
mentioned before, M P T usually accompanied with mitochondrial membrane (IFm) 
depolarization, hence the alternation of ¥ m by HKl8 on R-HepG2 cells was 
measured by flow cytometric analysis. The results were recorded in Fig 5.3. Treating 
R-HepG2 cells with HKl8 for 12 and 24 hours would induce ¥ m in a dose and time 
dependent manner. The occurrence of M P T in HKl 8 treated R-HepG2 cells were 
further examined by the addition of M P T inhibitor BA. It has been found that in the 
presence of BA，the cytotoxic effect of HKl 8 on R-HepG2 cells was diminished (Fig 
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5.4). Therefore, the apoptotic inducing activities of HKl8 on R-HepG2 cells have 
been shown to be mediated by MPT. 
Recently, there were numerous studies reported that elevated intracellular 
R O S and Ca2+ levels were two of the inducers of M P T onset. Thus, the intracellular 
H2O2 and Ca2+ levels of HKl 8 treated R-HepG2 cells were measured. It has been 
found that the intracellular H2O2 was elevated upon the treatment of HKl 8 (Fig 5.5). 
However, dissimilar to the case in HepG2 cells, the elevation of H2O2 in R-HepG2 
cells was not in a dose dependent manner. The level of H2O2 at 12 hours treatment 
was higher than the 24 hours treatment. Similar results were observed in studying the 
intracellular Ca2+ level. It has been found that HKl 8 could enhance intracellular Ca2+ 
level (Fig 5.6). However, the enhancement at 12 hours treatment was greater than 24 
hours treatment. The possible reason of this phenomenon may be due to the 
production or release of these two mediators to induce M P T was optimal at 12 hours 
already. And the intracellular levels of them leveled off and decreased afterwards. 
As mentioned above, apoptosis and M P T were governed by the Bcl-2 family 
members. Thus, the involvement of Bcl-2 protein was examined in HKl 8 treated 
R-HepG2 cells by Western blot analysis. Bcl-2 is an anti-apoptotic protein, 
down-regulation of this protein will flavor apoptotic cell death. It has been found that 
treating with HKl 8 for 12 and 24 hours, the protein level of Bcl-2 in R-HepG2 cells 
decreased in a concentration and time dependent manner (Fig 5.10). 
As discussed in the previous paragraphs, pro-caspase 9 is being activated in 
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mitochondrial dependent apoptosis pathway. Activation of pro-caspase 9 requires the 
association of apoptosome, which comprised of Apaf-1, pro-caspase 9, cytochrome c 
and dATP. Formation of apoptosome will lead to the induced proximity of 
pro-caspase 9 molecules and hence auto-activation into enzymatic active caspase 9 is 
resulted. The activated caspase 9 will then bind and activate pro-caspase 3 into the 
enzymatic active form. The activated caspase 3 will then act on a variety of 
substrates and eventually leads to apoptotic biochemical alternations. 
In view of this, the caspases activating activities of HKl 8 was studied. The 
activation of caspase 3 was first demonstrated by Western blot analysis. As observed 
from the film (Fig 5.7), treating R-HepG2 cells with HKl8 for 24 hours would lower 
the protein level of pro-caspase 3. The diminished pro-caspase 3 should be converted 
into the active caspase 3. It was confirmed by analyzing with the protein level of 
PARR It has been found that HKl8 reduced the intact PARP level while enhanced 
the level of cleaved PARP fragment (Fig 5.7). 
Besides of Western blot analysis, the enzymatic activity of caspase 3 was 
measured by its substrate cleaving activity. From Fig 5.8, it shows that treating 
R-HepG2 cells for 12 hours and 24 hours with HKl 8 would enhance its enzymatic 
activity. However, the activities at 12 hours was higher than at 24 hours. This might 
due to the optimal activity might have been reach at 12 hours. Another possible 
reason was that at 24 hours treatment, large proportion of the cells died out and hence 
their enzymes lost their activities. Similar results were obtained in measuring the 
enzymatic activity of caspase 9. The activity of caspase 9 increased upon 12 hours 
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HKl 8 treatment and returned to basal level (Fig 5.9 b). 
Apart from caspase 3 and 9, the enzymatic activity of caspase 8 was also 
assessed. It has been found that treating R-HepG2 cells with H K l 8 for 12 hours did 
not change the enzymatic activity of caspase 8 hence, caspase 8 had not been 
activated by HKl8 (Fig 5.9). Similarly, the activity of caspase 8 at 24 hours was 
lower than the basal level, which might due to dissipation of enzymatic activities in 
death cells. 
R-HepG2 cells are multidrug resistant cells with the over-expression of 
P-glycoprotein (P-gp). P-gp is a 170 kDa trans- plasma membrane protein that is 
glycosylated at a single site at the extracellular face. It belongs to the A B C 
(ATP-binding cassette) transpoters superfamily. Human P-gp (MDR-1) is a 1280 
amino acids protein arranged into two homolgous halves with each contains 6 
transmembrane domains and an ATP-binding domain (Jones and George, 1998). It is 
encoded by the MDR-1 gene, which is located on chromosome 7 (Di Pietro et al,, 
1999). They actively expel a variety of drugs differing in structures and action 
mechanisms in the expense of ATP. As a result, they prevent the accumulation of 
drugs inside the cell and hence the cell is free from the action of the drug. For instant, 
cells with overexpressed P-gp are resistant to doxorubicin, vincristine and 
methotrexate etc. that kill cells through different action mechanisms. P-gp 
transverses the plasma membrane to form pores. The diameter of the pore of hamster 
is around 5nm (Rosenberg et al., 1997). The pore size of the P-gp in human is still 
under elucidation. But the recent findings reported that the pore diameter of human 
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P-gp is between 9 n m to 25 n m (Loo and Clarke, 2001). 
For sustain the expression of P-gp on cell membrane, its substrates must be 
added for culturing. The substrate of P-gp varies in structure and action mechanisms, 
so it is difficult to generalize the characteristics of its substrates. However, recent 
studies found that there are several common properties among its substrate, they are 
hydrophobic, usually possess cationic charge (Szachowicz-Petelska et al., 2001) 
(since the P-gp has a negatively charged hydrophobic cavity) and at least 2 planar 
rings. Fig 6.2 shows several well known substrates of P-gp. Therefore, according to 
the present knowledge, for an agent to be bound and then pumped out by P-gp, it 
should be (1) cationic charged (2) hydrophobic and (3) 3 dimensional structure 
smaller than the pore size of P-gp. As illustrated in Fig 6.2, the popular substrates of 
P-gp usually possess amine group(s). They usually become protonized in tumor cells, 
where glycolysis is preferred for energy production. As a result, these substrates 
(drugs) usually bear positive charge(s) in the cells and hence easily to be bound and 
pumped out by P-gp. In comparison of the structure of H K l 8 (Fig 1.5) with those 
well-known substrates, H K l 8 does not possess any amine group and hence should be 
neutral inside tumor cells. Although the 3 dimensional structure of H K l 8 was still 
unclear，we speculated that H K l 8 is not a substrate of P-gp since it is a neutral 
molecule. 
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Fig 6.2 Structures of three substrates of P-gp. (a) Doxorubicin with M.W. 543.54. 
(b) Methotrexate with M.W. 454.46. (c) Vincrisine with M.W. 824.94. 
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R-HepG2 cells used in our experiments have over-expressed P-gp, which 
have been proven by Western blot and Northern blot analysis (Chan et al., 2000). 
Since they have over-expression of P-gp, the IC50 of them toward D O X is much 
higher than their parental cells HepG2 (> 250 jiM and 68 )iM of R-HepG2 cells vs 
4 . 5 |LIM and 1 juM of HepG2 cells for 24 and 48 hours respectively). However, HKl 8 
have shown to have similar IC50 towards both HepG2 and R-HepG2 cells. 
Furthermore, HKl 8 is a neutral molecule, thus we proposed that HKl 8 should not a 
substrate of P-gp as it could keep away from the pumping effect of P-gp. To examine 
this hypothesis, R-HepG2 cells were cultured in the presence of HKl 8 and then the 
protein expression level of P-gp was measured. R-HepG2 cultured in the presence of 
vincristine (one of the P-gp substrate) was used as a positive control. Besides, 
R-HepG2 cells were cultured with the withdrawal of D O X . In the absence of D O X , 
the P-gp level would decrease gradually. As shown in Fig 5.11, the P-gp expression 
level of vincristine-cultured R-HepG2 cells remained high throughout the study 
period. While the P-gp expression level ofR-HepG2 cells in the presence of HKl 8 or 
absence of D O X decreased gradually. Therefore, HKl 8 is not a substrate of P-gp and 
hence could exert its effects on multidrug resistance cells. 
As a summary, HKl 8 could induce R-HepG2 cells to undergo apoptosis. 
M P T was induced by HKl 8, which may be due to the elevated intracellular ROS and 
2+ 
Ca levels. It could reduce the expression of the anti-apoptotic Bcl-2 protein. 
However, the release of apoptogenic proteins such as cytochrome c，AIF and Smac 
remained to elucidate. It has been found that HKl 8 could induce caspase 9 activation, 
which might then lead to procaspase 3 activation. The activated caspases would then 
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activate an array of substrates, which contributed to catabolic degradation of HepG2 
cells. D N A fragmentation and PS extemalization were resulted. Furthermore, it has 
been found that HKl 8 was not a substrate of P-glycoprotein and thus it could induce 
apoptotic cell death in P-gp overexpressed R-HepG2 cells. Fig 6.3 summarized the 
possible action mechanisms of HKl 8 exerting on R-HepG2 cells. 
- 1 8 8 -
Chapter 6 Discussion 
Death R e c c ^   
X y ^ w W A ’ Pro-caspase 8 
—i 
AIF ‘ T Cytoc 1 
Smac jdATP / ATP 
Apaf-1 / cyto c 
j Pro-caspae 9 
J L Apoptosome: 
[Caspase 9 / Apaf-1/ cyto c 
• jjjy^ ^ Pro-caspase 3 
fragmentation C a ^ a s e 3 
\ V Apoptotic cell death j 
^ F S " 
Fig 6.3 Summary of the possible action mechanisms of HK18 exerted of 
R-HepG2 cells. 
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In the coming future, there are several directions that we can further study 
on HKl8. First of all, the involvement of other anti-apoptotic and pro-apoptotic 
Bcl-2 family proteins in HKl 8 induced apoptotic cell death of HepG2 cells and 
R-HepG2 cells can be elucidated. Also, the release of other apoptogenic proteins 
such as Smac can be examined. 
Moreover, as demonstrated in this research project, 
mitochondrial-dependent apoptotic pathway was involved in HKl 8 induced 
apoptosis in HepG2 cells and R-HepG2 cells. However, we do not know how HKl 8 
exert its effect on the mitochondrion. It may either enter into the cells and act on 
mitochondria directly or trigger intracellular mediators which then converge to 
mitochondria. To elucidate these possibilities, cell-free systems can be used 
(Costantini et aL, 2000). Mitochondria can be isolated from HepG2 and R-HepG2 
cells and then treated with HKl8. After that, alternation of mitochondria can be 
monitored (e.g. measuring of mitochondrial membrane potential) to see does HKl 8 
have direct effect on mitochondria. To further elucidate the release of apoptogenic 
proteins from mitochondria, the supernatant of the treated mitochondria can be 
mixed with nuclei purified from normal cells. The apoptogenic proteins will provoke 
apoptotic changes of nuclei such as chromatin condensation and D N A degradation. 
Alternatively, the supernatant of treated mitochondria can be mixed with cytosol 
form normal cells. The apoptogenic proteins present will induce pro-caspases 
activation, which can be measured by their enzymatic activities. On the other hand, if 
HKl 8 does not exert direct effect on mitochondria, it seems that it may first trigger 
mediators and then act on mitochondria. This route can be studied by first treating 
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cells with HKl8 and the cytosol was collected. The cytosol, which contains 
apoptosis mediators, can then add to mitochondria isolated from normal cells. The 
alternation of mitochondria can be monitored. 
Besides the usage of cell-free systems, we would like to conjugate HKl 8 
with fluorescent label. By these labeled HKl 8, the route of how HKl 8 act on the 
cells can be traced. 
Furthermore, the structure of HKl 8 can be modified in order to enhance its 
solubility (it is insoluble in water) and promote its anti-tumor potencies. 
Moreover, the dimensions of HKl 8 can be elucidated by X-ray 
crystallography. Thus we can see does HKl 8 can pass through the pore of 
P-glycoprotein. If its dimensions is greater then the pore size which has been 
proposed to be 9 - 25 nm (Szachowicz-Petelska et aL, 2001), then HKl 8 will not be 
a substrate of P-glycoprotien as it cannot pass through the pore. 
Apart from these, the anti-tumor activities of HKl8 on HepG2 and 
R-HepG2 cells with in vivo model can be carried out. The pilot study of the 
anti-tumor activity of HKl 8 on HepG2 tumor bearing nude mice showed that 
administration of 860 |Lig of HKl 8 per kg of mice via intravenously injection every 
alternate day (equivalent to 12.5 jiiM concentration) could cause a 70 % reduction of 
tumor weight after 3 weeks treatment (data not shown). If sufficient HKl8 can be 
organic synthesized, we will repeat the in vivo experiments in future. 
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